[
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "NADH脫氫酶可以以下列邊一個輔酶或者輔基為受氫體",
    "llm_output": "The correct answer is **B. NAD+**\n\nHere's why:\n\n* **NADH dehydrogenase** (also known as Complex I) is the enzyme responsible for catalyzing the oxidation of NADH to **NAD+**. This is the key step in the electron transport chain, where electrons are removed from NADH and passed along to the electron carriers, ultimately contributing to ATP production. \n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', 'FAD'], ['B', 'NAD+'], ['C', 'FMN'], ['D', 'CoQ']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺酶促反應中，決定反應特異性嘅係",
    "llm_output": "B. 酶\n\n**解釋：**\n\n* **NAD+ 和 C類結構**\n\n**分析：**\n\n酶促反應嘅特異性由酶蛋白本身決定，而非其他選項。\n\n* **酶促反應的机制** 决定反应的**特异性**，而并非酶的**活性**。\n\n**答案：**\n\nThe answer to the question is **B. 酶蛋白**.\n\n* **NADH** 係一種**还原剂**，它在细胞呼吸中扮演重要角色，将电子传递给细胞内的其他分子，从而参与能量的产生。\n\n* **辅酶**，如**C** (coenzyme) 和 **CoQ** (coenzyme Q)，是帮助酶进行反应的辅助分子，但它们不决定酶的反应特异性。\n\n* **CoQ** (coenzyme Q) 是一個**氧化還原反應**中參與電子傳遞的分子，而非一個直接决定酶的**反应**的**因素**。\n\n* 因此，决定酶促反应特异性的因素是酶本身的结构，也就是 **酶蛋白**。\n\n**關於大學醫學題目**\n\n大學醫學專業的課程通常會涉及到各種生物學概念，包括酶的結構和功能，以及它們如何與疾病相關聯。大學醫學題目需要結合醫學知識和生物學知識來解答，因此答案是 **B. 酵素**。\n\n**解释：**\n\n* **酶** (enzymes) 係一種生物催化劑，可以加速生物化學反應。\n\n* **酶的结构** 决定酶的活性位點形状和化学性质，从而决定它能催化哪些特定的反应。\n\n* 因此，答案：**酶的活性** \n \n **注意：**\n\n* 酵素**的**结构**决定其功能**，包括其**在** 不同环境下**的**活性**。\n\n* 虽然**C** 类和 **D** 选项中提到了**酶**，但它们並非决定酶的**反应**的**因素**。\n\n**总结：**\n\n大学生物化学课程中学习的**酶的结构与功能**的概念，可以帮助我们理解为什么**B. 酶的結構** 是一个**错误**的答案。\n\n**正确答案：**\n\n* **C. 右側的结构** 决定了其**反应**的**特異性**。\n\n**C** 选项中提到的**「右側胸腔」** 可能是指**胸部** 的**右側**，但**大学生物化学** 课程更关注的是**特定酶的结构和功能**，以及它们如何**与大学生物化学中的其他概念** 相关联。\n\n因此，答案是**C. 酵素的結構**。",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '輔酶'], ['B', '酶蛋白'], ['C', '無機離子'], ['D', '溶液PH']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺腦內，NH3嘅主要儲存同運輸形式係",
    "llm_output": "B \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '尿素'], ['B', '谷氨醯胺'], ['C', '天冬氨酸'], ['D', '丙氨酸']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "丙二酸對琥珀酸脫氫酶嘅抑制作用屬於",
    "llm_output": "答案：A. 非競爭性抑制作用\n\n**解釋：**\n\n非競爭性抑制作用 (Non-competitive inhibition) 是一種酶的抑制方式，其中抑制劑與酶的活性位點不同，而是與酶的 **其他** 位點結合，從而改變酶的形状，使其无法与底物结合。\n\n**其他选项解释：**\n\n* **B. 竞争性抑制剂 (Competitive inhibitor)** 是一种与酶的活性位點竞争的抑制剂。\n* **C. 非競爭性抑制作用 (Non-competitive inhibition)** 与选项B不同，选项C指的是 **非竞争性抑制** 的一种特性，而非抑制剂的类型。\n* **D. 非竞争性抑制剂 (Non-competitive inhibitor)** 是对 **丙二酸** 的描述，而不是一種與其相關的特定体徵。\n\n**因此，A. 非競爭性抑制劑 (Non-competitive inhibition) 是正确答案。** \n\n**注意：**\n\n* **A. 竞争性抑制剂 (Competitive inhibitor)** 是一种酶抑制机制，它會與酶的活性位點結合，阻止酶與其 **底物** 竞争。\n* **B. 抑制劑 (Inhibitor)** 通常指 **与酶的活性位点竞争的物质**，例如与酶结合的 **药物** 或 **分子**。\n* **C. 竞争性抑制** 是指 **酶的活性位点被抑制劑結合**，阻止酶与其 **底物** 结合，而非指一個特定的非競爭性抑制劑。\n\n希望這個解釋能幫助你理解為什麼答案是 A. \n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '非競爭性抑制作用'], ['B', '反競爭性抑制作用'], ['C', '非特異性抑制作用'], ['D', '競爭性抑制作用']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血液中嘅膽紅素主要運輸形式係",
    "llm_output": "A. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '膽紅素-Z蛋白'], ['B', '膽紅素-Y蛋白'], ['C', '葡糖醛酸-膽紅素'], ['D', '膽紅素-清蛋白']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "炎症介質嘅主要作用係使",
    "llm_output": "The correct answer is **D. 血管擴張通透性增強 (D. Non-competitive inhibition)**\n\n**Explanation:**\n\n* **Competitive inhibition** occurs when a molecule similar in structure to the substrate binds to the active site of the enzyme, preventing the substrate from binding.\n\n* **Non-competitive inhibition** occurs when a molecule binds to a site on the enzyme other than the active site, causing a change in the enzyme's shape and reducing its activity.\n\n* **Non-competitive inhibition** is a type of enzyme inhibition where the inhibitor binds to a site other than the active site, changing the enzyme's shape and making it less effective.\n\n* **Urea** is a waste product that is transported in the blood.\n\n* **Urea** is a **competitive inhibitor** of the enzyme **urease**.\n\nTherefore, the answer to the question is **D. 血管擴張通透性增加 (D. Increased permeability of blood vessels)**\n\n**Why?**\n\nThe question asks about the \"main\" effect of a substance on the interstitial fluid.  Let's break down the options:\n\n* **A. Increased permeability of blood vessels:** This is the correct answer.  Inflammation is characterized by increased permeability of blood vessels, allowing immune cells and other fluids to leak into the affected tissue.\n\n* **B. Non-competitive inhibition:** This is a type of enzyme inhibition, not a direct effect of the permeability of the blood vessel itself.\n\n* **C. 尿素 (Urea)**: This is a substance that is transported in the blood, but not the same as the one in the question.\n\n* **D. Non-competitive inhibition:** This is a type of enzyme inhibition, but the question is asking about the \"main\" effect of the substance, not the mechanism of its action.\n\nLet me know if you'd like to see more examples!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '組織間液滲透壓增高'], ['B', '組織分解代謝增強'], ['C', '局部氫離子濃度增高'], ['D', '血管擴張通透性增加']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "鳥氨酸循環嘅重要意義係",
    "llm_output": "A. 促进氨基酸的合成",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '解除氨毒'], ['B', '合成尿素'], ['C', '促進氨嘅轉運'], ['D', '促進氨基酸脫氨基']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於糖嘅有氧氧化，下述邊一項係錯嘅",
    "llm_output": "The answer is **B**. \n\nHere's why:\n\n* **A. 葡萄糖氧化成CO2及H2O時可以生成12分子ATP** - This is **incorrect**. While the complete oxidation of glucose through cellular respiration can yield up to 38 ATP molecules, the process of glycolysis itself is not the only way cells obtain energy from glucose.\n\nLet's break down why the other options are **correct**:\n\n* **A. 氧氣不足會導致乳酸生成** - This is **correct**.  The process of converting pyruvate to lactate (lactic acid) is a key part of anaerobic fermentation, which is a pathway for producing energy when oxygen is limited.\n\n* **D. 血管擴張通透性增加** - This is a **correct** answer.  \n\nLet's discuss why **A is incorrect** and **what is the correct answer**:\n\n* **A. 血液中嘅三大營養物** is a **correct** answer.\n\n* **A. 細胞外環境嘅酸度增加** - This is a **correct** answer. The breakdown of pyruvate to lactate in anaerobic conditions leads to the buildup of lactic acid, which can lower the pH of the cell's environment.\n\n* **A. 氧氣-蛋白質** is a **correct** answer.\n\nLet me know if you'd like to know more about the process of cellular respiration or other metabolic pathways.\n\n**The correct answer to the question is D. 血管擴張通透性增加**\n\nThis is because the question asks for the \"main\" function of glucose in the context of the cellular response to inflammation. \n\n**Why D is correct:**\n\n* **Glucose** is a key fuel source for cells, and its metabolism is central to cellular respiration.\n\n**Why D is incorrect:**\n\n* **Option A. 氧氣** (oxygen) is a **component** of the process of cellular respiration, but it's not the only way glucose is transported in the body.\n\n**The correct answer** to the question should be **\"A. 氧氣不足\"** (lack of oxygen)\n\n* **The answer is A. 氧氣不足**\n\n**Why A is correct:**\n\n* **\"A. 氧氣不足\"** means \"lack of oxygen\" in Chinese. This directly relates to the process of aerobic respiration, which is the process of breaking down glucose in the presence of oxygen to produce energy.\n\n**A. 氧氣** (oxygen) **is not the correct answer** because it focuses on the lack of oxygen, not the specific process of **transporting** glucose.\n\nLet me know if you'd like to know more about the process of cellular respiration.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '葡萄糖氧化成CO2及H2O時可以生成12分子ATP'], ['B', '有氧氧化可以抑制糖酵解'], ['C', '三羧酸循環係三大營養物互變嘅途徑'], ['D', '糖有氧氧化係細胞獲得能量嘅主要方式']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種維生素，參與構成轉氨酶嘅輔酶",
    "llm_output": "The correct answer is **C. VitB12**.\n\nHere's why:\n\n* **Vitamin B2 (riboflavin)** is a precursor to **FAD (flavin adenine dinucleotide)**, a coenzyme involved in many cellular reactions, but not specifically the citric acid cycle.\n* **Vitamin A, B1, B2, and B6** are involved in various metabolic processes, but not all of them are directly involved in the citric acid cycle.\n\nLet me know if you'd like to know more about the specific role of vitamin B12 (as a component of the citric acid cycle enzyme, **methylmalonyl-CoA mutase**) in cellular processes. \n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'VitB2'], ['B', 'VitB1'], ['C', 'VitB12'], ['D', 'VitB6']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "大葉性肺炎嘅併發症，錯誤嘅係",
    "llm_output": "The correct answer is **A. 肺膿胸 (lung abscess)**\n\nHere's why:\n\n* **肺膿胸 (lung abscess)** is a serious complication of pneumonia, but it's not a typical complication of **大葉性肺炎 (lobar pneumonia)** specifically.  Lobar pneumonia usually involves the entire lobe of the lung, while a lung abscess is a localized collection of pus.\n\nThe other options are all potential complications of lobar pneumonia:\n\n* **B. 肺膿胸 (lung abscess)** is a localized collection of pus within the lung tissue.\n* **C. 肺積液 (pulmonary edema)** is a condition where fluid builds up in the lungs, often a complication of pneumonia.\n* **D. 肺部感染** (pulmonary infection) is a general term for an infection in the lung tissue, which is a common feature of lobar pneumonia.**\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '肺膿腫'], ['B', '肺肉質變'], ['C', '肺褐色硬變'], ['D', '膿胸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "輔酶NADP+分子中含有下列邊種B族維生素",
    "llm_output": "The answer is **A. 煙酰胺**.\n\nHere's why:\n\n* **輔酶NADP+** (NADP+ is a coenzyme) is a form of niacin (**維生素B3**) that plays a crucial role in cellular processes. \n\nLet me know if you'd like to know more about the different metabolic pathways involved in inflammation and the role of NADP+. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '煙酰胺'], ['B', '核黃素'], ['C', '葉酸'], ['D', '吡哆醛']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於抑癌基因嘅敘述，正確嘅係",
    "llm_output": "The correct answer is **B. 具有抑制細胞過度增殖嘅作用**\n\nHere's why:\n\n* **Tumor suppressor genes** are genes that regulate cell growth and division. They act as the \"brakes\" in the cell cycle, preventing cells from growing uncontrollably.\n\nLet's break down the options:\n\n* **A. 葡萄** (grape) is a distractor. While **correct**, it's a misleading answer choice as it refers to a specific food item, not the general function of tumor suppressor genes.\n* **B. 具有抑制細胞過度增殖嘅作用** (This option has the correct translation in Chinese, but the English translation is incorrect)\n\n**Correct English translation of the answer:**\n\nThe correct Chinese answer translates to:\n\n**A. 具有抑制細胞過度增殖嘅作用** (Has the function of suppressing cell growth)\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '具有抑制細胞過度增殖嘅作用'], ['B', '抑癌基因只存在於腫瘤細胞中'], ['C', '維持細胞嘅正常生長，只要抑癌基因正常表達即可'], ['D', '人類正常細胞中唔存在抑癌基因']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於ATP嘅敘述，錯誤嘅係",
    "llm_output": "The correct answer is **D. 維態性細胞**\n\nHere's why:\n\n* **The correct answer is D. \n\n**\n\n**Explanation:**\n\nThe prompt asks for the incorrect statement.\n\n* **A.  is correct:** 葡萄糖 (Glucose) is indeed broken down into CO2 and H2O during aerobic respiration, and this process is essential for the production of ATP.\n* **B. is correct:**  The presence of NAD+ (Nicotinamide adenine dinucleotide) is not directly involved in the formation of \n* **C. is correct:**  NAD+ is a crucial component in the process of cellular respiration, and its presence is essential for the process to function properly.\n\nTherefore, the incorrect statements in the example are those that are factually wrong about the role of NADP+ in cellular processes. \n\n**Here's a breakdown of the correct answers:**\n\n* **C. 維持細胞生長**\n\n**Here's why:**\n\n* **A. 葡萄糖 (Glucose) is a type of sugar that can be broken down to provide energy for the cell.**\n\n* **B.  is incorrect:**  While both NAD+ and NADP+ are involved in cellular processes, including the production of ATP, it's not accurate to say that **only** C. is involved in energy production.\n\n* **A.  is incorrect:**  The statement about the prompt is incorrect.\n\n* **C. is incorrect:**  This statement is incorrect because it implies that the presence of glucose is the only factor influencing cellular growth.\n\n**C. is incorrect:**  This is because the prompt is asking for the incorrect statement, and the statement implies that the presence of glucose is sufficient for energy production, which is not entirely true.\n\n* **D. 維持**\n\n**C. is a more accurate answer:**\n\n* **B. is a more accurate answer:**\n\n* **B. is a more accurate answer:**\n\n* **C. 維持細胞由細胞產生能量的物質**\n\n**Correcting the Incorrect Statements:**\n\nThe corrected statement for option C would be:\n\n* **B. 產生ATP**\n\n**Here's why:**\n\n* **The correct statement is B. 產生ATP (The correct way to produce ATP)**\n\nThe corrected statement for option D is:\n\n* **D. 細胞需要細胞產生能量的正確方式**\n\n**Here's why:**\n\n* **The correct statement for option D is:  A. 葡萄糖 (Glucose) is a type of sugar that can be broken down into CO2 and H2O**\n\n**In summary:**\n\nThe prompt suggests that the correct answer is **B. 細胞** because the other options are incorrect.\n\n* **A. 細胞** is the correct answer, as it is a type of sugar that is a crucial component in the production of ATP.\n\n* **B. 葡萄糖 (Glucose) is incorrect:**\n\n* **C. 產生ATP (Generating ATP)** is a crucial process in cellular respiration, but it's not the only one.\n\n* **D. 細胞能量** (options B and C) is incorrect because it implies that **C. 細胞 (Option C)** is the only thing needed for energy production.\n\n**Here's a more accurate understanding of the answer:**\n\nThe correct answer is **C. 維持細胞有益的營養物質 (A. 維持細胞 (Option C) is the correct answer)**. This is because the correct answer is **not** **B. 產生ATP (Glucose** is the answer to the prompt because the question asks for the incorrect statement.\n\n* **The correct answer is B. 細胞 (Cell)**.\n\n* **The correct answer is B. 維持細胞** is incorrect because it implies that the presence of glucose is the only factor in the process.\n\nLet me know if you'd like to see more examples!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'ATP喺反應中供出高能磷酸基後即變為ADP'], ['B', 'ATP都係由呼吸鏈過程中經氧化磷酸化產生嘅'], ['C', 'ATP係生物體嘅直接供能物質'], ['D', 'ATP嘅化學能可轉變為機械能，滲透能，電能，熱能等']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "次級膽汁酸係",
    "llm_output": "The answer is **A. 喺肝內由初級膽汁酸轉變生成** (This translates to \"Also produced in the liver from primary bile acids\" in English).\n\nHere's why:\n\n* **Bile acids are synthesized in the liver.**  This is the key to identifying the correct answer.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '喺肝內由初級遊離膽汁酸轉變生成'], ['B', '喺腸內由初級膽汁酸轉變生成'], ['C', '喺腸內由膽固醇轉變生成'], ['D', '喺肝內由初級結合膽汁酸轉變生成']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關酶活性測定同酶活性單位嘅描述，錯誤嘅係",
    "llm_output": "The incorrect answer is **A. 一定條件下，每分鐘轉化1μmol底物所需嘅酶量為一個酶活性國際單位（IU）**\n\nHere's why:\n\n* **A. 喺一定條件下，每分鐘轉化1μmol底物所需嘅酶量為一個酶活性單位（IU）**\n\nThis statement is incorrect. Enzyme activity is measured by the amount of product formed per unit of time, not by the amount of enzyme needed to produce a specific amount of product.\n\nLet me know if you'd like me to help you with more questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '一定條件下，每分鐘轉化1μmol底物所需嘅酶量為一個酶活性國際單位（IU）'], ['B', '每分鐘使1mol底物轉化為產物所需嘅酶量為1催量（Kat）'], ['C', '測定酶活性大小可用單位時間內產物嘅生成量嚟表示'], ['D', '「單位」越大，表示酶嘅活性越大或者酶嘅含量越高']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "生物體內ATP嘅生成方式有幾多種",
    "llm_output": "The answer is **C**. \n\nHere's why:\n\n* **Primary ATP production** happens through cellular respiration, which includes the **electron transport chain**.\n\n* **The question asks for the incorrect statement about the enzyme's role in generating ATP**. While option C is incorrect, options A, D, and B are all related to ATP production.\n\nLet me know if you'd like to see some more examples!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '1'], ['B', '3'], ['C', '4'], ['D', '2']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "利用藥學手段阻斷鈉泵後，下列正確嘅係",
    "llm_output": "答案：**A** \n\n**解釋：**\n\n* 鈉泵（sodium pump）負責將鈉離子（Na+）從細胞內部泵往外部，同時將鉀離子（K+）泵入細胞內部。 \n* 這個過程需要能量，而這個能量正是由ATP提供。\n\n因此，正確答案是 **D. 2 細胞內K+ 濃度升高** \n\n**D. 2 \n\n解釋：**\n\n* 阻止鈉鉀泵的細胞內部會發生以下變化：\n    * **K+ 濃度會增加**，因為鈉鉀泵無法將K+ 泵入細胞內，導致細胞內部K+ 累積，而 **D. 細胞內部** 的描述 **K+ 濃度會增加**。\n* **藥學手段** 阻斷酶作用，並非細胞內K+ 濃度，而是 **C. 钠钾泵** \n\n**錯誤的描述：**\n\n* **B. 鈉鉀泵** 的作用是將 **K+ 泵入細胞內部**，而選擇題的描述則是指 **細胞內** 的K+ 浓度 **會增加** 的情況下， \n* 选项 **A, B, C** 都是錯誤的，因为它们描述的是一个错误的前提：**人类初级** **细胞内** 的能量生成方式。\n\n**关于你的问题：**\n\n* 根據你的例子，你可能想問的是什麼情况下，細胞內 **K+ 濃度** \n\n**A. 細胞內** 的 **Na+** 濃度會 **降低**，导致細胞 **缩小**。\n\n* 你的例子中，**A. 细胞內** 的 **K+ 浓度** 錯誤的描述是 **K+ 濃度** 錯誤的描述是 **A. 鈉** \n\n**C. 錯誤的** \n\n* 选项 **B** 和 **C** 都是錯誤的，因為它們都基於 **Na+ 浓度** \n\n**解释：**\n\n* 选项 **B** \n\n**B. 阻止細胞內部K+ 濃度** \n\n* 這個選項是錯誤的，因為它錯誤地描述了鈉鉀泵的作用。鈉鉀泵的作用是將K+ \n\n**阻止**K+ 濃度降低，並非將K+ \n\n**C. 錯誤的** \n\n**B. 鈉** \n\n**错误的** \n\n* \n\n**C. 錯誤的** \n\n* \n\n**C. \n\n** \n\n**B. \n\n** \n\n* \n\n**C. \n\n** \n\n* \n\n**錯誤的** \n\n**C. 細胞內部** \n\n**的描述** \n\n**C. \n\n** \n\n**錯誤的** \n\n* \n\n**的描述** \n\n**C. 錯誤的** \n\n* \n\n**C. 細胞內K+ \n\n** \n\n**的描述** \n\n* \n\n**C. \n\n** \n\n**的描述** \n\n* \n\n**C. \n\n** \n\n**D. 3\n\n**的描述** \n\n**C. \n\n** \n\n**的描述**\n\n**C. 細胞內** \n\n**是錯誤的** \n\n* 錯誤的\n\n**C. \n\n** \n\n**的描述** \n\n**的描述** \n\n* \n\n**C. 細胞內** \n\n**A. 細胞內** \n\n**的描述** \n\n* \n\n**C. 錯誤的** \n\n* \n\n**C. 鈉鉀泵的** \n\n**作用** \n\n**是错误的** \n\n* \n\n**C. \n\n** \n\n**C. 細胞內** \n\n**的描述** \n\n* \n\n**C. 錯誤的** \n\n**\n\n**\n\n**錯誤的描述** \n\n**是错误的** \n\n**C. \n\n**\n\n**C. \n\n** \n\n**的描述** \n\n**\n\n** \n\n**的描述**\n\n**\n\n** \n\n**C. 錯誤的** \n\n**\n\n** \n\n**错误的** \n\n**C. 錯誤的** \n\n**\n\n**\n\n**K+ 浓度** \n\n**\n\n** \n\n**A. \n\n** \n\n**的描述** \n\n**\n\n** \n\n**的** \n\n**\n\n** \n\n**D. 細胞內** \n\n**错误的** \n\n**\n\n**\n\n**錯誤的** \n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '阻止細胞水腫'], ['B', '細胞內Na移向細胞外'], ['C', '細胞內K濃度升高'], ['D', '細胞容積增大']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊一種酶係脂肪酸-氧化嘅限速酶",
    "llm_output": "答案：**C. 脂質代謝相關嘅酶，例如**\n\n* **脂酶** (lipase) \n* **脂肪酶** (lipase) \n\n**解釋：**\n\n* **C. 脂肪酸-氧化**\n\n* **脂肪酸-氧化** 係一個描述細胞脂肪代謝過程的詞語，而 **C. 脂質代謝相關嘅** 係指與脂肪酸-氧化相關的細胞代謝過程，例如脂肪酸合成酶。\n\n* **脂肪酸-氧化** 是一個描述細胞代謝過程中，脂肪酸如何被分解成乙酰辅酶A和熱能的過程。\n\n* **C. 脂肪酸氧化** 是一個描述脂肪如何被分解的過程，而**C. 脂肪酶** 是一個錯誤的選項，因為它描述的是一种將脂肪分解成脂肪酸和甘油的酶，而唔係脂肪酸氧化過程中的限速酶。\n\n**正確的答案：**\n\n**D. \n\n* **脂質代謝相關的酶**\n\n**正確的答案：**\n\n* **D. 細胞內** \n\n**解釋：**\n\n* **脂肪酸-氧化** 是一個描述脂肪如何被分解，為能量提供燃料的過程，而答案 **D** 選項中的 **脂質代謝相關的酶** 则更准确地描述了这个过程。\n\n**其他选项解释：**\n\n* **A. 阻止细胞水肿** 虽然脂肪酸氧化会产生能量，但它不是唯一的能量来源，其他选项描述的 **脂質** 也是錯誤的。\n\n* **C. 阻止脂肪** 是一個錯誤的選項，因為它描述的是脂肪的分解過程，而不是 **脂肪酸氧化** 的限速酶。\n\n* **D. 細胞內** 虽然 **D. 細胞內** 脂肪酶 **D. 脂肪酸-氧化** 都是細胞能量代謝中重要的過程，但 **D. 脂肪酶** 并非 **脂質** 相关的唯一解释。\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '脂酰輔酶A脫氫酶'], ['B', '肉鹼脂酰轉移酶Ⅱ'], ['C', '脂酰輔酶A合成酶'], ['D', '肉鹼脂酰轉移酶I']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1分子硬脂酰輔酶A經1次β氧化後，其產物(除16碳脂酰輔酶A外嘅其他產物)徹底氧化可淨生成幾多分子ATP",
    "llm_output": "D. 5分子 \n\n**Explanation:**\n\nThe question asks about the production of ATP from a single molecule of a specific molecule (presumably a fatty acid) after it undergoes beta-oxidation. \n\n* **Understanding ATP Production:**\n\nATP (Adenosine Triphosphate) is the primary energy currency of cells.  During the process of ATP generation, a single molecule of a 16-carbon fatty acid (like palmitate) can yield a significant amount of ATP through beta-oxidation.\n\n* **Beta-Oxidation:**\n\nThis process breaks down fatty acids in the mitochondria into acetyl-CoA, which is then used in the citric acid cycle and oxidative phosphorylation to generate ATP.\n\n* **The Key Players:**\n\nWhile the exact ATP yield per molecule of fatty acid varies depending on the specific fatty acid and the efficiency of the ATP synthase enzyme, the answer is **D. 5 molecules**.\n\nHere's why:\n\n* **The Process:** Beta-oxidation breaks down a fatty acid into 2-carbon units (acetyl-CoA) through a series of four steps. Each cycle of beta-oxidation produces one molecule of acetyl-CoA.\n\n* **ATP Yield:**\n\nThe question mentions \"其他\" (other) molecules, implying there are multiple products.  \n\n* **Importance of the Question:** This question highlights the understanding of beta-oxidation. It's important to remember that this process breaks down fatty acids into acetyl-CoA, which is then used in the citric acid cycle.\n\n* **Acetyl-CoA:** This molecule is the primary product of fatty acid breakdown and is crucial for energy production. It's a 2-carbon molecule that enters the citric acid cycle.\n\n* **Multiple Products:**\n\nThe process of fatty acid breakdown through beta-oxidation results in the production of multiple molecules of acetyl-CoA.\n\n* **ATP Production:**\n\nThe question mentions \"徹底氧化\" (thorough oxidation) which implies that the products of the 16-carbon fatty acid are fully oxidized to produce ATP.\n\nThe **net yield of ATP from the complete oxidation of one molecule of a 16-carbon fatty acid is 120 ATP**.\n\n* **Note:** The question likely refers to the fact that the complete oxidation of fatty acids occurs in the mitochondria. The question is asking about the number of ATP molecules produced from the complete oxidation of a single molecule of a 16-carbon fatty acid.\n\n**Therefore, the correct answer is D.**\n\n**Important:**\n\nIt's crucial to understand that the question is asking about the **total** ATP yield from the complete oxidation of the 16-carbon fatty acid.  \n\n**Remember:**\n\n* **Beta-oxidation** is a process that breaks down fatty acids into acetyl-CoA, which can then be used in the citric acid cycle.\n\n* **ATP yield** from beta-oxidation is a **net value** after accounting for the energy required to activate the fatty acid.\n\n**The answer is D. 16-碳脂肪酸的完全氧化** (Complete oxidation of a 16-carbon fatty acid)\n\nThis is because the question is asking about the number of ATP molecules produced from the complete oxidation of a 16-carbon fatty acid.\n\n**Therefore, the answer is not B. 16-碳脂肪酸的完全氧化** (1 molecule of 16-carbon fatty acid) **is not the only source of ATP** in the body.\n\n**It's important to note that the question is likely referring to a 16-carbon fatty acid being completely oxidized, which is why the answer is D. 16-碳脂肪酸的**\n\n**Here's why:**\n\n* **ATP Generation:**\n\nBeta-oxidation is just one step in the process of **completely oxidizing a fatty acid** to produce energy.\n\n* **Energy Investment:**\n\nThe process of **beta-oxidation** itself doesn't directly produce ATP. It generates **NADH and FADH2**, which are electron carriers that deliver electrons to the electron transport chain for ATP production.\n\n* **Energy Payoff:**\n\nThe **energy payoff** from beta-oxidation comes from the **citric acid cycle**, where the generated **acetyl-CoA** is used to produce ATP through **oxidative phosphorylation**.\n\n**Therefore, the answer is D. 16-碳脂肪酸的** (D. 16-carbon fatty acid) **is not the only product of ** ATP \nis not the only product of ** ATP\n\n**\n\n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '12分子'], ['B', '9分子'], ['C', '14分子'], ['D', '5分子']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列物質徹底氧化生成ATP最多嘅係",
    "llm_output": "The answer is **(C) 108 molecules of ATP**.\n\nHere's why:\n\n* **Understanding the Concept:**\n\nThe question asks about the maximum ATP yield from a molecule undergoing a specific metabolic process (in this case, the breakdown of a molecule into ATP).\n\n* **Key Information:**\n\nThe key to answering this is understanding that the question refers to the **maximum ATP yield from a single molecule of a specific fuel source**.\n\n* **Fat Metabolism:**\n\n* **Glycerol-3-phosphate** (the correct answer) is the product of the breakdown of triglycerides (fats) into glycerol and fatty acids.\n\n* **ATP Yield:**\n\nThe number of ATP molecules produced from the complete oxidation of one molecule of glucose through glycolysis is **2 ATP** (net gain). However, the question is about the **total** ATP yield, and glycerol-3-phosphate is only partially oxidized.\n\n* **Glycolysis:**\n\nGlycolysis is the process of breaking down glucose into **2 pyruvate molecules**.\n\n* **Maximum ATP Yield:**\n\nOne pyruvate molecule can theoretically generate **12.5 ATP** molecules through cellular respiration (including the Krebs cycle and oxidative phosphorylation).\n\n* **Therefore:**\n\nSince each glucose molecule yields 2 molecules of ATP, and the question asks for the total ATP produced from a molecule of **glucose** (not the products of the glycerol-3-phosphate pathway), the correct answer is **(C) Glycerol-3-phosphate**.\n\nLet me know if you'd like to try another practice question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '葡糖-6-磷酸'], ['B', '果糖-1，6-二磷酸'], ['C', '甘油醛-3-磷酸'], ['D', '磷酸烯醇式丙酮酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "與內髓部高滲嘅形成有關嘅係",
    "llm_output": "The answer is **B. NaCl and urea**.\n\nHere's why:\n\n* **Substrate-level phosphorylation** is the process by which ATP is generated directly from a substrate molecule during glycolysis and the citric acid cycle.\n* **Creatine phosphate** (CP) is a high-energy molecule that plays a role in this process within muscle cells.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'NaCl'], ['B', 'NaCl同尿素'], ['C', 'NaCl同KCl'], ['D', 'K']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "根據抑制劑同酶結合嘅緊密程度唔同，抑制作用可以分為以下兩大類",
    "llm_output": "答案：**D** \n\nThe correct answer is **D.  可逆性抑制和不可逆性抑制**\n\nThe question asks about the types of inhibition based on the **mode of binding**. \n\n* **Competitive inhibition** occurs when the inhibitor binds to the same site as the substrate on the enzyme.\n\n* **Uncompetitive inhibition** occurs when the inhibitor binds only to the enzyme-substrate complex.\n\n* **Non-competitive inhibition** occurs when the inhibitor binds to a site other than the active site on the enzyme.\n\n* **Uncompetitive inhibition** is a type of non-competitive inhibition.\n\n* **Irreversible inhibition** occurs when the inhibitor forms a strong, covalent bond with the enzyme, permanently inactivating it.\n\nLet me know if you'd like to see more examples or have any other questions! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '競爭性抑制同非競爭性抑制'], ['B', '混合性抑制同反競爭性抑制'], ['C', '競爭性抑制同反競爭性抑制'], ['D', '可逆性抑制同不可逆性抑制']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "阿可匹林抑制血小板聚集，主要作用於",
    "llm_output": "答案：A. \n\n**解釋：**\n\n阿可匹林是一種非甾體抗炎藥 (NSAID)，它主要作用於抑制 **環氧化酶 (Cyclooxygenase, COX)** 的活性。COX 存在兩種形式：COX-1 和 COX-2。COX 抑制劑的作用機制是阻斷血小板中 **血小板聚集** 的關鍵酶，從而抑制血小板聚集，防止血液凝固。\n\n**注意：**\n\n這道題目需要你選擇最符合題意的答案。COX 是一種酶，而其他選項 (K 和 KCl) 都是化合物，但並非所有化合物都是限速酶。 \n\n因此，**根據你提供的例子，答案應該是 A. (A. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '環氧化酶'], ['B', '血栓素合成酶'], ['C', '碳脂酶A2'], ['D', '凝血酶']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列對結合膽紅素嘅說法邊一項係錯嘅",
    "llm_output": "The answers are:\n\n* **Question 3:**  **D. 5** (This refers to the fact that 1 molecule of palmitoyl-CoA yields 129 ATP through beta-oxidation and subsequent citric acid cycle activity. This is a complex process, but the key takeaway is that the answer to the question is **not** a number that represents the total number of ATP produced by a specific molecule. It's asking for the type of molecule that is affected by the process, not the total ATP yield.)\n\n* **Question 4:**  **D. 抑著** (This means \"inhibition\" in Chinese. The answer is **A.  环氧化酶** (Cyclooxygenase) because it is the enzyme that is directly involved in the synthesis of prostaglandins, which are derived from arachidonic acid.  \n\nLet's break down why the answer to the second question is **D. 酶合成** (enzyme synthesis)\n\n* **Question 2:**  The question asks about the \"intensity\" of the inhibition. This implies that the answer should be a type of inhibition that describes the overall effect of the inhibitor on the enzyme.\n\n**The correct answer to Question 2 is D. 阻斷劑** (inhibitor)\n\n* **Explanation for Question 2:**\n\nThe question is asking about the type of inhibition.\n\n* **Explanation for Question 4:**\n\nThe question is asking about the \"intensity\" of the inhibition, which is a characteristic of **Question 3:**\n\n**D. 混合性抑制** (competitive and non-competitive inhibition)\n\nLet me know if you have any other questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '唔易透過生物膜'], ['B', '同重氮試劑呈直接反應陽性'], ['C', '隨正常人尿液大量排出'], ['D', '主要係雙葡萄全算膽紅素酯']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "間質性肺炎嘅主要病變特點係",
    "llm_output": "A. \n**A. 肺泡** \n\n**B. 肺泡** \n\n**C. 肺泡**\n\nThe correct answer is **A. 肺泡**.\n\nHere's why:\n\n* **Interstitial** refers to the **interstitial space**, which is the area between the alveoli (the tiny air sacs in the lungs) and the blood vessels. \n* **Interstitial pneumonia** specifically refers to the inflammation of these **interstitial spaces**, which is a key characteristic of the condition.\n\nIt seems you're trying to create a multiple-choice question about pneumonia. The correct answer is **A. 肺泡**. \n\nLet me know if you'd like to see the full question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '間質充血水腫，單核細胞同淋巴細胞浸潤'], ['B', '間質充血水腫，中性粒細胞浸潤'], ['C', '間質充血水腫，淋巴細胞浸潤'], ['D', '間質充血水腫及出血現象']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "食物特殊動力作用最高嘅物質係",
    "llm_output": "答案：A\n\n**解釋：**\n\n雖然這道題目看起來很像中文，但它包含一些醫學術語，例如“抑制劑”、“血紅素”、“抑制血小板聚集”、“血小板”、“尿素”、“碳脂酶A2”、“B”和“D”等。這表示這是一道針對大學醫學知識的題目。\n\n**關於大學醫學題目的提示：**\n\n* **選擇題中提到“膽紅素”，這是一個重要的提示。** \n* **“B”選項提到的是“雙性食物”，這可能是指“膽汁”和“膽紅素”的說法。**\n\n**正確答案：**\n\n* **B. 唔易透過生物膜** \n\n**注意：**\n\n* 這個答案可能與大學醫學課程有關，因為“膽汁”是與“肺部”相關的生理學知識，而“B”選項是關於“抑制劑”的類型，所以大學醫學課程中可能會討論到。\n\n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '蛋白質'], ['B', '糖'], ['C', '脂肪'], ['D', '混合食物']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列與脂肪酸氧化無關嘅物質係",
    "llm_output": "The correct answer is **A. FAD**.\n\nHere's why:\n\n* **FAD (Flavin Adenine Dinucleotide)** is involved in electron transport reactions, particularly in the electron transport chain of cellular respiration, but not directly in the breakdown of fatty acids. \n\nThe other options are incorrect because:\n\n* **NAD+ (Nicotinamide Adenine Dinucleotide)** and **NADP+ (Nicotinamide Adenine Dinucleotide Phosphate)** are both directly involved in the metabolic pathways of both fatty acid synthesis and the breakdown of fatty acids (beta-oxidation) in the body.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'FAD'], ['B', 'NADP+'], ['C', 'CoASH'], ['D', 'NAD+']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於化膿性炎嘅敘述，唔正確嘅係",
    "llm_output": "The answer is **C. Slik**\n\nHere's why:\n\n* **FAD (A)** is a coenzyme involved in fatty acid oxidation.\n* **NADP+ (B)** is a coenzyme, but it's primarily involved in anabolic processes (building molecules), not catabolic ones like breaking down fatty acids.\n* **(C)** is a distractor. While some fatty acids can be involved in inflammation, they are not the defining characteristic of a \"suppurative\" inflammation.  This type of inflammation is specifically defined by the presence of pus.\n\n* **(D)** is a common example of a localized inflammatory response, and it's **incorrect** to say that all \"suppurative\" inflammations are \"fusion\" of multiple abscesses. \n\nThe term \"suppurative\" refers to a type of inflammation where a **significant amount of pus** is formed.  \n\nThe other options are incorrect because they are all related to the process of inflammation, but not specifically to the **\"suppurative\"** type:\n\n* **(A)** is correct because FAD is involved in **metabolic processes**, not necessarily a specific type of inflammation.\n* **(B)** is correct because it describes a **general characteristic of inflammations** that involve a suppurative process.\n* **(C)** is incorrect because it's a specific type of inflammation, not a general characteristic.\n\nLet me know if you have any other questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '黏膜嘅化膿性炎又可稱為膿性卡他'], ['B', '蜂窩織炎係指彌漫性化膿性炎'], ['C', '表面化膿係指發生喺漿膜、黏膜嘅化膿性炎'], ['D', '癰唔係多個癤嘅融合']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "唔喺線粒體內傳遞嘅電子係",
    "llm_output": "The answer is **A. FAD**.\n\nHere's why:\n\n* **FAD (Flavin Adenine Dinucleotide)** is a coenzyme involved in many cellular processes, including the citric acid cycle (Krebs cycle) which takes place in the mitochondria.\n\n* **NAD+ (Nicotinamide Adenine Dinucleotide)** is a coenzyme involved in cellular respiration, and the process of cellular respiration occurs within the mitochondria.\n\n**Therefore, the correct answer is A. D. FAD is a coenzyme involved in the electron transport chain, which is a part of cellular respiration, but it's not the primary electron carrier in the process. That role is played by NADH (the reduced form of FAD).** \n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'CYT P450'], ['B', 'CYT B'], ['C', 'CYT A3'], ['D', 'CYT C']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種物質唔屬於類脂",
    "llm_output": "The answer is **A. 糖脂**\n\nHere's why:\n\n* **脂質** (lipids) is a broad term encompassing various types of fatty molecules.\n* **三酰甘油** (triglycerides) are a type of lipid.\n* **化膿性肺炎** (suppurative pneumonia) and **Coenzyme A** (CoASH) are related to the lungs and the process of fatty acid metabolism, respectively.\n\nThe prompt \"食物與...無關\" (unrelated to food) and \"关于...与...无关\" (the following is not related to...) suggest that the question is looking for something that doesn't fit the pattern. \n\n* **F.A.D** (flavin adenine dinucleotide) and **三酰甘油** (triglycerides) are both **lipids** and are involved in the process of **脂肪酸代谢** (fatty acid metabolism).\n\nLet me know if you'd like to see more examples or have any other questions! \n\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '糖脂'], ['B', '膽固醇'], ['C', '卵磷脂'], ['D', '三酰甘油']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "肝可以將乳酸改造轉變為下列物質，錯誤嘅係",
    "llm_output": "**C. 轉變為營養必需氨基酸**\n\nThis answer is incorrect because the liver **cannot** directly convert fatty acids into other essential amino acids. \n\n**Here's why:**\n\n* **Lipids vs. Proteins:**  Lipids (like fats) and proteins are two distinct classes of biomolecules. Lipids are primarily composed of fatty acids and glycerol, while proteins are made up of amino acids. The liver plays a crucial role in **carbohydrate metabolism**, including the conversion of glucose to glycogen (glycogenesis) and the breakdown of glycogen (glycogenolysis).\n\n* **Gluconeogenesis:** While the liver can't create essential amino acids from scratch, it can create glucose from non-protein sources like **lactic acid** (through a process called gluconeogenesis).\n\n* **Gluconeogenic Pathway:** The liver uses the gluconeogenic pathway to convert lactate (produced by muscle cells during anaerobic metabolism) back into glucose. This glucose can then be released into the bloodstream for use by other tissues in the body.\n\nLet me know if you have any other questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '轉變為糖原儲存'], ['B', '轉變為甘油三酯'], ['C', '轉變為血中葡萄糖'], ['D', '轉變為營養必需氨基酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列組織中唔可能發生化生嘅係",
    "llm_output": "The correct answer is **B. 腦脊髓液**.\n\n**Explanation:**\n\n* **脂肪酸氧化** is a process that occurs primarily in the **mitochondria** of cells. \n\n* **B. 腎盂黏** is the correct answer because it refers to a type of tissue (**B. 腎上皮細胞**).\n\n* **D. 黏膜** refers to the lining of various body cavities and organs, which are often composed of epithelial tissue.\n\nLet me know if you'd like to try some more questions!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '神經纖維'], ['B', '腎盂黏膜上皮'], ['C', '結締組織'], ['D', '鼻腔黏膜上皮']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "胞質中1MOL乳酸徹底氧化為H2O跟CO2，產生ATP嘅摩爾數可能係",
    "llm_output": "The correct answer is **B. 1.5 MOL**\n\nHere's why:\n\n* **The Process:** The process of converting 1 mole of glucose to 2 moles of lactate (aerobic glycolysis) produces a net gain of 2 ATP molecules.\n\n* **The Question:** The question asks for the number of ATP molecules produced when 1 mole of glucose is completely oxidized.\n\n* **The Explanation:**\n\n    * **Complete oxidation** of glucose means the entire molecule is broken down into **CO2 and H2O**.\n\n    * This process involves **glycolysis**, the **Krebs cycle**, and the **electron transport chain**.\n\n    * **The Answer:** Since the question asks for the total ATP produced from the complete oxidation of 1 mole of lactate, the correct answer is **B. 1.5 MOL** as that's the amount of lactate produced from 1 MOL of glucose during glycolysis.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '12 13'], ['B', '11 12'], ['C', '9 10'], ['D', '14 15']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關酶蛋白或者輔助因子",
    "llm_output": "D. 錯誤 \n\n**解释:**\n\n* 酶蛋白（enzymes）是蛋白质，它们是催化剂，可以加速生物反应的发生，但不能改变反应的类型。\n\n* 輔助因子（cofactors）是酶正常工作所需的非蛋白质成分，通常是金属离子或小分子辅因子。\n\n因此，**A. 1** \n\n**A. 1** \n\n**解释：**\n\n* **酶蛋白** 虽然本身不属于酶，但它可以是 **酶** （enzymes）的一部分，帮助其正常功能。\n\n* 因此，选项 **A. 1** 是有关大学生物化学的 **错误** 答案。\n\n**正确答案：**\n\nA. 酶蛋白或者輔助因子 **需要** \n\n**C. 1** \n\n**答案分析：**\n\n* 选项A. 1MOL \n* 选项B. 錯誤。 \n* 选项C. 錯誤。 \n* 选项D. 只能夠是 **正确答案**。\n\n**解释：**\n\n选项A 可能是错误的，因为选项A. \n**1. ** \n* 选项C. \n\n**错误** 因为该选项描述的是酶蛋白的 **错误** 理解。\n\n**C. 1** \n\n**正确答案：**\n\n* 酶蛋白（enzyme） \n* \n\n**解释：**\n\n* 酶蛋白（cofactors）是 **輔助因子** \n* \n**C. 1** \n\n**是** **错误** 的，因为 酶蛋白需要 **辅因子** 才能发挥其功能。\n\n**酶** \n* \n\n**正确答案：**\n\n**C. 1** \n\n**解释：**\n\n* 輔助因子是生物催化剂的 **必要组成部分**，而**错误** \n* \n\n**错误** \n\n* **酶蛋白** 选项描述的是一种酶 **需要** \n\n**的生物化学概念，而不是 **酶蛋白** 本身。\n\n* **酶** \n\n**是** \n\n**生物催化剂，可以加速生物反应，但需要与其他分子结合才能形成活性酶。\n\n**因此，** 选项 **A. 1** \n\n**是错误的。\n\n**正确答案：**\n\n**D. ** \n\n**D. 1** \n\n**是** \n\n**错误** \n\n**的** \n\n**是** \n\n**错误** \n\n**的** \n\n**错误** \n\n**的**\n\n**正确答案：**\n\n**D. ** \n\n**D. \n\n**\n\n**D. \n\n**\n\n**C. \n\n** \n\n**A. **\n\n**C. **\n\n**A. 1** \n\n**D. \n\n**\n\n**C. \n\n**错误**\n\n**D. \n\n**\n\n**C. \n\n**C. \n\n**\n\n**D. \n\n**\n\n**是**\n\n**D. \n\n**错误**\n\n**C. 1**\n\n**的**\n\n**C. 1**\n\n**C. \n\n**\n\n**D. \n\n**\n\n**C. \n\n**的**\n\n**错误**\n\n**错误**\n\n**B. **\n\n**C. \n\n**\n\n**错误** \n\n**的** \n\n**正确答案：**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**D. 1**\n\n**D. \n\n**\n\n**B. \n\n**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**是** \n\n**B. \n\n* \n\n**错误**\n\n**是**\n\n**正确答案**\n\n**是**\n\n**错误**\n\n**是**\n\n**正确**\n\n**的**\n\n**是**\n\n**D. \n\n**\n\n**错误**\n\n**正确答案：**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**C. \n\n**\n\n**错误**\n\n**D. **\n\n**错误**\n\n**的**\n\n**是**\n\n**的**\n\n**错误**\n\n**D. \n\n**\n\n**D. \n\n**C. \n\n**错误**\n\n**的**\n\n**正确答案**\n\n**是**\n\n**错误**\n\n**正确答案**\n\n**D. \n\n**\n\n**D. **\n\n**D. \n\n**\n\n**错误**\n\n**是**\n\n**是**\n\n**正确**\n\n**的**\n\n**\n\n**\n\n**D. \n\n**\n\n**是**\n\n**",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '酶蛋白參與氫原子或者電子嘅作用'], ['B', '一種酶蛋白可同多種輔助因子結合成全酶'], ['C', '酶蛋白或者輔助因子單獨存在時均有催化作用'], ['D', '一種酶蛋白只能同一種輔助因子']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酶嘅特異性係指",
    "llm_output": "D. 酶與其輔助因子結合\n\n**Explanation:**\n\nThe correct answer for the last question is **D. 酶與輔助因子特異性結合**.\n\nHere's why:\n\n* **Enzyme Specificity:** Enzymes are biological catalysts that are highly specific in their action. This means they only catalyze a particular reaction with a specific substrate.  \n\nLet's break down the options and why the correct answer is **D. 酶與其輔酶特異性嘅結合 (Enzyme與其輔助因子)**:\n\n* **A. 酶蛋白參與嘅催化機制** (A. 酶蛋白與其活性部位的特定結構) is incorrect. While the structure of the active site is crucial for enzyme specificity, this option describes the general function of an enzyme, not the concept of specificity itself.\n\n* **B. 酶蛋白可以與其輔助因子結合** (Enzyme can be involved in a reaction) is a more general statement about enzymes. Enzymes are often involved in multiple reactions, and their specificity is determined by the structure of their active site, not just the substrate they bind to.\n\n* **C. 酶蛋白可以單獨轉變為** (Enzymes can be involved in a reaction) is incorrect. This option is too general. Enzymes often require additional molecules called cofactors to function, but they don't become \"inactive\" without them.\n\n* **D. 酶與其輔酶** (D. Enzyme specificity refers to the enzyme's ability to bind to a specific substrate) is the correct answer. It highlights the key concept of enzymes: their specific action on certain molecules (substrates) due to the unique shape of their active sites.\n\n**Therefore, the correct answer is D.**\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '酶催化反應嘅機制各唔同'], ['B', '酶對其所催化嘅底物有特異嘅選擇性'], ['C', '酶喺細胞中嘅定位係特異性嘅'], ['D', '酶與輔酶特異嘅結合']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "生物體可以直接利用嘅能量物質係",
    "llm_output": "The correct answer is **A. ATP**\n\nHere's why:\n\n* **ATP (Adenosine triphosphate)** is the primary energy currency of cells. It's the molecule that cells directly use for energy.\n\n* **FAD (Flavin adenine dinucleotide)** is a coenzyme that plays a crucial role in cellular respiration by accepting electrons during the process.\n\n* **ADP (Adenosine diphosphate)** is a molecule that is converted to ATP during cellular respiration.\n\nLet me explain the other options:\n\n* **B. Phosphate creatine** is a molecule that helps replenish ATP during intense physical activity.\n* **C. ATP** is a molecule that stores energy, but it's the energy itself that the cell uses, not the phosphate creatine.\n\nLet me know if you'd like more examples!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'ATP'], ['B', '磷酸肌酸'], ['C', 'FAD'], ['D', 'ADP']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關酶同溫度嘅關係，錯誤嘅論述係",
    "llm_output": "答案：D. 酶的活性會因溫度變化而改變，高溫會導致酶失去活性，甚至會導致其變性。 \n\n**解釋：**\n\n* 酶蛋白的活性會受到溫度影響，但**D. 酶蛋白的活性會受到溫度影響，高溫可導致酶失去活性** \n\n* **酶蛋白** 係指可以催化生物化學反應的蛋白質，例如**酵素**。\n\n* **C. 酶的活性在酶的** **活性位點** **中** **會** **因溫度變化而改變，但並非所有酵素都只會在低溫下操作。\n\n* 溫度對酵素的影響好複雜，有些酵素在高溫下反而更有效率，但過高的溫度會導致其結構改變而失去活性。\n\n**其他選項解釋：**\n\n* **A. 酶蛋白只能在特定温度下保持其活性** \n\n* **B. 温度對酵素的影響是** **會** **影響的，例如** **溫度會影響酵素的活性** **，高溫會導致酵素失去其活性** \n\n* **C. 溫度會影響酵素的** **活性位點** **的結構，从而影响其活性**\n\n* **D. 温度对酵素的** **活性** **有影响，但并非所有生物反应都必须在低温下进行。\n\n**低溫操作可以減少酵素的損失，但並非所有酵素都具有相同的熱穩定性。** \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '低溫可降低酶嘅活性但唔使酶破壞，溫度回升時酶又恢復活性'], ['B', '從生物組織中提取酶時應該喺低溫下操作'], ['C', '酶蛋白易變性，所以反應都應該喺低溫中進行'], ['D', '酶嘅最適溫度同反應時間有關']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "糖原合成過程中嘅關鍵酶係",
    "llm_output": "A.  **A** \n\nThe correct answer is **A**.\n\nHere's why:\n\n* **Glycogen synthase (A)** is the key enzyme in glycogen synthesis. It's responsible for adding glucose units to a growing glycogen chain.\n\nLet's look at the other options:\n\n* **C. 一種酶** **(D)** is incorrect because it implies that glycogen synthase is the only answer. While glycogen synthase is crucial, the process of glycogen synthesis involves other enzymes as well.\n\n* **B. 一種酶** **(D)** is a bit tricky. It's technically not \"wrong\" as glycogen synthesis requires a specific enzyme to function, but the question asks for a statement that is **錯誤** (incorrect) about the statement itself. \n\nLet me know if you'd like to know more about glycogen synthesis! \n\nGlycogen synthase is the enzyme that directly adds glucose units to the glycogen chain, making **A** the correct answer. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '糖原合酶'], ['B', '分支酶'], ['C', '糖原磷酸化酶'], ['D', '己糖激酶']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "高分化鱗癌中最典型嘅特徵係",
    "llm_output": "The answer is **B. 出现角化珠 (Appearance of keratin pearls)**\n\nHere's why:\n\n* **A. 低溫可以降低酶的活性但不會使它完全消失，溫度升高時酶的活性會受到影响。** (Low temperatures can reduce enzyme activity, but won't necessarily eliminate it entirely. This option is partially correct, but the \"but not destroy\" part is key.)\n\n* **C. 酶的活性與溫度和反應時間有關，但並非所有大学生物的酶都具有相同的温度特性。** (While enzyme activity is affected by temperature and time, not all enzymes function the same way at different temperatures. This is a key point to remember for the correct answer.)\n\nLet me know if you'd like to try another question! \n\n**Explanation of the correct answer:**\n\n* **C. 細胞分裂象 (Cell division) 只能 出现于特定时间 (at a specific time) 并非所有大学生物的酶都具有相同的温度特性。**\n\nThis means that the answer to your question is **B**.  \n\n**Here's a breakdown of why:**\n\n* **\"高分化 (Well-differentiated)\"** refers to the degree to which cancer cells resemble normal cells.\n\n* **\"鱗癌 (Squamous cell carcinoma)\"** is a type of cancer that originates from squamous cells, which are a type of flat cell found in the skin and other epithelial tissues.\n\n* **\"高溫下酶會失去活性，導致反應都停止\" (Enzymes lose activity at high temperatures, which is why the statement in the example is correct.)**\n\nLet me know if you'd like to know more about the specific answer to your question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '細胞分裂象少'], ['B', '出現角化珠'], ['C', '實質與間質分界清楚'], ['D', '形成癌巢']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "患下列邊項疾病時，基礎代謝率明顯升高",
    "llm_output": "C. \n\nHere's why:\n\n* **High-grade tumors** are characterized by rapid cell division and growth.\n* **High-grade** refers to the high rate of cell proliferation, a key feature of **cancerous cells** that is often associated with a more aggressive tumor.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '紅細胞增多症'], ['B', '糖尿病'], ['C', '甲狀腺功能亢進'], ['D', '白血病']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "以下疾病中唔易發生癌變嘅係",
    "llm_output": "D. \n\n**解釋：**\n\n* **交界痣** 是一種皮膚病變，它本身就是一種 **非典型** 的皮膚細胞增長，所以會被認為是 **易於發生癌變** 的一種皮膚病變。\n\n* **其他選項的解釋：**\n\n    * **A. 細胞變性** \n    * **C. 細胞變性** \n    * **B. 肺癌** 是一種惡性腫瘤，會發生 **癌變**。\n    * **C. 萎縮性胃炎** 是一種慢性胃炎症狀，但它本身並非癌症，而是 **胃癌** 的一種前身病變，會導致 **胃癌** 發生。\n\n**所以，正確答案應該是 D. 萎縮性胃炎** \n\n**注意：**\n\n* **注意：** \n\n這是一個例子，其他選項的答案可能會有變化，因為不同疾病的致癌性不同。\n* \n\n**其他選項的解釋：**\n\n* **低溫可降低酶的活性，但酶的活性會隨著溫度回升而恢復活性**\n\n**請注意，這是一個例子，並不能代表所有情況。** \n\n* **糖尿病** 是一種與 **代謝紊亂** 有關的慢性疾病，但不是所有糖尿病患者都會發展為癌症。\n\n* **高分化癌** 是一種癌症的 **分類**，指癌細胞在顯微鏡下觀察到的 **結構和功能** 與正常細胞更相似，增殖能力較弱的類型。\n\n* **己糖激酶** 是一種參與細胞 **代謝** 的酶，但它 **並非** 所有的情況下都會導致糖尿病患者的 **癌變**。\n\n**因此，在其他情況下，A, B, C 都是錯誤的答案。**\n\n**總結：**\n\n* **A. 細胞** \n* **B. 糖尿病** 是一種與細胞 **代謝** 失衡有關的 **慢性疾病**，但 **非** 典型情況，因為 **低分化** 細胞的 **增殖能力** 較低。\n\n* **C. 己糖** 是一種與 **糖代謝** 有關的 **高代謝** 細胞類型，但 **糖尿病** 是一種與 **高分化** 細胞 **失衡** 的情況，所以 **C. 萎縮性** 胃炎 **D. \n** \n* **低溫** 可降低酶的活性，但 **不** 會導致 **癌變**。\n\n**正確答案：D. \n\n**希望這個解釋對你有所幫助！**",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '結腸多發性腺瘤'], ['B', '十二指腸潰瘍'], ['C', '萎縮性胃炎'], ['D', '交界痣']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列關於酶嘅活性中心嘅論述，錯誤嘅係",
    "llm_output": "The answer is **B**. \n\nHere's why:\n\n* **與酶活性有關的必需基團以外的因素**\n\nLet's break down the options:\n\n* **A. 與酶活性有關的必需基團在酶的活性中心**\n\nThis statement is true. The active site is the specific region on an enzyme where the substrate binds and the chemical reaction takes place.\n\n* **B. 與酶活性有關的必需基團以外的結合基團與酶活性以外的結構有關**\n\nThis is the incorrect statement. This option suggests that the active site of an enzyme is not important for the enzyme's function, which is not true.\n\n* **C. 酶分子中各種的化學基團在酶活性以外的分子上都可能與其他因素有關**\n\nThis statement is true. The structure of an enzyme determines its function, and the presence of specific chemical groups in the active site is crucial for the enzyme's catalytic activity.\n\n* **D. 酶在反应中发生变化**\n\nThis statement is true. Enzymes are catalysts, and they often undergo conformational changes at the active site during the catalytic process.\n\n* **E. 酶在反应中发生 conformational changes**\n\nThis statement is true.  Enzymes are often involved in complex processes that require specific interactions with other molecules.\n\n* **D. \n\nThe correct answer is **B**.\n\nThe statement \"酶的化学性质以外的结构与酶活性有关\" is the most accurate.\n\nHere's why this is the key to understanding the function of enzymes:\n\n* **Enzymes are highly specific:**  The shape and chemical environment of the active site are crucial for the enzyme's function.\n\n* **Induced fit:** The active site doesn't have a rigid shape. It's flexible and can change to better fit the specific shape of the substrate.\n\n* **Other factors:** While the statement \"活性中心的形状和结构会发生变化，以适应酶的特定功能\" is true, it's important to remember that the active site is just one part of the overall structure of the enzyme. The environment around the active site, the shape of the protein outside the active site, and other factors like pH and temperature can also influence enzyme activity.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '與酶活性有關嘅必需基團喺一級結構上彼此靠近，形成活性中心'], ['B', '活性中心以外嘅必需基團與維持酶嘅特定空間構象有關'], ['C', '酶分子中嘅各種化學基團唔一定都與酶活性有關'], ['D', '活性中心嘅結合基團與底物結合形成酶-底物複合物']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "以下邊一組酶係糖酵解嘅關鍵酶",
    "llm_output": "The correct answer is **C**.\n\nHere's why:\n\n* **Hexokinase** is the enzyme that catalyzes the first step of glycolysis, phosphorylating glucose to glucose-6-phosphate. This is a crucial step in initiating the pathway.\n* **Glucose-6-phosphatase** is the enzyme responsible for the reverse reaction of hexokinase, dephosphorylating glucose-6-phosphate to glucose. It's involved in gluconeogenesis, not glycolysis.\n* **Phosphofructokinase-1 (PFK-1)** is a key regulatory enzyme in glycolysis.\n\nTherefore, the correct answer is **C**. \n\nThe correct answer to the question is **C**. \n\n**已糖激酶，醛縮酶，** **和** **葡糖-6-磷酸酶** are all involved in glucose metabolism, but **已糖-6-磷酸酶** is a key enzyme in the process of glycogenolysis (the breakdown of glycogen).",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '已糖激酶，果糖磷酸激酶-1，丙酮酸激酶'], ['B', '已糖激酶，醛縮酶，丙酮酸激酶'], ['C', '已糖激酶，果糖磷酸激酶-1，葡糖-6-磷酸酶'], ['D', '已糖激酶，果糖-1，6-二磷酸酶，丙酮酸激酶']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "非競爭性抑制劑對酶促反應速度嘅影響係",
    "llm_output": "The correct answer is **A**.\n\nHere's why:\n\n* **Km (Michaelis constant) is a measure of how well an enzyme binds to its substrate.** A competitive inhibitor binds to the active site of an enzyme, preventing the substrate from binding.\n\nLet me know if you'd like to know more about enzyme kinetics and different types of inhibitors. \n\nLet me know if you'd like to know more about enzyme kinetics and different types of inhibitors. \n\n\n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'Km唔變，Vmax下降'], ['B', 'Km下降，Vmax上升'], ['C', 'Km下降，Vmax下降'], ['D', 'Km上升，Vmax唔變']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "以下生理功能活動中存在負反饋調節嘅係",
    "llm_output": "D. \n\n**The answer is (D).**\n\nHere's why:\n\n* **Negative feedback** is a regulatory mechanism where the output of a process inhibits the process itself. This helps maintain homeostasis in biological systems.\n\nThe examples you provided illustrate this concept:\n\n* **(C) 萎縮性胃炎** is the correct answer because the process of enzyme regulation is a complex one involving various factors. \n\nLet's break down the examples:\n\n* **(A) 萎縮性胃炎** - This is a physiological process, not a disease.\n\nLet me know if you'd like to explore the concept of negative feedback in biological systems further. I can provide more information and examples. \n\n\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '望梅止渴嘅過程'], ['B', '血糖維持穩定嘅過程'], ['C', '生理性止血嘅過程'], ['D', '膝跳反射嘅過程']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺肌肉組織中，氨基酸脫氨基嘅主要方式係",
    "llm_output": "The answer is **C. 氧化脫氨作用 (Oxidative deamination)**.\n\nHere's why:\n\n* **氧化脫氨作用 (Oxidative deamination)** is the process where the body breaks down excess amino acids. This process is crucial for the regulation of blood glucose levels.\n\nLet me know if you'd like me to explain how the other options are incorrect. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '嘌呤核苷酸循環'], ['B', '轉氨基作用'], ['C', '氧化脫氨基作用'], ['D', '直接脫氨基作用']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1分子葡萄糖經磷酸戊糖途徑轉變為核糖-5-磷酸過程中，仲可產生",
    "llm_output": "The correct answer is **C. 氧化脫氨酸 (Oxidation of pentose phosphate pathway)**\n\nHere's why:\n\n* **氧化脫氨基作用 (Oxidation)** is a process that occurs in the **嘌呤核苷酸循環 (pentose phosphate pathway)**. This pathway is not directly involved in the conversion of amino acids to **核糖-5-磷酸 (ribulose-5-phosphate)**, which is a key product in the **pentose phosphate pathway**.\n\n* **C. ** **已** \n\n**Here's a breakdown of the answer and the reasoning:**\n\n* **The question asks for the correct answer to a specific question about the **\"pentose phosphate pathway\"** and asks for the product of the process.\n\n* **Option C** is the correct answer because it accurately reflects the process of **\"oxidative phosphorylation\"** which is a process that generates **NADPH** (a key coenzyme in many metabolic reactions)\n\nLet me know if you'd like to know more about the pentose phosphate pathway!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '2分子NADH+H+'], ['B', '1分子NADH+H+'], ['C', '2分子NADPH+H+'], ['D', '1分子NADPH+H+']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺生物氧化中NAD+嘅作用係",
    "llm_output": "答案：C\n\n**解釋：**\n\n* **嘌呤核苷酸代謝途徑** 涉及分解葡萄糖並產生能量，但係 **C** 選項描述的是 **B. 葡萄糖-6-磷酸** 的作用，而并非 **生物合成** 过程。\n* **生物氧化** 是一個複雜的過程，它涉及將能量從食物分子轉化為細胞可利用的能量（ATP）。\n\n**因此，正確答案是 C. 2. 直接產生核糖-5-磷酸**\n\n**其他選項解釋：**\n\n* **A. 1. 葡萄糖-5-磷酸** 係一個錯誤答案，因為它描述的是一個與能量生產無關的錯誤過程。\n\n**A. 遞糖** 是一種生物化學過程，並非大學醫學中常見的術語。\n\n**C. 嘌呤核苷酸** 是一种与 DNA 和 RNA 相关的核苷酸，而 A. 2. **直接脫氫** 则是一个错误的选项，因为肌肉组织中的葡萄糖主要通过 **糖酵解** 途径产生能量，而不是通过 **糖酵解** 途径被分解。\n\n**A. 碳水化合物代謝** 是一個正确答案，因為它描述的是 **肌肉組織** 中能量的產生和利用過程，而 A. 1. **葡糖-6-磷酸** 是一個重要的中间产物，它在 **糖酵解** 中被还原成 **NADH+H+** 的一个中间产物。\n\n**因此，正確答案是 C. 6. 葡萄糖-6-磷酸** \n\n**注意：**\n\n* 这是一个关于 **酶** 的问题，所以我们关注的是 **直接** 产生 **NADH+H+** 的过程。\n* **已糖** 是一种糖类物质，在生物化学反应中，它通常 **通过其他途径** 产生，例如 **糖酵解** 过程中的 **非氧化性磷酸化**。\n\n**所以，C 选项是错误的。**\n\n**正確答案：**\n\n* **A. 2. 6個碳原子** \n\n**A. 6. 6. 葡萄糖-6-磷酸** 是一個重要的 **糖酵解** 过程中的 **一个中间产物**，因为它是一个 **糖类代谢** 途径的产物，而不是一个 **直接** 产生能量的途径。",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '遞氫'], ['B', '脫羧'], ['C', '加氫'], ['D', '遞電子']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "漏出性出血嘅發生機制係由於",
    "llm_output": "The answer is **A. 血管壁病變**.\n\nHere's why:\n\n* **Competitive Inhibition:** This involves a molecule (the inhibitor) binding directly to the enzyme's active site, preventing the substrate (in this case, glucose) from binding.\n\n* **Non-competitive Inhibition:** This involves a molecule binding to a site on the enzyme *other than* the active site. This binding alters the enzyme's shape, making it less effective at binding to the substrate.\n\nLet's break down the options:\n\n* **A. 血管壁病變 (Tissue damage):** This is the most likely answer.  The examples provided show that the question is about the process of glucose metabolism and the role of a metabolic pathway.\n\n* **B. 血管壁周圍嘅** **(Other options are irrelevant):** This option focuses on the product of the pathway, not the type of inhibition.\n\n* **C. 2分子NADH+H+** **(Incorrect):**  The question asks for the \"main\" product of the process, not necessarily the only products.\n\n* **D. 血管壁嘅滲透壓增高 (Increased vascular permeability):** This option describes a process, not a product.\n\nSince the question is asking about the mechanism of a biological process, the most accurate answer is **competitive inhibition**.\n\nLet me know if you'd like to see more examples! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '血管壁周圍病變侵犯'], ['B', '毛細血管壁通透性增加'], ['C', '組織嘅滲透壓增高'], ['D', '血漿膠體滲透壓降低']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "磺胺類藥物嘅類似物係",
    "llm_output": "D. \n\n**遞電子** (decarboxylation) \n\n**Explanation:**\n\nThe answer is **D**.\n\n* **Biologically active molecules:**\n\nThe question asks about a process that is analogous to the function of the enzyme **decarboxylase**.\n\n* **Decarboxylation:**\n\nThis is the process of removing a carboxyl group (COOH) from a molecule.\n\n* **Decarboxylation in muscle tissue:**\n\nWhile decarboxylation occurs in various metabolic pathways, the question specifically asks about the mechanism of a biological process, implying a specific biological process related to muscle function.\n\n* **The answer:**\n\nThe enzyme that removes a carboxyl group from a molecule in muscle tissue is **pyruvate decarboxylase**. This enzyme plays a crucial role in the conversion of pyruvate to **acetyl-CoA**, a key step in the metabolism of carbohydrates.\n\n**Therefore, the answer to the question is A. ** \n\nLet me know if you'd like to know more about the process! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '葉酸'], ['B', '二氫葉酸'], ['C', '對氨基苯甲酸'], ['D', '四氫葉酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "糖酵解過程中，下列邊一反應過程為耗能階段",
    "llm_output": "The correct answer is **B. 果糖-1，6-二磷酸→乳酸**\n\n**Explanation:**\n\nThe question asks for the answer that describes the \"耗能階段\" (energy-consuming stage) of a process. This implies we're looking for a step that requires energy input.\n\n* **A. 葡萄糖→果糖1，6-二磷酸** (Glucose → Fructose-1,6-bisphosphate) is part of the **glycolysis pathway**, which is the **preparatory phase** of glycolysis where energy is *invested*.\n\n* **C. 磺酸鹽** (Sulphate) and **D. 葡萄糖→** (Glucose →) are irrelevant to the question as they are not related to the energy-consuming or energy-producing aspects of the process.\n\nTherefore, the answer must be **C. 答案：** (Answer: ) **C. 葡萄糖→** (Glucose →) **D. 四氫** (tetrahydroxy) **is the correct answer. \n\nThe **energy-consuming** phase of glycolysis is the **investment phase**, where glucose is converted to two molecules of glyceraldehyde-3-phosphate. This process requires 2 ATP molecules.\n\n**C. 磷酸丙糖** (Glucose →) **→ 磷酸丙糖** (Glyceraldehyde-3-phosphate) **C. 耗能階段** (is the energy-producing phase)\n\n**D. 耗能階段** (Energy-consuming phase) **is the correct answer**\n\n**Answer: A. 3-磷酸甘油酸**\n\n**Explanation:**\n\nThe question asks for the correct answer to be a product of the process, not the mechanism.\n\nThe correct answer is **A. 3-磷酸丙酮酸→** (Glyceraldehyde-3-phosphate).\n\nThe answer is **C. 3-磷酸丙糖** (Glucose-6-phosphate)\n\n**This is because the process of converting glucose-6-phosphate to 3-磷酸丙糖** (fructose-1,6-bisphosphate) **requires the use of ATP, making it an energy-consuming step.**\n\n**Therefore, the answer is C. 3-磷酸甘油酸** (3-Phosphoglycerate).",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '葡萄糖→果糖1，6-二磷酸'], ['B', '果糖-1，6-二磷酸→磷酸丙糖'], ['C', '丙酮酸→乳酸'], ['D', '磷酸丙糖→丙酮酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於風濕性肉芽腫嘅敘述，錯誤嘅係",
    "llm_output": "The answer is **A. 多發生於心肌間質**. \n\nHere's why:\n\n* **Rheumatoid fever** is a disease caused by an immune reaction, often triggered by a streptococcal infection. This reaction is not specific to the heart muscle (myocardium) but can affect various tissues, including the joints, skin, and brain.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '多發生於心肌間質血管旁'], ['B', '中心部位有較多纖維蛋白'], ['C', '特徵性細胞係Aschoff細胞'], ['D', '常伴有淋巴細胞、漿細胞浸潤']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種酶係糖酵解同糖異生途徑中共有嘅",
    "llm_output": "C. 已糖激質 (Pyruvate) \n \n \nLet me explain why:\n\n* **Glycolysis** is the process of breaking down glucose into pyruvate.\n\n* **Glycolysis** is a metabolic pathway that occurs in all living cells and is the first step in cellular respiration.\n\n* **Glucose-6-phosphatase** is an enzyme involved in the **opposite** process, **gluconeogenesis**, which is the production of glucose from non-carbohydrate sources.\n\n* **Glycolysis** is a key pathway in **metabolism**, and the **conversion of pyruvate to glucose** is a crucial step in **gluconeogenesis**.\n\nTherefore, the answer to the question is **C. 丙酮酸** (pyruvate). \n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '甘油醛-3-磷酸酶'], ['B', '丙酮酸羧化酶'], ['C', '已糖激酶'], ['D', '丙酮酸激酶']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "全酶係指",
    "llm_output": "The correct answer is **B. 酶蛋白-抑制劑複合物**\n\nHere's why:\n\n* **酶 (enzymes) are biological catalysts** that speed up chemical reactions in living organisms. They are proteins that facilitate the binding of substrates (the molecules they act upon) and are essential for life.\n\n* **The \"耗能階段\" (energy-consuming phase) in the answer choices refers to the process of glycolysis.**\n\nLet me break down the answer choices for you:\n\n* **A. 錯 (incorrect)** because it refers to a process within glycolysis, not the entire process.\n* **B. 錯誤 (incorrect)** because the question asks for a substance that is a \"substrate\" for the enzyme, implying a specific interaction.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '酶-抑制劑複合物'], ['B', '酶蛋白-輔助因子複合物'], ['C', '酶-底物複合物'], ['D', '酶-別構劑複合物']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於小葉性肺炎，錯誤嘅係",
    "llm_output": "答案：**A. 酶-抑制劑複合物** \n\n**解釋：**\n\n* **酶-底物複合物** 指的是酶与其底物结合后的中间产物，是**錯誤**的答案。\n\n**關於小儿麻痹症的解释：**\n\n* 小儿麻痹症是由病毒引起的，并非由所有選項所述的“酶-抑制劑複合物”。 \n\n**其他關於小兒麻痹症的正確答案：**\n\n* **B. 酶-蛋白-輔因子** \n* **C. 酶-底物-輔基** \n* **D. 酶-底物** \n\n**B. 病毒** \n\n* **B. 病毒** \n\n**解释：**\n\n* **全 answers：**\n\n* **B. 病毒** \n\n**C. 病毒**\n\n* **C. 酶-抑制劑複合物** \n\n**D. 病毒** \n\n**解釋：**\n\n* **B. 錯誤** \n\n**A. \n\n**B. 酶-抑制劑複合物** \n\n* **C. 酶-底物-複合體** \n\n**C. 酶-** **C. \n\n**D. \n\n**B. 病毒** \n\n* **D. \n\n**D. 病毒** \n\n**關於細菌和病毒的解释：**\n\n* 小儿麻痹症是由**病毒**引起的，并非由所有**病毒**感染导致的。\n\n**B. 酶-抑制劑複合體** \n\n* **B. \n\n**B. 酶-底物** \n\n**B. 病毒** \n\n* **B. \n\n**B. \n\n**C. \n\n**B. 病毒** \n\n* **C. \n\n**D. \n\n**B. \n\n* **C. 酶-抑制劑複合體** \n\n**C. \n\n**B. \n\n* **C. \n\n**C. \n\n**D. 酶-病毒** \n\n* **B. \n\n**答案：**\n\n* **B. \n\n**C. \n\n**D. \n\n* **B. \n\n**B. 病毒** \n\n* **C. \n\n**\n\n* **C. \n\n**C. \n\n* **\n\n**B. \n\n**\n\n**解釋：**\n\n* **B. 酶-抑制劑複合體** \n\n**其他关于B. 病毒的解释：**\n\n* \n\n* **B. 錯誤** \n\n* **C. 病毒** \n\n**C. \n\n**B. 酶-抑制劑複合體** \n\n* **D. \n\n**C. \n\n**\n\n* **C. \n\n**\n\n* **C. \n\n**B. \n\n**\n\n**C. 抑制劑**\n\n* **B. 錯誤** \n\n* **B. \n\n**C. \n\n**C. \n\n**B. \n\n**D. \n\n**B. 病毒** \n\n* **D. \n\n**B. \n\n**\n\n**B. \n\n**\n\n* **C. \n\n**B. \n\n**\n\n**C. 抑制劑**\n\n* **C. \n\n**B. \n\n**\n\n* **B. \n\n**\n\n**B. \n\n**C. \n\n**C. \n\n**C. \n\n**D. 抑制劑**\n\n* **B. \n\n**B. \n\n**C. \n\n**\n\n**C. \n\n**\n\n**C. \n\n* **C. \n\n**\n\n* **C. \n\n**B. \n\n**C. \n\n**\n\n**B. 抑制劑** \n\n**C. \n\n**\n\n**C. \n\n* **B. \n\n**B. \n\n**D. \n\n**\n\n**B. \n\n**D. \n\n**\n\n**B. \n\n**\n\n**B. \n\n**\n\n**\n\n**B. \n\n**\n\n**D. \n\n**B. \n\n**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**D. \n\n**B. \n\n**B. \n\n**D. \n\n**\n\n**D. \n\n* **B. \n\n**\n\n* **D. 病毒** \n\n**B. \n\n**D. \n\n**\n\n**\n\n**C. \n\n**\n\n* **B. \n\n**B. \n\n**B. \n\n**B. \n\n**C. \n\n**B. \n\n**\n\n**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '病竈融合為肺肉質變'], ['B', '可由多種細菌引起'], ['C', '常係某啲疾病嘅併發症'], ['D', '易激發肺嘅細菌同病毒感染']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "正常人血漿中下列邊種膽紅素量好低",
    "llm_output": "The answer is **B. 丙酮酸-底物**\n\nHere's why:\n\n* **Indirect bilirubin** is the unconjugated form of bilirubin found in the blood. It's not yet water-soluble and can't be easily excreted.\n\n* **Indirect bilirubin** is the form of bilirubin that is **not** directly conjugated in the liver. This means it's the form that is still bound to albumin (a protein in the blood) and is considered \"toxic\" to the body.\n\n* **Bilirubin-albumin complex** (D. \n\n**結合膽紅素**\n\n) is the form of bilirubin that is conjugated in the liver and is therefore less harmful.\n\n* The question implies that the normal, healthy state of a person's blood plasma should have a low concentration of a specific type of bilirubin. \n\nThe correct answer is **B. 丙酮酸** (**indirect bilirubin** is the correct answer, as it's the unconjugated form that is bound to albumin).\n\n**Here's a breakdown of the terms:**\n\n* **Direct bilirubin:** Also known as conjugated bilirubin, this is the form that is bound to glucuronic acid in the liver and can be easily excreted.\n* **Indirect bilirubin:** This is the unconjugated bilirubin, which is the form that is not directly excreted by the body and needs to be processed by the liver.\n\n**Therefore, the answer is B. \n\n**\n\nLet me know if you'd like to try more questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '遊離膽紅素'], ['B', '間接膽紅素'], ['C', '膽紅素-清蛋白'], ['D', '結合膽紅素']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "右心衰竭時組織液生成增加而致水腫，主要原因係",
    "llm_output": "答案： **B. 血管內水壓增高**\n\n**Explanation:**\n\nWhile the provided answer key says \"A\" (unconjugated bilirubin) is the answer, it's important to note that **the answer choices for multiple choice questions should be plausible and distinct**.\n\nIn this case, the question seems to be asking about the role of bilirubin in the context of blood plasma, not about the type of bilirubin.  \n\n**Here's why:**\n\n* **Unconjugated bilirubin** is the form of bilirubin found in the blood before it is processed by the liver. It's not directly related to the question of edema.\n\n* **Edema** is the swelling caused by excess fluid in the body's tissues.\n\n**The correct answer should be focused on the underlying cause of edema in the context of right heart failure.**\n\n**Here's a more appropriate set of choices:**\n\nA. **肝門靜脈血壓升高** (This is incorrect as it's a consequence of heart failure, not the cause)\nB. **血管內水壓增高**\nC. **血漿蛋白質濃度降低**\nD. **腎臟功能正常** (This is incorrect, as this option implies right heart failure doesn't cause edema, which is not true)\n\n**A more accurate question would be:**\n\n**Which of the following is NOT a typical characteristic of right heart failure?**\n\nA. **Increased blood volume in the peripheral circulation**\nB. **Increased blood pressure in the pulmonary circulation**\nC. **Increased unconjugated bilirubin in the blood**\nD. **Fluid retention due to increased venous pressure**\n\n**The correct answer to this question is C. 腎蛋白質**\n\n**Explanation for the correct answer:**\n\n* **C. 结膜下黄疸**\n\nThe question likely intends to focus on the **mechanism** of edema in right heart failure.\n\n**Here's why the original answer is incorrect:**\n\n* **Edema caused by right heart failure is due to a complex interplay of factors, but it's not primarily caused by a lack of bilirubin in the blood.**\n\n**The original question likely intended to ask about the cause of edema in the context of right heart failure, which is the answer to the question:**\n\n* **D. 血管內水壓增高** (Increased blood pressure in the blood)\n\n**This is the correct answer because it directly addresses the physiological cause of edema in the context of right heart failure.**\n\n**The original answer choices are incorrect because:**\n\n* **A. 血管內血壓升高** (Increased liver blood pressure) is a factor in edema, but not the direct cause in this case.\n\n**Correct answer to the original question:**\n\n* **B. 淋巴細胞、淋巴球蛋白增高** (B. Increased unconjugated bilirubin)\n\n**This is the correct answer because it refers to the specific type of bilirubin (unconjugated) that increases in the blood during edema, leading to the correct answer being the answer to the original question.**\n\n**C. 淋衡** (C. 淋衡) is not a correct answer choice.\n\n* **C. 淋巴細胞減少** (Lymphocyte count is decreased)\n\n**This is incorrect as it is not a typical characteristic of right heart failure.**\n\n**Here's why the other options are incorrect:**\n\n* **A. 血管内水壓增高** (A. Increased blood pressure in the blood) is a common cause of edema, but it's not the only cause.\n\n**The correct answer to the original question is C. 血管內水壓升高 (Bilirubin level is not a typical characteristic of right heart failure)\n\n**\n\n**Explanation for the correct answer:**\n\n* **The correct answer is C. 淋巴細胞 count is not a primary cause of edema.**\n\n**Why the other options are incorrect:**\n\n* **A. 肺** (A. Increased lymphocyte count) is incorrect because it is not a typical cause of edema.\n\n**Why the other options are incorrect:**\n\n* **A. 淋巴細胞** (A. 淋巴細胞) is incorrect as it is a type of cell, not a physiological condition.\n\n**The correct answer, \"B. 淋巴细胞减少\" (B. Decreased lymphocyte count) is incorrect because it is a potential consequence of certain types of edema, but not a characteristic of the condition itself.\n\n**\n\n**The correct answer is C. Decreased lymphocyte count is not a typical cause of edema.\n\n**The other options are incorrect because they are not related to edema.\n\n**Here's a more accurate explanation of the answer choices:**\n\n* **C. Decreased lymphocyte count** (C. 淋巴细胞减少) is the correct answer.\n\n**Here",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '組織液靜水壓降低'], ['B', '組織膠體滲透壓增高'], ['C', '毛細血管血壓增高'], ['D', '血漿膠體滲透壓降低']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "頸動脈竇壓力感受器反射屬於",
    "llm_output": "The answer is **A. 神經-組織液生成**\n\n**Explanation:**\n\n* **Carotid sinus reflex** is a baroreceptor reflex, meaning it's a physiological response to changes in blood pressure. \n\n* **Baroreceptors** are specialized sensory receptors that detect pressure changes in the blood vessels.\n\n* **The carotid sinus reflex** is triggered by a decrease in carotid sinus pressure, which is a type of **baroreceptor reflex** that involves the carotid sinus.\n\nLet me know if you'd like to try another practice question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '神經—體液調節'], ['B', '自身調節'], ['C', '體液調節'], ['D', '神經調節']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "呼吸阻力中非彈性阻力嘅主要成分係",
    "llm_output": "The correct answer is **C. 肺泡表面張力 (Lung compliance)**. \n\nHere's why:\n\n* **呼吸阻力 (Airway resistance)** is the resistance to airflow in the airways.\n* **非彈性阻力 (Non-elastic resistance)** refers to the resistance to airflow due to factors other than the fluid in the lungs, such as the chest wall and the muscles involved in breathing.\n\nLet me know if you have any other questions!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '氣道阻力'], ['B', '組織粘滯阻力'], ['C', '肺回縮力'], ['D', '肺泡表面張力']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "甘油-3-磷酸穿梭機制中3-磷酸甘油脫氫酶喺胞質中嘅輔酶係",
    "llm_output": "C. \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'FAD'], ['B', 'NAD+'], ['C', 'CoQ'], ['D', 'FMN']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於PH酶促反應速度影響嘅論述，錯誤嘅係",
    "llm_output": "The correct answer is **C**. Here's why:\n\n* **A. FAD (A) is incorrect.** FAD (flavin adenine dinucleotide) is a coenzyme involved in some enzymatic reactions, but not all.\n\n* **B. 呼吸阻力 (B) is a term that refers to the resistance to airflow in the airways, not a specific factor in the process.**\n\nLet's break down why the other options are incorrect and why PH 影響酶、底物或者組織膠體 is the correct answer:\n\n* **A.  is incorrect.**  FAD is a coenzyme, and while it can be affected by pH changes, it's not the only factor. \n\n* **B.  is incorrect.** This is a partially correct statement. While the \"breathing\" process itself doesn't directly involve PH, it's the process of **cellular respiration** that relies on the proper functioning of the mitochondria, which are affected by pH changes.\n\n* **D. is incorrect.**  This option is incorrect because it implies that PH is a type of enzyme.  \n\n**Therefore, the correct answer is (D) because it's the only option that contains a completely incorrect statement.**\n\nLet me know if you'd like to know more about how pH affects enzyme activity. \n\nLet me know if you have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'PH過高或者過低可使酶發生變性'], ['B', '最適PH係酶嘅特性常數'], ['C', '最適PH唔係酶嘅特性常數'], ['D', 'PH影響酶、底物或者輔助因子嘅解離度，從而影響酶促反應速度']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種離子能激活唾液澱粉酶嘅活性",
    "llm_output": "C. \n\nHere's why:\n\n* **Enzymes and their activation:**  Enzymes are biological catalysts that require specific conditions to function optimally. One crucial factor is the presence of cofactors, which can be metal ions or small molecules.\n\n* **Cofactors and enzyme activity:**\n\n   * **Coenzymes** are organic molecules that assist enzymes. \n   * **Cofactors** are inorganic or organic compounds that are essential for the activity of some enzymes. They are often metal ions (like **Zn2+** or **Mg2+**), but can also be organic molecules like vitamins.\n\n* **Correct answer:**\n\n   * **Chloride ions (Cl-)** are essential for the proper function of **salivary amylase (also known as ptyalin)**, which is the correct answer.\n\n* **Incorrect answers:**\n\n   * **A. Zn2+** (Zinc ions) are often cofactors for enzymes, but **not** all enzymes require them.\n   * **B. Mg2+** (Magnesium ions) are also cofactors for enzymes, but they are not the primary activator for the specific enzyme mentioned in the question.\n   * **D.  B.  Mg2+** (Magnesium ions) are essential for the activity of some enzymes, but they are not the primary activator for the enzyme mentioned in the question.\n\n**Therefore, the correct answer is C. K+**\n\nLet me know if you'd like to try another question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'Zn2+'], ['B', 'Mg2+'], ['C', 'K+'], ['D', 'Cl-']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酶同一般催化劑嘅區別係",
    "llm_output": "C. \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '只能加速熱力學上可以進行嘅反應'], ['B', '唔改變化學反應嘅平衡點'], ['C', '具有高度特異性'], ['D', '縮短達到化學平衡嘅時間']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有機磷農藥中毒時，下列邊一種酶受到抑制",
    "llm_output": "The answer is **B. 膽鹼酯酶**\n\nHere's why:\n\n* **Organophosphate poisoning** specifically targets **acetylcholinesterase (AChE)**, an enzyme crucial for breaking down the neurotransmitter acetylcholine in the nervous system. \n\nThe examples you provided illustrate the format of the questions and the nature of the answer.  \n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '已糖激酶'], ['B', '膽鹼酯酶'], ['C', '乳酸脫氫酶'], ['D', '碳酸酐酶']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於膽鹼酯酶嘅描述唔正確嘅係",
    "llm_output": "C. \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '可受有機磷化合物抑制'], ['B', '係催化乙酰膽鹼水解嘅酶'], ['C', '屬典型嘅巰基酶'], ['D', '該酶失活，可造成乙酰膽鹼喺體內過多堆積而中毒']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "磷酸戊糖途徑嘅主要產物係",
    "llm_output": "The answer is **B. NADPH+H2**.\n\nThe pentose phosphate pathway (PPP) is a metabolic pathway that produces **NADPH** and **pentoses** (5-carbon sugars) as its main products. \n\nLet me know if you have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'NADPH+H+同FADH2'], ['B', 'NADPH+H+同核糖-5-磷酸'], ['C', 'NADPH+H+同甘油-3-磷酸'], ['D', 'NADPH+H+同葡糖-6-磷酸']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "岡崎片段產生嘅原因係",
    "llm_output": "回應：A \n\n岡崎片段的产生是因为DNA聚合酶只能在一条DNA链上5'到3'方向连续地进行DNA复制。 \n\n在DNA复制过程中，DNA聚合酶需要一个RNA引物来开始合成新链。DNA链的解链方向是固定的，但由于DNA双螺旋结构的限制，DNA聚合酶只能在5'到3'方向上添加新的核苷酸。\n\n在DNA双链复制时，由于DNA双螺旋的双链结构，DNA聚合酶只能在5'到3'方向上进行连续的合成。 因此，DNA的滞留链（5'到3'方向）需要先形成岡崎片段，然后在 DNA 复制过程中进行合成。 \n\nThis is a bit of a trick question! While the answer is technically **A.岡崎片段** (Okazaki fragments), it's designed to test your understanding of the concept rather than a specific enzyme. \n\n* **A. 5'到3'方向** (5' to 3' direction) is the direction in which DNA polymerase adds nucleotides to the growing DNA strand during replication.\n\n* **B. NADPH+H+** is incorrect because DNA polymerase is not inhibited by the product of DNA polymerase activity, but rather by the leading strand's direction of synthesis.\n\n* **C. 5'到3'方向** (5' to 3' direction) is the correct answer because it highlights the key limitation of DNA polymerase: the leading strand can be built continuously, but the lagging strand is not.\n\n* **D. 關於岡崎片段嘅形成** (Okazaki fragments) **is a bit misleading.** While the lagging strand is indeed the result of DNA being synthesized in a 5' to 3' direction, the question asks for a description that is **incorrect**, and this option highlights the process of DNA replication, not an incorrect statement about it.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '複製同解鏈方向相反'], ['B', '雙向複製'], ['C', '複製中DNA有纏繞打結現象'], ['D', 'DNA複製速度太快']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "高血壓病時，細小動脈硬化嘅主要病理改變係",
    "llm_output": "答案： **A. 內膜** **增生** \n\n**解釋：**\n\n* **A. 內膜** **增締** **固醇沉著**：這是錯誤的。高血壓病主要導致 **中層肌肉層** 的 **增生**，而非内膜。\n\n* **B. 雙向複製**：\n\n有機磷農藥中毒會導致內層肌肉層增生，但並非答案選項中所述的「內膜膽固醇沉著」。 \n\n* **B. 內層肌肉層** **增生** **B. 係導致** **雙向複製** **的典型特徵是** **血管的損傷和血管平滑肌的增生**，而非其本身被抑制。\n\n* **C. 肌肉層** **內膜** **增生**：\n\n這是一個正確的描述，因為 **血管內膜的增生** 是高血壓病導致的 **常見** 的病理改變。\n\n* **D. \n\n高血壓時，會導致 **血管內壁的平滑肌增厚**，而非產生「岡崎片段」。岡崎片段是 **DNA复制过程中** 产生的 **短片段**，与 **RNA \n\n**相关** 的 **DNA聚合酶** \n\n**在** **DNA 复制** 中，**DNA 複製** 過程中會產生 **新的 DNA 片段**，這些片段稱為 **A. 血管** **內層** 的 **岡崎片段** \n\n**B. \n\n** \n**在** DNA 複製中，**高血壓** 是一種常見的 **併發症**，而非 **高血壓** 是一種 **疾病**。\n\n**血管內膜** \n在 **DNA 複製** 中，岡崎片段 **B. 血管** 的 **血管** \n**相關** 的 **選項** 錯誤**\n\n**血管** **內壁** 的 **血管** 的 **血管** \n\n**C. \n\n** \n\n**D. \n\n** \n**B. 血管** 的 **內層** \n**B. 血管** 的 **內層** \n**B. 血管** 的 **原因** \n**A. 導致** **A. 血管** 的 **抑制** \n**B. 典型** 的 **B. \n**\n\n**B. 血管** 的 **B. 碎片** \n**B. \n\n** \n\n**A. \n\n**B. \n**\n\n**答案：** **A. 內層肌肉層的** **B. 血管** **的** **B. \n\n**B. 抑制** **\n\n**B. \n\n**B. \n\n**\n\n**B. \n\n**A. \n\n**B. \n\n**B. \n\n**\n\n**答案：** **A. 內層** 的 **A. \n\n**B. \n\n**\n\n**B. 產生\n\n**解釋：**\n\n* **高血壓** \n\n**\n\n**\n\n**B. \n\n**\n\n**C. \n\n**A. 血管** 的 **B. \n\n**\n\n**產生**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '內膜結締組織增生'], ['B', '內膜膽固醇沉著'], ['C', '管壁玻璃樣變'], ['D', '內膜彈力纖維增生']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "抑制動脈粥樣硬化症發病嘅因素係",
    "llm_output": "答案：A.  \n\n解释：\n\n* **DNA复制的双向性**\n\n大学醫学中，**DNA 复制** 是指DNA 聚合酶在DNA 双链上进行复制时，只能**沿着 5' 到 3' 的方向合成新的 DNA 链**。这与 **DNA复制过程** 中的**岡崎片段**形成有关，因为 **DNA复制** 涉及解开 DNA 双螺旋结构并复制两条链，而 **DNA 複製** 过程中，新链的合成是通过**断續性合成**的方式进行的，即 **5' 到 3' 的方向**进行，形成短片段，称为 **Okazaki片段**。\n\n其他选项不正确，因为它们描述的是 **DNA 复制** 的过程，而不是 **抑制** 产生的原因。 \n\n* **高血壓病** 的主要原因是 **高血壓**，而並非高血壓病本身導致血管硬化。 \n\n希望這個解釋對您有幫助！",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '極低密度脂蛋白'], ['B', '膽固醇'], ['C', '低密度脂蛋白'], ['D', '高密度脂蛋白']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於糖酵解嘅正確描述係",
    "llm_output": "**答案：A**\n\n**解釋：**\n\n* **A. 喺** **(In the) 細胞質中進行 (cytoplasm)**\n\n大學醫學 (University medicine) 係指在細胞質中進行的生物化学过程，包括 **生成** **(glycolysis)**，而 **生成** 38 分子 ATP 嘅過程係指 **細胞呼吸** 嘅過程，而非所有嘅細胞都進行緊。\n\n* **其他選項不正確，因為：**\n\n    * **B. 生成38分子ATP** 係錯誤嘅，因為 38 ATP 係細胞呼吸過程中總共產生的能量數量，而唔係極小動脈粥樣硬化 (atherosclerosis) 嘅描述。\n    * **C. 細胞呼吸** 係錯誤嘅，因為呢個選項描述的是 **細胞呼吸** 的過程，而非 **生成** 的過程。\n    * **D. 喺** **(B. 產生) 細胞質中進行 (cytoplasm) **(cytoplasm)** 係一個錯誤的描述，因為 38 個分子 ATP 係 **細胞呼吸** 過程產生能量的總量，而非 **生成** 的過程。\n\n**其他選項** **(D. 典型嘅細胞質) 係錯誤嘅，因為 **\n\n* **B. 38 係指** **生成** **過程中產生嘅** **ATP** **數量** 係一個錯誤的描述，因為 38 個分子 ATP 係指在 **有氧** 呼吸過程中，通過 **電子傳遞鏈** 產生能量的總量。\n\n**正確答案：C**\n\n**A. 喺** **細胞質中進行** 係錯誤的，因為 38 係指**電子傳遞鏈** 產生能量的總量，而非所有細胞都進行** \n\n**Let me know if you'd like to try another question!**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '喺細胞質中進行'], ['B', '生成38分子ATP'], ['C', '全過程係可逆嘅'], ['D', '唔消耗ATP']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有機磷殺蟲劑對膽鹼酯酶嘅抑制作用屬於",
    "llm_output": "The answer is **C. 不可逆性抑制作用 (Non-competitive inhibition)**. \n\nHere's why:\n\n* **Organic phosphate insecticides** inhibit the function of **acetylcholinesterase**, an enzyme crucial for nerve signal transmission in insects.\n\nLet me know if you'd like to know more about enzyme inhibition!  I can explain the different types if you're interested. \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '反競爭性抑制作用'], ['B', '非競爭性抑制作用'], ['C', '不可逆性抑制作用'], ['D', '競爭性抑制作用']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "符合輔酶嘅敘述係",
    "llm_output": "The correct answer is **B. 參與氫原子、電子或者化異性**\n\nHere's why:\n\n* **符合** means \"to conform to\" or \"to be consistent with\".\n\n* **B. 參與氫原子、電子或者化學基團嘅傳遞** translates to \"participate in the transfer of hydrogen atoms, electrons, or chemical groups\".\n\nLet's break down the meaning in relation to the answer choices:\n\n* **A. 唔能用透析與酶分離** means \"cannot be separated from the enzyme by dialysis\". This is a characteristic of **prosthetic groups**, which are permanently bound to enzymes, not the enzymes themselves.\n\n* **B. 參與... 或者... 嘅** means \"participate in... or...\". This implies that prosthetic groups are involved in the process.\n\n* **C. 構成** means \"to constitute\".  While prosthetic groups are part of enzymes, this option doesn't directly relate to the concept of enzyme inhibition.\n\n* **D. 唔參與... 或者... 嘅** means \"does not constitute or... \"\n\nTherefore, **B. 參與** is the correct answer as it accurately describes the role of a prosthetic group in enzyme activity.\n\n\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '唔能用透析與酶蛋白分開'], ['B', '參與氫原子、電子或者化學基團嘅傳遞'], ['C', '決定酶嘅特異性'], ['D', '唔參與活性部位嘅組成']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關原發性高血壓嘅敘述，錯誤嘅係",
    "llm_output": "答案：**B**\n\n**解釋：**\n\n高血壓通常不會導致糖尿病。\n\n**糖尿病** 是一种由多种因素引起的慢性疾病，包括基因、生活方式和环境因素。 \n\n**高密度脂蛋白** (HDL) **和** **低密度脂蛋白** (LDL) **的解释：**\n\n* **A. 肾脏** \n  **B. 继发性高血壓** \n  * 肾脏：**A. 肾臟** \n  * **C. \n\n**C. 答案：** **C. 高密度脂蛋白**\n\n以下是其他選項的解釋：\n\n* **A.  关于高血壓的描述：**\n\n高密度脂蛋白**（HDL）** \n* 肾脏：**C. 肾臟** \n* **D. 无法与肾脏** \n* **B. \n  **C. \n\n**正确答案：**\n\n* **A. \n  **B. \n\n**A. \n** \n* **B. 无法** \n* **C. \n  **D. \n* **C. \n* **C. \n** \n\n**B. 肾脏** **C. \n  **B** \n\n**D. \n** **A. 競爭性** \n\n**C. \n** \n* **C. \n**C. \n* **D. \n* **A. \n* **B. \n* **D.  \n* **\n\n**C. \n**\n\n**C. \n**\n\n**A. \n** \n* **A. \n**C. \n* **A. \n**\n\n**A. \n** \n* **A. \n**C. \n* **D. \n** \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '高血壓晚期嘅腎臟常為顆粒性固縮腎'], ['B', '高血壓可繼發糖尿病'], ['C', '高血壓病常引起左心室肥大'], ['D', '高血壓常引起下肢壞疽']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "反競爭性抑制作用嘅描述正確嘅係",
    "llm_output": "根據你提供的例子，我推斷你想要我回答的是关于大学生物学，特别是酶动力学方面的知识。\n\n**答案：D**\n\n**解释：**\n\n你提供的正确答案是 **C. 抑制劑使酶的活性部位被抑制**\n\n**关于抑制劑的解釋：**\n\n* **A, C** 錯誤\n\n* **B. 錯誤**\n\n* **D. 正確**\n\n**关于选项的解释：**\n\n* **D. 抑制劑會使酶的Km值降低**\n\n**选项D** 是关于抑制剂的正确描述。 \n\n**关于其他选项的解释：**\n\n* **选项A. 抑制劑既同酶相結合又使酶的Vmax降低** \n    * 这是部分正确的，因为抑制剂可以与酶结合，但它不会改变酶的Vmax值。\n* **选项B. 酶促反应的Vmax值** \n    * **Vmax** 是酶催化反应在饱和状态下达到最大速度的条件，即所有酶都与底物结合，并以最大速度工作时，酶的反应速率。\n* **选项C. 抑制劑** \n\n**选项C** 也是错误的，因为抑制剂的结合方式有很多种，并非只有选项中描述的两种。\n\n**关于你提供的例子中，选项A. 错，选项B. 正確，选项D. 抑制劑使酶促反應的Vmax值** \n\n**选项B. 符合以下情况：**\n\n* 选项 **B. 抑制反應的Vmax值** \n\n**D** 选项是正确的，因为 Vmax 值表示的是酶在饱和状态下反应的最大速率，而这个选项描述的是抑制剂的结合方式**是** 选项 **B. 抑制劑** 的一种情况。\n\n希望这个解释清楚！",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '抑制劑既同酶相結合又同酶-底物複合物相結合'], ['B', '抑制劑使酶促反應嘅Km值降低，Vmax升高'], ['C', '抑制劑只同酶-底物複合物結合'], ['D', '抑制劑使酶促反應嘅Km值升高，Vmax降低']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酶同一般催化劑具有以下共性，例外嘅係",
    "llm_output": "The answer is **A**.\n\nHere's why:\n\n* **Enzymes can change the reaction equilibrium.** This statement is incorrect. Enzymes, like all catalysts, do not change the equilibrium position of a reaction. They speed up the rate at which a reaction reaches equilibrium but don't affect the final ratio of products to reactants.\n\nLet's break down why the other options are correct descriptions of enzyme characteristics:\n\n* **B. 降低反應活化能 (Lower the activation energy of a reaction)** This is a key function of enzymes. They act as catalysts, meaning they facilitate chemical reactions by lowering the activation energy required for the reaction to occur.\n\n* **D. 參與反應，但係唔改變反應後嘅產物嘅數量** (Facilitate chemical reactions) This is a more general way of saying that enzymes are catalysts, meaning they speed up the rate of a reaction without being consumed in the process.\n\nLet me know if you'd like to know more about enzymes! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '唔能改變反應平衡點'], ['B', '降低反應活化能'], ['C', '反應前後自身冇質同量嘅改變'], ['D', '由特定構想嘅活性中心發揮作用']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "葡糖-6-磷酸→葡萄糖酸-6-磷酸，需要參與嘅輔酶係",
    "llm_output": "C. \n\n**Explanation:**\n\nThis is a question about the specific enzyme involved in the conversion of glucose to glucose-6-phosphate. The correct answer is **C. NADP+**.\n\nHere's why:\n\n* **NAD+** (Nicotinamide adenine dinucleotide) and **FAD** (Flavin adenine dinucleotide) are both coenzymes, but they are not the primary enzymes involved in the specific conversion of glucose to glucose-6-phosphate.\n\n* **NADP+** is the specific coenzyme involved in the process. \n\nLet me know if you'd like to try another practice question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', 'FMN'], ['B', 'NAD+'], ['C', 'NADP+'], ['D', 'FAD']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1分子乙酰輔酶A經三羧酸循環氧化可產生ATP分子數",
    "llm_output": "The correct answer is **C. 15**.\n\nHere's why:\n\n* **The Citric Acid Cycle (Krebs Cycle) produces 1 molecule of ATP per molecule of acetyl-CoA that enters the cycle.**\n\nLet's break down the question and answer:\n\n* **The question asks about the number of ATP molecules produced per molecule of \n\"substrate\" in the context of \"enzymes\".** This is a bit of a trick, as it's trying to make you think about the citric acid cycle.\n\n* **The question mentions a specific molecule, \"葡萄糖-6-磷酸\" (glucose-6-phosphate), which is a precursor to glucose-6-phosphate dehydrogenase (G6PD) in the cycle.** This is a clue that the question is specifically referring to the citric acid cycle, not the electron transport chain.\n\n* **The Citric Acid Cycle (G6PD) is a metabolic pathway that occurs in the mitochondria.** This is a key piece of information.\n\n* **The Citric Acid Cycle is a key part of cellular respiration, which is the process of generating energy (ATP) from the breakdown of glucose.**\n\nLet me know if you'd like to see more examples of this type of question! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '9'], ['B', '15'], ['C', '11'], ['D', '10']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列物質喺體內氧化成CO2及H2O時生成ATP最多嘅係",
    "llm_output": "The correct answer is **C. 15**\n\nHere's why:\n\n* **The correct answer is D. C. 6-磷酸**\n\nThe question asks for the answer choice that represents the substance which produces the most ATP when oxidized.  \n\n* **1分子葡萄酸 (one molecule of glucose-6-phosphate) can be oxidized to produce 1 molecule of ATP.**\n\nThis is a bit of a trick question. It's important to remember that glucose-6-phosphate is an intermediate in metabolic pathways, not a direct source of significant ATP production.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '乳酸'], ['B', '丙酮酸'], ['C', '穀氨酸'], ['D', '草酰乙酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於前饋控制嘅敘述中，正確嘅係",
    "llm_output": "The correct answer is **C**. \n\nHere's why:\n\n* **Feedback control** is a type of regulation in which the product of a metabolic pathway inhibits an enzyme earlier in the pathway. This is a mechanism for controlling the rate of metabolic reactions based on the concentration of the end product.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '常喺局部同短時間內發揮作用'], ['B', '具有滯後同波動嘅缺點'], ['C', '具有預見性，適應範圍大'], ['D', '前饋控制唔會發生失誤']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "飢餓時肝中邊個代謝途徑加強",
    "llm_output": "A.  **糖酵解**\n\n**解釋：**\n\nThe correct answer is **A. 糖異生**\n\nHere's why:\n\n* **糖異生 (Gluconeogenesis)** is the metabolic pathway that generates glucose from non-carbohydrate sources. This process is crucial during fasting as the body needs to maintain blood glucose levels.\n\nThe other options are incorrect because:\n\n* **脂肪合成 (Lipogenesis)** is the process of creating fatty acids from excess energy, and this process is generally suppressed during fasting.\n* **脂肪的氧化 (Fatty Acid Oxidation)** is the process of breaking down fatty acids for energy, which is the opposite of what happens during fasting.\n\nLet me know if you have any other questions!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '糖異生'], ['B', '脂肪嘅合成'], ['C', '糖酵解'], ['D', '糖有氧氧化']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1分子軟脂酸徹底氧化分解，淨產生幾多分子ATP",
    "llm_output": "The answer is **D. D) 脂肪酸氧化** (fatty acid oxidation).\n\nHere's why:\n\n* **脂肪酸氧化** (Fatty acid oxidation) is the process of breaking down fatty acids to produce energy (ATP).\n\nLet me know if you'd like to try another university-level question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '127'], ['B', '128'], ['C', '106'], ['D', '131']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "乾性壞疽同濕性壞疽嘅區別在於前者",
    "llm_output": "C. \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '全身中毒症狀嚴重'], ['B', '同正常組織分界清楚'], ['C', '靜脈迴流通暢'], ['D', '好發生於四肢末端']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "亞急性細菌性心內膜炎嘅贅生物脫落後最常見嘅栓塞部位係",
    "llm_output": "The answer is **C. 肺栓塞** (pulmonary embolism)\n\n**Explanation:**\n\nThe question asks for the most common location of embolization in the case of a specific type of infection:\n\n* **亚急性細菌性心內膜炎** (subacute bacterial endocarditis)\n\nThis means the answer should reflect a specific aspect of the disease.  \n\nWhile the other options might be involved in some cases, the most common and characteristic complication of bacterial endocarditis is **embolization to the lungs (肺栓塞)**. This is because the bacteria in the bloodstream can clump together with platelets and fibrin, forming small vegetations (thrombi) that can break off and travel to the lungs, causing a pulmonary embolism.\n\nLet me know if you have any other questions! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '脾'], ['B', '皮膚'], ['C', '腦'], ['D', '腎']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "胰島素降低血糖係多方面嘅綜合作用效果，但唔包括",
    "llm_output": "The answer is **C. 加速糖嘅有氧氧化**.\n\nHere's why:\n\n* **Insulin** is a hormone that works to *lower* blood sugar levels. It does this by promoting glucose uptake into cells and stimulating the conversion of glucose into glycogen (glycogenesis) for storage, rather than accelerating its breakdown.**\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '抑制糖原嘅分解'], ['B', '加強糖原嘅合成'], ['C', '加強脂肪動員'], ['D', '加速糖嘅有氧氧化']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "三羧酸循環嘅起始反應係",
    "llm_output": "D. 腦 \n\nThe correct answer to the last example is **A. 乙酰輔酶A**\n\n**Explanation:**\n\nThe prompt \"What is the most common site of embolism in the body?\" is asking for the general location where emboli (blood clots) typically lodge.  \n\nWhile the other options might be true in specific cases, the most common site for embolism is the **肺部 (lungs)**. \n\nThe other answers are incorrect because they refer to specific processes that are not directly related to the location of embolism. \n\n* **A. 抑制糖原嘅分解 (inhibiting glycolysis)**: This is a function that is related to insulin, but not the specific answer to the question.\n* **B. 抑制血糖 (inhibiting glucose) **: This is not a specific medical term and doesn't accurately describe a function of insulin.\n\nLet me know if you'd like more examples or explanations about the citric acid cycle!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '乙酰輔酶A同二氧化碳縮合'], ['B', '乙酰輔酶A同草酰乙酸縮合'], ['C', '丙酮酸同草酰乙酸縮合'], ['D', '丙酮酸同二氧化碳縮合']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "溫度對酶促反應速度影響嘅論述，正確嘅係",
    "llm_output": "答案：C.\n\n**解釋：**\n\n* **A. 最適溫度係酶嘅特性常數，** \n**同酶活性無關**\n\n這是一個錯誤的敘述。最適溫度是酶最有效率地催化反應的溫度，與反應時間的關係是複雜的，溫度會影響酶的催化效率。\n\n* **B. 溫度升高可使大多數酶發生變性**\n\n這是一個錯誤的敘述。雖然高溫會導致酶失去活性，但**溫度升高通常會使酶促反應速度加快，直到達到一個最佳溫度點後，就會開始降低**。\n\n* **C. 溫度升高可加速酶的活性**\n\n這是一個**正確**的敘述。酶的活性會隨著溫度升高而增加，直到達到其最佳溫度，之後溫度再高，酶就會開始**失活**。\n\n* **D. 溫度升高會使酶的活性降低**\n\n這是一個**正確**的敘述。酶的活性會隨著溫度升高而**增加**，直到達到一個**特定溫度**後，就會**降低**。\n\n**總結：**\n\n溫度對酶促反應速度影響的，是**溫度對酶的活性**，而答案C選項中**溫度升高**导致的**酶活性降低**是正确的。 \n\n**注意：**\n\n* 酶的**最佳溫度**是其活性最高時所處的溫度。\n* 溫度過高會導致酶**失活**，因為其三維結構會被破壞，导致**酶的活性降低**。\n\n**因此，答案是C。**\n\n**C. 以下關於酶的敘述**\n\n**正確**的敘述是**酶的活性會随着溫度升高而** **降低** **，因為溫度過高會導致酶** **失活** **。**\n\n**溫度對酶的影響**\n\n* 溫度升高會使酶的活性**升高**，直到達到一個**特定溫度**後，**酶會開始** ** **變性** **，** 導致其活性**降低**，因為高溫會破壞酶的**三維結構**，使其無法正常工作。\n\n**A. 溫度升高會使酶的活性開始降低**\n\n**B. 溫度降低** **會使酶的活性降低** **。**\n\n**C. 溫度會** **導致酶的活性降低** **。**\n\n**B. 溫度降低** **會使酶的活性開始降低**\n\n* 溫度降低**會使酶的活性降低**，因為低溫會**減慢反應速度**，直到反應完全停止。\n\n**B. 溫度** **會** **導致酶的活性降低**\n\n**C. 溫度** **會影響** **酶的活性** **，使其** **失去活性** **。**\n\n**答案：**\n\n* **A. 最適溫度** **係** **酶的特性** **，** 溫度升高**會使酶的活性降低** **。**\n\n**D. 溫度升高** **會使酶的活性降低**\n\n* 溫度**會** **影响** **酶的活性**\n\n**C. 溫度降低** **會使酶的活性降低**\n\n* 溫度降低**會** **影响** **酶的活性** **，** 因為酶的活性會隨著溫度**降低**而降低。\n\n**C. 溫度** **會** **使酶的活性降低** **，** 這是**正確**的答案。\n\n**C. 溫度升高** **會使酶的活性降低**\n\n* 溫度降低**会** **影响** **酶的活性** **，** 因為溫度升高**会** **使酶的活性降低** **。**\n\n**C. 溫度** **會** **影响** **酶的反應速度**\n\n**C. 溫度降低** **會使酶的活性降低**\n\n* 酶的活性會随着温度降低而**降低** **，** 因為酶的**最佳反應溫度** **存在** **，** 且**酶的活性** **會** **降低**\n\n**B. 溫度降低** **會使酶的活性降低**\n\n**的** **反应速度** **，** 因为**溫度** **升高**会使酶的活性**開始** **降低** **。**\n\n* \n\n**C. 溫度** **降低**\n\n**會使酶的活性降低**\n\n**的** **答案** **是** **正确**的。**",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '最適溫度係酶嘅特性常數，同反應時間無關'], ['B', '溫度升高反應速度加快，同一般催化劑完全相同'], ['C', '低溫可使大多數酶發生變性而使酶活性降低'], ['D', '最適溫度唔係酶嘅特性常數，延長反應時間，其最適溫度降低']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "液化性壞死常見於",
    "llm_output": "C. 小腸 \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '腦'], ['B', '腎臟'], ['C', '小腸'], ['D', '心臟']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊項情況下可以發生代謝性酸中毒",
    "llm_output": "C. \n\n**Here's why:**\n\n* **Acidosis** refers to a condition where the body has too much acid.\n\n* **Metabolic acidosis** specifically means the excess acid is due to a problem with the body's metabolism, not the respiratory system.\n\n* **Respiratory acidosis** occurs when the body cannot get rid of carbon dioxide (CO2) effectively, leading to a buildup of acid. \n\nLet me know if you'd like me to elaborate on the other types of questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '低血鉀'], ['B', '腎小管NH生成過多'], ['C', '醛固酮分泌過少'], ['D', '通氣過度']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "浦肯野纖維細胞同心室肌細胞動作電位嘅區別主要係",
    "llm_output": "The correct answer is **C. 1期 (Phase 1) 嘅自動除極 (depolarization) 速度 (duration) 唔同 (different)**\n\nHere's why:\n\n* **The question asks about the difference between the options.** This means we're looking for a factor that specifically distinguishes between the two types of cells.\n\n* **Option C is the correct answer because it highlights a key functional difference between the two cell types.**  Purkinje fibers are specialized cardiac cells that conduct electrical impulses quickly, while other cells in the body are not involved in this rapid conduction.\n\nLet's break down the terms:\n\n* **Purkinje fibers:** These are specialized cardiac muscle cells that form part of the heart's electrical conduction system. They are responsible for rapidly conducting electrical impulses throughout the ventricles, causing them to contract and pump blood.\n* **Purkinje fiber cells:** These are **specialized cardiac muscle cells** that conduct electrical impulses.\n\n* **代謝性酸中毒 (Metabolic acidosis):**  This is a condition where the blood becomes too acidic due to a buildup of acids or a loss of bicarbonate.\n\n* **The other options are incorrect because:**\n    * **A. 1期 (Phase 1) 係自動除極 (phase 1 depolarization) 係指** **心臟內心肌細胞** **的** **動作電位 (action potential) **的特性，而呢個選項並非描述** **心臟** **與** **代謝性 (metabolic) 細胞** **形成** **的** **特性 (characteristics) ** 係一個關鍵。\n\nTherefore, the correct answer is **C. 3. 3期 (Phase 1) 係 1. 係 (phase 3 depolarization) 係** **特性 (is a characteristic) ** of the heart's electrical conduction system。\n\n**Here's a more detailed explanation of why option C is correct:**\n\n* **3期復極 (Phase 3 repolarization)** **is the process of the heart muscle cell returning to its resting state after a contraction.** This process is crucial for the heart to function properly.\n\n**Here's a more detailed explanation of why option C is the correct answer:**\n\n* **3. 3期 (Phase 3) 形成 (of the action potential) 係** 3期 (phase 3) 係 **心臟 (of the heart)** 3期 (phase 3) 係** (3rd phase)** **的** **is the recovery phase** **of the action potential** where the cell returns to its resting potential. This phase is essential for the heart to prepare for the next contraction cycle.\n\n**3. \n\n**\n\n**3. 3期 (Phase 3) 3期 (Phase 3) 係 (is) 係** **心臟 (heart)** **的** **(is the) 3rd phase** **of the action potential**\n\n* **The heart's conduction system has a unique characteristic:** It relies on the rapid conduction of electrical impulses, which is essential for its function. This is due to the unique properties of the **Purkinje fiber** **cells**\n\nLet me know if you'd like to know more about the heart's conduction system!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '4期自動除極有無'], ['B', '1期形成機制唔同'], ['C', '3期復極速度唔同'], ['D', '平臺期持續時間相差較大']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "動脈粥樣硬化複合病變中最危險嘅併發症係",
    "llm_output": "A.  \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '血栓嘅形成'], ['B', '鈣化'], ['C', '斑塊內出血'], ['D', '動脈瘤嘅形成']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "三酰甘油嘅主要功能係",
    "llm_output": "A. \n\n**解釋：**\n\n* **D. 尿素的形成**\n\n**為什麼是A？**\n\n* 尿素是肝脏中蛋白质代谢的最终产物，在氨的分解过程中发挥作用。\n\n**为什么不是B, C, 或 D？**\n\n* **B. 构成生物膜的成分** 虽然一些蛋白质参与构成生物膜，但它不是三酰甘油的主要功能。\n* **C. 参与構成細胞膜的成分** 脂肪是生物膜的主要成分，而 D. 尿素的构成是生物膜的**主要成分** 并不准确。\n* **C. 参与构成生物组织的成分** 尿素是構成蛋白質的組成部分，但它不是三酰圖的**主要成分**。\n* **D. 構成細胞的成分** 虽然不准确，但这个选项最接近正确答案。 \n\n**补充说明：**\n\n* 尿素是蛋白质代谢的废物产物，**不是**构成三酰甘油的成分。\n* 尿素是构成**尿液**的**主要成分**，而不是构成生物膜的。\n* 尿素的形成过程涉及**氨的分解**，但并非所有涉及氨的生物过程都必须通过尿素进行。\n\n**结论：**\n\n因此，**最准确的答案是A**，因为三酰甘油的**主要功能**是作为能量储备。 \n\n**为什么是D？**\n\n* **D. 反应时间** \n\n**为什么不是A？**\n\n* **A. 尿素的** \n\n**三項選擇題的答案：**\n\n* **D. 延长反应时间** 并非所有生物都使用尿素作为主要生物过程的产物。\n\n**正確答案：**\n\n* 选项**A** \n\n**解释：**\n\n* 尿素是**蛋白质分解**的**最终产物**，而不是**生物膜**的组成部分。\n\n* 选项**B** \n\n* 选项**C** \n\n* 选项**D** \n\n**注意：**\n\n* 选项**B** 并非**三酰基甘油**的**主要功能**。\n* 选项**D** \n\n**三酰甘油的合成和分解都与** \n\n**三**酰**性**的合成和分解是两个不同的过程。\n\n* 选项**D** 应该包含在选项中，因为**三酰甘油**的合成和分解是生物化学中的重要反应。\n\n**三酰甘油的合成和分解**\n\n* **合成：** 脂肪酸和甘油在脂肪细胞中通过**酯化反应**合成三酰甘油。\n\n* **酯化反应**是将脂肪酸与甘油连接起来形成三酰基甘油的化学反应，它在**肝脏**中发生，并由**甘油-3-磷酸**途径完成。\n\n**请记住：**\n\n* 脂肪的**合成和分解**都与**能量**有关。\n\n**解释：**\n\n* **三酰甘油**是脂肪的**主要形式**，它在身体中**储存能量**，并提供**绝缘和保护**作用。\n\n**总结：**\n\n* 尿素是**蛋白质**的**代谢**产物，用于**能量储存**。\n\n* 选项**A** \n\n**三酰甘油**的**合成**是**脂肪**的**主要**途径，选项**D** 并非正确。\n\n* 选项**A** 并非**三酰基甘油**的**合成**途径。\n\n**三酰** \n\n**A. 储存能量** \n\n**B. 储存** \n\n**C. 储存能量** \n\n**D. 脂肪细胞** \n\n* **A. 选项** \n\n* 尿素是**蛋白质**的**最终**产物，它在**蛋白质**的**分解**过程中形成。\n\n**结论：**\n\n* 选项**D** 储存能量的**主要**功能是**最终储存**\n\n**三酰酰甘油**的**主要**功能是**提供能量**。\n\n**选项** \n\n* 选项**A** \n\n**D. 储存能量的** \n\n**C. 储存能量**\n\n**C. 并非最终** \n\n**储存能量**的**功能**\n\n**C. 储存能量的** \n\n**D. 选项**\n\n**A. 蛋白质** \n\n**C. 选项** \n\n**D. 并非** \n\n**C. 选项**\n\n**C. 选项**\n\n* 选项**C",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '儲能供能'], ['B', '係構成神經組織嘅成分'], ['C', '係構成生物膜嘅成分'], ['D', '係體液嘅主要成分']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "原發性高血壓腦出血最常見嘅部位係",
    "llm_output": "The correct answer is **A. 腦幹**\n\n**Explanation:**\n\nWhile the provided answer choices suggest the brain is a common site for hemorrhages, it's important to be precise.  \n\n* **Basal ganglia hemorrhages** are common in cases of **hypertension** (high blood pressure), but **brainstem hemorrhage** is the most dangerous type of primary hemorrhagic stroke.\n\n**Therefore, the correct answer is A. 腦幹 (Brainstem)**.\n\n**Important Note:**\n\nThis is a general knowledge question and the answer provided is a simplification. \n\n* **It's crucial to understand that:**\n\n    * **Hypertension** is a risk factor for stroke, and while the basal ganglia are a common site for bleeding, **any part of the brain can be affected by a stroke**.\n    * **A. 腦幹 (Brainstem)** is a common site for **brainstem stroke**, which is a serious type of stroke because the brainstem controls vital functions like breathing, heart rate, and consciousness.\n\n* **A more complete answer to the question would be:**\n\n    * **\"Which of the following is a common site for a primary hemorrhagic stroke, which can be a life-threatening condition?\"**\n\n    * **A. 腦幹 (Brainstem)**\n    * **B. 腦室 (Ventricles)**\n    * **C. 腦室 (Ventricles) **\n\n**A. 腦幹 (Brainstem) is the most common site for a brainstem hemorrhage.**\n\n* **It's important to note that the provided answer is a simplification.**\n\n    * **D. 腦幹 (Brainstem) \n**\n\n**The original question is a bit ambiguous.** It's likely that the question writer intended to ask about the **most common location** of a brain hemorrhage in the context of **hypertension**.\n\nLet me know if you have any other questions.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '蛛網膜下隙'], ['B', '大腦皮質'], ['C', '內囊同基底核'], ['D', '豆狀核同丘腦']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "急性炎症病竈中滲出嘅炎細胞主要係",
    "llm_output": "The answer is **B. 中性粒細胞**.\n\nHere's why:\n\n* **Neutrophils (中性粒細胞)** are the most common type of white blood cell (WBC) and are the primary responders to acute inflammation. They are phagocytes, meaning they engulf and destroy bacteria and other foreign particles.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '單核細胞'], ['B', '中性粒細胞'], ['C', '淋巴細胞'], ['D', '嗜酸性粒細胞']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "交感縮血管纖維分佈最密集嘅血管係",
    "llm_output": "A. 腦血管\n\n**解释:**\n\nThe **sympathetic nervous system** is responsible for the \"fight-or-flight\" response. It stimulates the release of norepinephrine, which causes vasoconstriction (narrowing of blood vessels) in most parts of the body. This vasoconstriction is designed to increase blood flow to essential organs like the **heart and lungs (冠狀血管)** during times of stress. \n\n**Therefore, the answer is A. 冠狀血管 (coronary arteries)**. \n\n**Note:**\n\n* The question asks for the blood vessels where inflammatory changes are most likely to occur in the context of a \"primary\" inflammatory process. \n* In a **healthy individual**, the **sympathetic nervous system is not directly involved in the process of inflammation.\n\nIt's important to note that the **sympathetic nervous system** is primarily involved in the **\"fight-or-flight\" response**, which is part of the **sympathetic nervous system** is a part of the **autonomic nervous system**, and while it can influence blood flow to certain areas, it's not the primary site where **inflammation** would cause a change in the **blood vessels** themselves. \n\nLet me know if you have any other questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '冠狀血管'], ['B', '腦動脈'], ['C', '骨骼肌血管'], ['D', '皮膚血管']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺心肌組織中，邊一種乳酸脫氫酶同工酶嘅含量最高",
    "llm_output": "The answer is **B. LDH1**.\n\nHere's why:\n\n* **LDH3** is the most common lactate dehydrogenase isoenzyme found in the heart muscle. \n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'LDH1'], ['B', 'LDH3'], ['C', 'LDH4'], ['D', 'LDH2']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "與形成竇道有關嘅病變係",
    "llm_output": "The answer is **C. 靜脈曲張**\n\nHere's why:\n\n* **LDH1** is the answer to the first example question, indicating it's a key enzyme involved in the process.\n\n* **The correct answer is B. LDH1**\n\nLet me know if you'd like me to explain more about the context of the question. \n\n**Explanation of the example question:**\n\nThe example questions you provided seem to be asking about the most common site of rupture for a specific type of hematoma. \n\n* **Hematoma** is a collection of blood outside of blood vessels, primarily outside the blood-brain barrier.\n\n* **The context of the question suggests a focus on the location of the hematoma within the body, and the answer to the first example indicates that LDH (lactate dehydrogenase) is involved.**\n\n* **Therefore, the answer to the question is C. 內囊和氣管**\n\n**Understanding the answer choices:**\n\n* **A. 腦血管** (Cerebral vessels) is the most common site of rupture for a **sinus hematoma**, which is a type of hematoma that occurs when a blood vessel in the area of the **sinus** ruptures.\n\n* **B. 胃部** (Brain) is incorrect because the question asks about the brain, not the sinuses.\n\n* **C. 胃血管** (Stomach) is the correct answer. This option is likely referring to the **stomach**, not the stomach and a specific part of the brain.\n\n* **D. 腦血管** (Brain) is a more accurate answer than the previous options, as it directly relates to the brain's function.\n\n**It's important to note:**\n\n* The question seems to be designed to test knowledge of the brain and the location of **sinus** related issues.\n\n**The correct answer to the question is C. 血管** (Blood vessels) **is the answer**.\n\n**Therefore, the answer to the question is C. 血管** (Blood vessels) **are the most common site of rupture for a brain** aneurysm.\n\nLet me know if you have any other questions! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '肛門直腸膿腫穿破皮膚'], ['B', '胃黏膜壞死脫落'], ['C', '深部組織膿腫穿破皮膚'], ['D', '食管癌穿破至氣管']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "小葉性肺炎係",
    "llm_output": "答案：**D. 肺泡內部嘅血管發炎** \n\n**解释:**\n\n小叶性肺炎 (Lobar pneumonia) 是一种感染性肺炎，其特征是肺叶的**整个肺泡区域**都发生炎症反应，与肺部其他组织 (如肺间质) 的感染不同。 \n\n**正确的答案是A. 纖發炎性炎 (Lobar pneumonia)**\n\n**注意:** \n\n* **C. 肺部感染** 是一个更广泛的描述，而小叶性肺炎是发生在肺叶的特定区域的。\n* **D. 肺泡性肺炎** 是一种更具体的描述，指明了感染的部位，因此是正确的答案。\n\n希望這個解釋清楚！",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '纖維素性炎'], ['B', '化膿性炎'], ['C', '急性漿液性炎'], ['D', '間質性肺炎']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "肌肉中產生嘅氨喺血液中嘅運輸形式係",
    "llm_output": "B. 谷氨酸\n\n**解釋：**\n\n肌肉中產生嘅氨主要通過轉化為氨基酸**谷氨酸**來在血液中運輸。 \n\n**原因：**\n\n肌肉中的氨是**由蛋白質代謝產生的**，而血液中自由氨的濃度會對身體造成毒害，因此肌肉會將氨轉化為**尿素**，一種對身體無害的氨的废物形式，通過血液循環到肝臟进行處理。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '尿素'], ['B', '谷氨醯胺'], ['C', '丙氨酸'], ['D', 'NH3']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關乳酸脫氫酶同工酶嘅論述，正確嘅係",
    "llm_output": "B. 佢哋嘅**isoform** (同工酶) 具有不同的**affinity** for substrates. \n\n**Explanation:**\n\n* **LDH** stands for Lactate Dehydrogenase. This enzyme comes in different forms called isozymes, each with a slightly different structure and function.\n\n* **Km** value represents the Michaelis constant, which indicates the enzyme's affinity for a specific substrate.\n\n* **LDH3** and **LDH5** are the muscle-specific isoforms.\n\nTherefore, the answer to the question is **B. 佢哋嘅** **Km** **值** **isoform** **is 不同** (different) **for different tissues**. \n\n**Note:**\n\n* **Option A** is incorrect because the statement implies that all isoforms are the same, which is not true.\n* **Option C** is incorrect because it suggests a universal difference in composition between LDH isoforms, which is not the case. \n\n**LDH** is a tetrameric enzyme, meaning it's composed of four subunits.  The different **isozymes** of LDH have different combinations of these subunits. **LDH2** is the predominant form in **skeletal muscle**, but **other tissues** also have **LDH1**, **LDH2** and **LDH3** present.\n\nLet me know if you have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '佢哋嘅電泳行為相同'], ['B', '佢哋對同一底物有唔同嘅Km值'], ['C', '佢哋喺人體各組織器官嘅分佈無顯著差別'], ['D', 'M亞基同H亞基喺乳酸脫氫酶同工酶中分佈一樣']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "具有抑制糖異生作用嘅激素係",
    "llm_output": "D. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '胰高血糖素'], ['B', '腎上腺素'], ['C', '腎上腺皮質激素'], ['D', '胰島素']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關非競爭性抑制作用嘅論述，正確嘅係",
    "llm_output": "The answer is **B. 酶**\n\nHere's why:\n\n* **Competitive inhibitors** bind to the active site of an enzyme, directly competing with the substrate.\n* **Non-competitive inhibitors** bind to a site on the enzyme *other than* the active site, affecting the enzyme's activity.\n\nThe question implies that the focus is on the metabolic pathway of glycolysis, which is the process of glucose breakdown.  \n\nThe correct answer is **B. 腎上腺素**. \n\nWhile **insulin** is a hormone that regulates glucose uptake and metabolism, **insulin** is not directly involved in the process of glycolysis. \n\nLet me know if you'd like more examples or have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '酶同底物、抑制劑可同時結合，但唔影響其釋放出產物'], ['B', '抑制劑同酶結合後，唔影響酶同底物嘅結合'], ['C', '改變Km值'], ['D', '唔改變酶促反應嘅最大限度']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血漿中脂類物質嘅運輸形式係",
    "llm_output": "The answer is **D. 脂蛋白**.\n\nHere's why:\n\n* **Lipoproteins** are the primary transport vehicles for lipids in the blood. They are complexes of lipids (like cholesterol and triglycerides) and proteins that allow these hydrophobic molecules to travel in the bloodstream. \n\nLet me know if you'd like to know more about lipoproteins! They are fascinating and play a crucial role in our bodies. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '球蛋白'], ['B', '核蛋白'], ['C', '糖蛋白'], ['D', '脂蛋白']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列物質徹底氧化時，生成30或者32分子ATP係邊一個",
    "llm_output": "The answer is **D. 丙酮酸**\n\n**Explanation:**\n\nThis question is testing your knowledge of how different molecules are processed in the body.\n\n* **A. 葡萄糖 (Glucose)** is the primary source of energy for our bodies, but it's not the specific molecule mentioned that is completely oxidized.\n* **B. 丙酮酸 (Pyruvate)** is the correct answer. It's the end product of glycolysis, the process that breaks down glucose. The question implies a comparison to other molecules, suggesting the answer lies in the products of complete oxidation.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '葡萄糖'], ['B', '丙酮酸'], ['C', '檸檬酸'], ['D', '硬脂酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種氨基酸脫氨基生成嘅α-酮酸係三羧酸循環嘅中間產物",
    "llm_output": "D. 亮氨酸 \n\n**Explanation:**\n\nThe question asks for the amino acid that is a **product of the citric acid cycle**.\n\n* **Citrate** is a product of the citric acid cycle's first step, but it's not the correct answer here.\n\n* **The citric acid cycle is also known as the Krebs cycle or the TCA cycle.**\n\n* **Alpha-ketoglutarate** (α-ketoglutarate) is a key intermediate of the citric acid cycle.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '丙氨酸'], ['B', '穀氨酸'], ['C', '賴氨酸'], ['D', '亮氨酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "α-酮戊二酸徹底氧化成CO2同H2O，可生成幾多分子ATP",
    "llm_output": "The correct answer is **C**. \n\nHere's why:\n\n* **α-ketoglutarate** (also known as 2-oxoglutarate) is a key intermediate in the citric acid cycle (Krebs cycle or TCA cycle).\n\nLet's break down the other options:\n\n* **A. 葡萄糖 (Glucose)** - While glucose is the starting point for the citric acid cycle's involvement in energy production, it's not a molecule that is directly converted to α-ketoglutarate.\n* **B. 核蛋白 (Nuclear protein)** - This is a general term for proteins found in the nucleus of a cell. While some nuclear proteins are involved in metabolic processes, they are not directly related to the citric acid cycle.\n* **C. 檸檬酸 (Citrate)** - This is the first molecule formed in the citric acid cycle. It's important to note that the citric acid cycle doesn't directly \"generate\" α-ketoglutarate from it, but rather, it's a product of the breakdown of glucose.\n\nLet me know if you have any other questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '8'], ['B', '12'], ['C', '20'], ['D', '9']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "競爭性抑制劑對酶促反應速度影響係",
    "llm_output": "答案：**A. 8** \n\n**D. 檸檬酸**\n\nThe correct answer is **D. 20**.\n\nThis is because the question asks for the \"**maximum**\" number of ATP molecules produced from the complete oxidation of a single molecule of **glucose**. \n\nHere's why:\n\n* **Glucose** is a key molecule in cellular respiration.\n\n* **D. 亮氨酸** (Leucine) is a common example of an amino acid that can be converted into **acetyl-CoA**, which then enters the **citric acid cycle** (also known as the Krebs cycle or TCA cycle).\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'Km下降，Vmax上升'], ['B', 'Km上升，Vmax唔變'], ['C', 'Km唔變，Vmax下降'], ['D', 'Km下降，Vmax下降']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "神經處於靜息電位時",
    "llm_output": "答案：**D. 2** \n\nHere's why:\n\n* **Km** (Michaelis constant) represents the substrate concentration at which an enzyme works at half its maximum velocity. A competitive inhibitor binds to the active site of an enzyme, directly competing with the substrate. This binding is reversible, meaning the inhibitor can be displaced by increasing the concentration of the substrate.\n\n* **Competitive inhibitors** increase the apparent Km of an enzyme because they compete with the substrate for binding to the active site.  A higher concentration of substrate is needed to overcome the inhibitor and reach half the maximum velocity.\n\n* **Non-competitive inhibitors** bind to a site other than the active site, causing a conformational change in the enzyme. This type of inhibition reduces the enzyme's Vmax (maximum velocity) because some enzyme molecules are permanently inactivated by the inhibitor.\n\n* **The other options are incorrect because:**\n\n    * **A. Km下降，Vmax不變** is incorrect. This describes a non-competitive inhibitor's effect on an enzyme, not the inhibitor itself.\n    * **A. 选项C. 仅有少量K外流** and **D. 选项D. 选项** are incorrect because they describe the effect of a specific inhibitor on the reaction, not the general effect of the enzyme being in its normal state.\n\nLet me know if you'd like more examples!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '冇K外流亦冇Na內流'], ['B', '既有K外流亦有少量Na內流'], ['C', '僅有少量K外流'], ['D', '僅有少量Na內流']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "心室肌細胞動作電位快速復極末期嘅原因",
    "llm_output": "答案：D. K+外流 \n\n**解釋：**\n\nK+ 的外流是心臟肌細胞動作電位快速復極階段的關鍵因素。 \n\n在心臟的動作電位中，K+ 的快速復極是心肌細胞膜電位快速回歸至靜止狀態的原因。 \n\n這是一個重要的細節，因為它說明了K+ 的作用，而 Ca2+ 的內流和 Na+ 的外流是导致其动作电位在快速复极阶段快速恢复的原因。 \n\n**因此，正確答案是 A. Ca2+ 的外流** \n\n**錯誤答案的解釋：**\n\n* A. 8 (這是一個錯誤的答案，因為它只描述了心肌細胞的動作電位的一部分)\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'Ca2+內流'], ['B', 'Na+內流'], ['C', 'Cl-內流'], ['D', 'K+外流']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "已知受血者血型為B型，喺交叉配血試驗中主側唔凝集，次側凝集，供血者血型可能係",
    "llm_output": "D.  O型 \n\n**Explanation:**\n\nThis question refers to a blood typing test called the **crossmatch test**. This test is performed to ensure compatibility between a donor and recipient's blood before a transfusion.\n\nThe answer is **D. O type** because:\n\n* **K+外流** (outflow) in option D is likely referring to the **K+ outflow** which is a key characteristic of a **compatible** blood transfusion. \n* A crossmatch test checks for compatibility by mixing a small amount of the recipient's blood with a small amount of the donor's blood. \n* If the recipient's blood has **anti-A antibodies** (which is what happens in **D. 9**), it will cause the donor's red blood cells to clump together (agglutinate) if they are mixed with the **B+ blood type** (as in the example).\n\nLet me know if you'd like to see how different blood types react in the crossmatch test. \n\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'B型'], ['B', 'AB型'], ['C', 'A型'], ['D', 'O型']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "對於結合酶嚟講，決定反應特異性嘅係",
    "llm_output": "C. **酶的形状** \n\nThe answer is **C. K+ 僅有少量K+**\n\n**Explanation:**\n\nThe correct answer is **C. 酶的形状 (The shape of the enzyme)**.\n\nThis is because:\n\n* **C. 全酶 (Active site)** refers to the specific region on an enzyme where the substrate binds.\n\n* **C. 酶的形状 (Enzyme shape)** is crucial for its function. Enzymes are highly specific catalysts, meaning they only work on certain substrates. This specificity is due to the unique shape of the enzyme's active site, which is complementary to the shape of the substrate.\n\nThe other options are incorrect because they don't accurately describe what determines enzyme specificity:\n\n* **A. 輔酶 (Coenzymes)** are organic molecules that assist enzymes but don't determine their specific shape.\n\n* **B. 鹽離子 (Salt ions)** are important for some enzyme functions, but they don't define the enzyme's inherent specificity.\n\nLet me know if you'd like more details on how enzyme shape determines its function! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '輔酶'], ['B', '全酶'], ['C', '酶蛋白'], ['D', '金屬離子']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列生化反應主要喺線粒體中進行嘅係",
    "llm_output": "C. 脂肪酸-氧化 \n\n**解释：**\n\n* **脂肪酸-氧化** is the process of breaking down fatty acids for energy production. This process occurs in the mitochondria and is a key part of cellular respiration.\n\n* **脂肪酸合成** (fatty acid synthesis) occurs in the cytoplasm.\n* **A. 辅酶** (cofactors) 雖然酶需要辅酶才能正常工作，但并非所有生物過程都需要它們。\n* **B. 僅有**A. \n\n* **D. 脂肪酸-氧化** 选项描述的是一个错误的假设。 \n\n**所以，答案是C。**",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '脂肪酸合成'], ['B', '甘油磷脂合成'], ['C', '脂肪酸-氧化'], ['D', '三酰甘油合成']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊個為糖異生過程中嘅關鍵酶",
    "llm_output": "The answer is **A. 醛縮酶**\n\nHere's why:\n\n* **Gluconeogenesis** is the process of creating glucose from non-carbohydrate sources.\n* **Gluconeogenesis** is the opposite of glycolysis.\n\n* **Gluconeogenesis** is the opposite of glycolysis. **Glycolysis** is the process of breaking down glucose, and it's the **first step** in **glucose metabolism**.\n\n* **Phosphofructokinase** (PFK) is a key enzyme in the early stages of glycolysis, which is the process of **breaking down glucose** (the opposite of making it).\n\nLet me know if you'd like to try another example!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '醛縮酶'], ['B', '丙酮酸激酶'], ['C', '果糖-1，6-二磷酸酶'], ['D', '烯醇化酶']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "含有維生素B1嘅輔酶係",
    "llm_output": "The answer is **(C) NAD+**\n\n**Explanation:**\n\n* **CoA (Coenzyme A)** is a coenzyme that is involved in many metabolic pathways, including **fatty acid metabolism**. \n* **TPP (Thiamine pyrophosphate)** is a crucial coenzyme for the enzyme **pyruvate dehydrogenase**, which is involved in the conversion of pyruvate to acetyl-CoA in the **link reaction** (also known as the pyruvate dehydrogenase complex reaction)\n\nLet me know if you'd like me to explain any of these terms!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'CoA'], ['B', 'TPP'], ['C', 'NAD+'], ['D', 'FAD']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "某人潮氣量為500ml，生理無效腔為150ml，呼吸頻率為18次/分，此時每分肺泡通氣量為",
    "llm_output": "C. 9000ml \n\n**Explanation:**\n\nThe question is asking for the tidal volume (the amount of air inhaled and exhaled with each normal breath) of a person with a known physiological dead space (the volume of air in the respiratory system that doesn't participate in gas exchange) and a given tidal volume.\n\n* **Tidal volume (TV)** is the amount of air inhaled and exhaled during normal breathing.\n* **Physiological dead space (PDS)** is the volume of air in the airways that doesn't reach the alveoli for gas exchange.\n\nTherefore, the tidal volume (the total amount of air inhaled and exhaled) is the sum of the given values:\n\n**Tidal Volume (TV) =  Lung Volume (500ml) + Dead Space (18 breaths/minute x 500 ml/breath x 18 breaths/minute = 16200 ml)**\n\n**Answer:**\n\nThe answer is **B. 16200 ml**. \n\n**Here's why:**\n\nThe question is asking for the total volume of air breathed in, which is the **tidal volume** (the amount of air inhaled and exhaled with each breath) multiplied by the number of breaths per minute.\n\n* **Tidal volume (TV) = 18 breaths/minute x 500 ml/breath = 9000 ml**\n\n**Important Note:**\n\nIt's crucial to understand that the question asks for the total volume of air breathed in, not the amount of air reaching the alveoli (which is the tidal volume). \n\nTherefore, the answer is **9000 ml**.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '8850ml'], ['B', '6000ml'], ['C', '9000ml'], ['D', '6300ml']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊一種組織中缺乏高活性嘅甘油激酶，唔能好好地利用甘油",
    "llm_output": "The answer is **A. 脂肪組織**. \n\nHere's why:\n\n* **Glycolysis** is the process of breaking down glucose. \n* The prompt states that the question is about glycolysis, implying we're looking for a component involved in that process.\n* The answer choices are all related to different organs and tissues.\n\nWhile all of the options list tissues that utilize glucose, the prompt focuses on the process of glucose breakdown, suggesting the answer is related to the metabolic pathway of glycolysis. \n\nTherefore, the answer is **A. 脂肪組織 (脂肪組織)**. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '脂肪組織'], ['B', '心'], ['C', '腸'], ['D', '腎']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊啲抑制作用屬競爭性抑制作用",
    "llm_output": "The answer is **C. 腸**.\n\nHere's why:\n\n* **C. 磺** is the correct answer because it refers to the **liver**, which is where the majority of **glycolysis** (the process of breaking down glucose for energy) occurs. \n\n* **C. 脂肪酸-1，6-二磷酸酶** is incorrect as it's a **glycolytic enzyme**, meaning it's involved in the breakdown of glucose, not its inhibition.\n\n* **C. 脂肪組織** is the answer because it refers to the **adipose tissue**, which is where the liver stores and releases glucose.\n\nLet me know if you'd like to try another question! \n\n**Note:**\n\n* The question likely intends to ask about **\"non-competitive inhibition\"** of enzymes. \n* The liver is the primary site for the metabolism of glucose, and the liver's role in metabolizing glucose is crucial for the body's energy production.\n\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '敵敵畏對膽鹼酯酶嘅抑制作用'], ['B', '磺胺類藥物對細菌體內二氫葉酸合成酶嘅抑制作用'], ['C', '氰化物對細胞色素氧化酶嘅抑制作用'], ['D', '砷化合物對巰基酶嘅抑制作用']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血中邊一種膽紅素增加會使尿紅素定性試驗呈陽性反應",
    "llm_output": "答案：C. 間接膽紅素\n\n**解釋：**\n\n* **結合膽紅素 (Conjugated Bilirubin)** 係指已經經過肝臟代謝嘅直接膽紅素，直接膽紅素 係由紅血球分解產生，並被結合到葡萄糖分子上，形成一種易於溶於水嘅 **間接膽紅素 (Indirect Bilirubin)**，會被血清白蛋白結合，而 **直接反應膽紅素 (Indirect Bilirubin)** 係指血中嘅膽紅素，係由紅血球代謝產生，產生後會被排出體外。\n\n* **直接膽紅素 (Direct Bilirubin)** 係由紅血球分解產生，但係直接膽紅素本身並唔溶於水，所以需要被結合到其他物質上，先可以被排出體外。\n\n* 因此，**未結合膽紅素 (Unconjugated Bilirubin)** 係**直接** 嘅代謝產物，而 **結合膽紅素 (Indirect Bilirubin)** 係指未被肝臟代謝，而仍然游離狀態嘅膽紅素。\n\n* **脂肪組織 (Adipose Tissue)** 係主要負責將未結合膽紅素轉化為直接膽紅素，而直接膽紅素並非直接影響人體健康嘅物質，所以**不溶於水**。\n\n* 答案：**C. 肝臟代謝**\n\n* **總結：** 脂肪組織**不**能直接將直接膽紅素轉化為間接膽紅素，因為它缺乏**高活性直接膽紅素 (high-affinity bilirubin binding sites)**，呢啲位點負責將直接膽紅素轉化為間接膽紅素。\n\n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '結合膽紅素'], ['B', '遊離膽紅素'], ['C', '未結合膽紅素'], ['D', '間接反應膽紅素']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "有關競爭性抑制劑嘅論述，錯誤嘅係",
    "llm_output": "The answer is **A. 抑制程度只同抑制劑嘅濃度有關**.\n\nHere's why:\n\n* **Competitive inhibition** involves a molecule (the inhibitor) that competes with the substrate for the enzyme's active site. \n* The statement \"The type of inhibition that increases the concentration of a specific compound in the urine\" describes a **biological effect**, not the mechanism of inhibition itself.\n\n**Explanation of the other options:**\n\n* **Competitive inhibition** is a type of enzyme inhibition where the inhibitor binds to the active site of the enzyme, preventing the substrate from binding. This is a key characteristic of competitive inhibition.\n* **競爭性抑制劑** (inhibitors that bind to the active site) are generally considered **reversible** inhibitors. This means the inhibitor can bind and unbind to the active site, allowing the enzyme to still function when the inhibitor concentration is lowered.\n* **A. 具有相似性嘅** (FAD) is a common type of **competitive inhibitor**, as it's a molecule that can bind to the enzyme's active site and compete with the substrate.\n\n**Therefore, the correct answer is B. 磺胺類藥物對** (The statement \"The following is a competitive inhibitor\" is a correct description of the nature of the inhibitor, not the compound itself.\n\n**Note:**\n\nThe correct answer is in Chinese because the question and some of the answer choices are also in Chinese. I've provided the English translation for clarity.\n\n**Correct Answer:**\n\nThe correct answer to the question is **B. 磺胺類藥物對** (A. 砷化合物) because it's the only option that describes a specific inhibitor.\n\n**Explanation of the Correct Answer:**\n\n* **A. 具有相似性嘅** (A. 具有相似性) refers to the **structure of the enzyme** itself, not the compounds it interacts with.\n\n**Inhibitors and Enzymes:**\n\nIt's important to remember that **competitive inhibitors** are molecules that bind to the active site of an enzyme, competing with the natural substrate for binding. \n\n**The other options are incorrect because:**\n\n* **D. 尿酸** (uric acid) is a product of purine metabolism, not a compound directly involved in the inhibition process.\n\n**Therefore, the correct answer is not A. 具有相似性嘅** (A. 磺胺類藥物) because the question asks for the type of inhibition, not the type of molecule.\n\nLet me know if you'd like to explore any of these concepts further!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '抑制程度只同抑制劑嘅濃度有關'], ['B', '喺結構上同底物相似'], ['C', '同酶嘅結合係可逆嘅'], ['D', '同酶嘅活性中心相結合']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1分子乳酸徹底氧化生成ATP分子數",
    "llm_output": "The correct answer is **B. 36**.\n\nHere's why:\n\n* **Aerobic Respiration:** This refers to the process where glucose is completely broken down in the presence of oxygen, generating a maximum of 36 ATP molecules per glucose molecule.\n\n* **Complete Oxidation of Glucose:** This process, which occurs in the mitochondria, involves glycolysis, the Krebs cycle, and the electron transport chain.\n\nLet's break down the answer choices:\n\n* **A. 20**  is incorrect. It's too low a number for the total ATP yield from a single glucose molecule.\n* **B. 36** is the correct answer.\n\n**Key Points about the Answer:**\n\n* **Aerobic Respiration:** The full process of aerobic respiration yields a maximum of 36-38 ATP molecules per glucose molecule.\n* **Glycolysis:** This initial step of glucose breakdown in the cytoplasm produces 2 ATP molecules per glucose molecule.\n\n* **Anaerobic Respiration:** This process, which occurs in the cytoplasm, only produces 2 ATP molecules per glucose molecule.\n\nIt seems like the examples you provided are from a multiple-choice quiz about enzymes and their activity.  \n\n**Here's a more detailed explanation:**\n\nThe process of breaking down one glucose molecule into pyruvate through glycolysis yields 2 ATP molecules. However, the process of aerobic respiration, where the pyruvate is further broken down in the mitochondria, can produce a much higher yield of ATP.\n\n**Important Note:**\n\nIt's crucial to understand that the number of ATP molecules produced per glucose molecule in the examples you provided is a simplification. The actual yield can vary depending on the efficiency of the ATP synthase enzyme and other factors.\n\nThe examples you provided highlight the importance of understanding the context of enzyme activity. \n\n* **Option B (36)** is the correct answer because it represents the maximum theoretical yield of ATP from one glucose molecule through aerobic respiration. \n\nLet me know if you have any other questions about the question or the answer choices.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '20'], ['B', '36'], ['C', '14'], ['D', '15']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "最容易受毒性代謝產物損傷嘅器官係",
    "llm_output": "The answer is **A. 腎臟**\n\n**Explanation:**\n\nThis question is asking about the most common target of a toxic metabolite. \n\n* **Bilirubin (option C)** is a byproduct of heme breakdown and is a known toxin to the **liver**.\n\nLet me know if you'd like to try another one!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '腎臟'], ['B', '肺臟'], ['C', '肝臟'], ['D', '脾臟']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於酶活性中心嘅敘述，錯誤嘅係",
    "llm_output": "B \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '必需基團可位於活性中心區域之內，亦可位於活性中心之外'], ['B', '一般嚟講，形成酶活性中心嘅必需基團總係喺多肽鏈嘅一級結構上相對集中嘅相鄰嘅幾個氨基酸嘅殘基上'], ['C', '當底物分子同酶分子相接觸時，可引起酶活性中心嘅構象改變'], ['D', '酶同底物接觸只限於酶分子上同酶活性密切有關嘅較細區域']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "對胃腸平滑肌收縮節律起決定性作用嘅係",
    "llm_output": "答案：A",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '平滑肌本身嘅節律'], ['B', '慢波嘅頻率'], ['C', '動作電位嘅頻率'], ['D', '動作電位嘅數值']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列那一種酶唔參與糖異生過程",
    "llm_output": "The answer is **C**.\n\nHere's why:\n\n* **Gluconeogenesis** is the process of making new glucose from non-carbohydrate sources. \n* This process is complex and involves multiple enzymes.\n\n* **Phosphoenolpyruvate carboxykinase (PEPCK)** is the enzyme that is **not** directly involved in the gluconeogenesis pathway.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '丙酮酸激酶'], ['B', '磷酸烯醇式丙酮酸羧激酶'], ['C', '丙酮酸羧化酶'], ['D', '果糖-1，6-二磷酸酶']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "影響酶促反應速度嘅因素唔包括",
    "llm_output": "D. \n\n**解釋:**\n\n酶原是酶的 inactive 前体，它需要被激活才能变成活性酶。酶原本身不参与酶促反应，它需要被其他酶 (例如，**酶**的**活性**) 或非酶因素 (如**酶原** 嘅 **活化劑**，例如胃蛋白酶原轉換成胃蛋白酶需要胃液中的低 pH 值。\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '酶嘅濃度'], ['B', '反應環境嘅PH'], ['C', '反應溫度'], ['D', '酶原嘅濃度']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "高滲性脫水時，下列邊段小管液嘅滲透壓可為低滲",
    "llm_output": "D. 髓袢升支長直段 \n\n**解釋：**\n\n* **高血糖** (高血糖) 係指血液中糖分濃度過高，而 **內髓集合管** (內髓管) 係負責調節尿液中尿液濃度的一個较小的区域。\n\n* 關於 **內髓集合管** 嘅答案係 **A. 腎小管** (腎小管) 因為腎臟的 **濃度** 係指血液中 **尿原** 嘅濃度，而 **B. 腎小管** 係指血液中 **尿素** 嘅濃度。\n\n* **腎臟** 係通过 **調節尿液濃度** 來調節尿液的。\n\n* **髓袢** 是一個腎小管的結構，負責 **重新吸收水份** 嘅主要功能 係 **在腎小管的較早段落** 發生，所以選項 **D. 髓袢升支** 係 **錯誤** 嘅答案。\n\n* **C. 尿液濃度** 係 **D. 髓質** (A. 腎小管的**近端**部分) \n\n**注意：** \n\n* 腎小管**近端** (proximal convoluted tubule) 負責 **重新吸收大部分營養物質**，包括葡萄糖。\n* 腎小管**後半段** 係指 **A. 腎小管** (腎小管) 嘅 **近端** \n\n**所以，正確答案係 D. 腎臟**\n\n**A. 腎臟** 係一個正確答案，但係 **D. 丙酮酸** (proximal convoluted tubule) 係一個 **更具體** 的答案。\n\n**其他選項：**\n\n* **B. 丙酮酸** 係一個錯誤答案，因為它**並非** 腎臟的**一個** 区域。**C. 肾小管** 係指一个 **特定的** 区域**，**\n\n**錯誤答案：**\n\n* 關於 **B. 腎臟** 係 **錯誤** 嘅，因為它**不是**一个**單一**的**反应** \n\n**A. 肾小管** (proximal convoluted tubule) 因為它**不是** 尿液的**主要** \n\n**其他選項** 係指 **B. 腎小管** (腎臟) \n\n**其他** 錯誤的，例如**B. 尿酸** (urinary acid) \n\n**其他** \n\n**B. 腎小管** (腎臟) 係一個**錯誤** \n\n**其他** \n\n**其他** \n\n**C. 腎臟** (A. 肾小管) \n\n**D. 溫度** (A. \n\n**其他** \n\n**B. 尿液** (C. 尿液) \n\n**其他** \n\n**其他** \n\n**其他**\n\n**B. 尿液** (A. 尿液) \n\n**其他** \n\n**B. 腎臟** \n\n**其他** \n\n**其他選項** \n\n**其他** \n\n**C. 腎臟** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他選項** \n\n* **C. 腎臟** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他選項** \n\n**其他** \n\n**C. 腎小管** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他**\n\n**其他**\n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他選項** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**C. 其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他** \n\n**其他",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '內髓集合管'], ['B', '近端小管後半段'], ['C', '腎小囊超濾液'], ['D', '髓袢升支粗短末']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "唔參與糖酵解作用嘅酶係",
    "llm_output": "The correct answer is **D. 己糖激酶-1**\n\n**Explanation:**\n\nThis is a trick question! While the options list enzymes involved in metabolic pathways, it's designed to test if you understand that **all** of them are not necessarily involved in the **same** pathway.\n\n* **B. 己糖酸磷酸酶** is a specific enzyme involved in the gluconeogenesis pathway (gluconeogenesis is the opposite of glycolysis, so it's a valid answer).\n\n* **A. 磷酸烯醇式丙酮Lysis** is a process that breaks down glucose, not builds it up like the gluconeogenic pathway.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '磷酸烯醇式丙酮酸羧激酶'], ['B', '果糖磷酸激酶-1'], ['C', '丙酮酸激酶'], ['D', '己糖激酶']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "急性炎症局部疼痛發生嘅主要原因係",
    "llm_output": "D. \n\n**解釋：**\n\n* **A. 大學醫學** \n\n  * 這是個錯誤的選項。大學醫學是一個廣泛的學科，它涵盖了医学的许多方面，而其他选项更直接描述了局部疼痛的生理机制。\n* **B. 答案** \n\n  * **A. 血液循環改變** \n* **C. 答案** \n\n  * **A. 组织损伤** \n  * **D. 血液循環** \n\n  **正確答案：D**\n\n  * **D. 滲出物** \n\n**分析：**\n\n* 細胞發炎時，會釋放一些炎症介质，例如 **组胺** 和 **前列腺素** 等，这些物质会刺激神经末梢，导致疼痛。\n\n**其他选项的解释：**\n\n* **A. 细胞發生的原因** \n  * 這是指炎症过程中，身体的免疫反应会引起 **疼痛** 的现象，但它并不能解释疼痛的发生机制。\n* **B. 細胞發生的原因** \n  * 这是指 **细胞增生** 的原因，但它与疼痛的发生机制无关。\n* **C. 这是錯誤的答案** \n  * 因为是 C. 选项的答案是 **血液中的成分**，而并非疼痛的发生机制。\n\n**D. 这是正確的答案，因为它描述了疼痛的生理机制：**\n\n* 疼痛发生的原因是 **A. 细胞的疼痛** \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '局部充血及血流量增多'], ['B', '局部組織嘅變性及壞死'], ['C', '細胞增生壓迫神經末梢'], ['D', '滲出壓迫及炎症介質刺激']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酶嘅活性中心係",
    "llm_output": "The correct answer is **C. 酶蛋白分子同輔酶喺空間結構上集中形成嘅一個區域，能與特定嘅產物**\n\n**Explanation:**\n\nThe **active site** of an enzyme is the specific region where the enzyme binds to its substrate and catalyzes the chemical reaction. \n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '酶發揮催化作用嘅部位'], ['B', '酶蛋白分子同輔酶結合嘅部位'], ['C', '酶嘅必需基團喺空間結構上集中形成嘅一個區域，能與特定嘅底物結合並使之轉化為產物嘅部位'], ['D', '酶分子表面具有解離基團嘅部位']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列關於蜂窩織炎嘅敘述，正確嘅係",
    "llm_output": "The correct answer is **C. \n下列關於大學醫學嘅** **C. 酶嘅必需基團**\n\nHere's why:\n\n* **A. 錯誤**  While the statement about the spread of bacteria is true for some types of infections, it's not the primary cause of pain in the context of inflammation.\n\n* **B. 錯誤** This option describes the characteristics of a specific type of inflammation, but the question asks for the general cause of pain in the context of inflammation.\n\n* **C. 正確** This option correctly identifies the key factor in the pain of inflammation:\n\n**C. 是一個** **inflammation \nis a complex process involving a variety of factors, but the statement \"酶嘅必需基團\" (essential components of enzymes) is a strong clue that the answer relates to the **inflammatory response** itself.\n\n* **D. 錯誤**  This option describes a location where inflammation can occur, but it's not the reason for the pain.**\n\n**Explanation:**\n\nThe question refers to the general phenomenon of inflammation, which is caused by the body's immune response to injury or infection. This option describes a general characteristic of the inflammatory process, which is the presence of pain caused by the inflammatory mediators released by the body in response to injury or infection.\n\n**Therefore, the correct answer is C.**\n\n**C. 是一個** **(C is correct)\n\n**C. 酶的活性中心** (the enzyme's active site) is the key to understanding the question. The active site is the specific region of an enzyme where the substrate binds and the catalytic reaction occurs.\n\n**D. 腎小管蛋白質** (renal tubules) is a distraction. While the question mentions \"腎小泵\" (renal tubules), this is a specific part of the kidney and not a general cause of inflammation.)\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '細菌唔容易經組織間隙、淋巴管同血道蔓延擴散'], ['B', '常由草綠色鏈球菌感染引起'], ['C', '病變特點與鏈球菌分泌嘅鏈激酶同透明質酸酶有關'], ['D', '常見部位係內臟器官、肌肉同闌尾']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "心力衰竭細胞係指",
    "llm_output": "B.  心力衰竭時，心臟功能受損，導致無法有效地泵送血液。 \nD.  **B. 腎小球內** \n\nLet me know if you'd like me to explain why! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '心力衰竭時肺泡內含有含鐵血黃素嘅巨噬細胞'], ['B', '心力衰竭時肺內吞噬炭末嘅巨噬細胞'], ['C', '心力衰竭時肺內嘅泡沫細胞'], ['D', '心力衰竭時出現嘅含脂褐素嘅心肌細胞']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於肺氣腫患者嘅臨牀表現，下面錯誤嘅係",
    "llm_output": "The correct answer is **D. 胸透肺部組織透亮度增加**.\n\nHere's why:\n\n* **Emphysema** is characterized by the destruction of the alveoli (air sacs in the lungs) leading to **increased air trapping** in the lungs, hence the \"lunges\" in the question.\n\nThe other options are incorrect because:\n\n* **A. 磷酸烯醇式** (A. Phosphoenolpyruvate) is a molecule, not a symptom of a specific condition.\n* **B. 肺氣腫** (B. Emphysema) is a symptom of emphysema, not a general term for any lung condition.\n* **C. 細胞** (C. Cells) is a general term for \"cells\" and doesn't specify the type of cell affected.\n\nLet me know if you'd like to know more about emphysema or have any other questions! \n\n\n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '桶狀胸'], ['B', '低氧血癥'], ['C', '逐漸加強嘅吸氣性呼吸困難'], ['D', '胸透肺野透明度增加']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列有關類脂生理功能嘅敘述，正確嘅係",
    "llm_output": "The correct answer is **C. 係構成構成各種生物膜嘅重要成分**. \n\nHere's why:\n\n* **Correct Answer:**  The question asks for the correct statement about the function of lipids. Option C accurately describes a key function of lipids, which is to form biological membranes.\n\n* **Incorrect Answers:**\n\n    * **A. 係體內理想嘅供能** (Lipids are ideal energy sources) is too vague. While lipids are energy-dense, the question asks for a specific physiological function.\n    * **B.  B. 係** (This option is incomplete and doesn't accurately describe a specific function of lipids)\n    * **D. 係 係** (This is a repetition of option A and doesn't make a complete statement)\n\n* **D. 肺泡內** (This is a general statement about the function of lipids in the body. The question asks for a specific function related to the context of the question)\n\nLet me know if you have any other questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '係體內理想嘅供能同儲能物質'], ['B', '保持體溫'], ['C', '係構成機體各種生物膜嘅重要成分'], ['D', '保護同固定重要臟器']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "感染係由以下邊項引起嘅炎症",
    "llm_output": "The correct answer is **D. 生物性因子**\n\nHere's why:\n\n* **Option C (酶嘅活性中心)** refers to a specific part of a cell, not a cause of inflammation.\n\nThe term \"inflammation\" is often used in the context of a biological response to injury or infection. While options A, B, and C can all contribute to inflammation in some way, **Option D (生物性生物因子)** is the most accurate and specific answer to the question \"What causes inflammation?\"\n\nLet's break down why:\n\n* **Inflammation** is the body's natural response to harmful stimuli like pathogens, damaged cells, or irritants. \n\n* **Infection** is a specific type of trigger for inflammation, often causing the body to release inflammatory mediators in response to the invading pathogen.\n\n* **Option A (鏈球菌係)** is a specific example of a cause of inflammation, while options B and C are general terms.\n\n* **The other options** (A, B, and C) are too broad. While they can be associated with inflammation, they are not the *ideal* answer to a question about the cause of inflammation.\n\nThe other options are more related to the *types* of infections that can cause inflammation, but **Option D** focuses on the general mechanism of inflammation itself. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '物理因子'], ['B', '壞死組織'], ['C', '變態反應'], ['D', '生物性因子']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "生成組織液嘅有效濾過壓等於",
    "llm_output": "The correct answer is **B. (毛細血管 hydrostatic pressure + interstitial fluid hydrostatic pressure) - (blood colloid osmotic pressure)**\n\nHere's why:\n\n* **Effective filtration pressure (EFP)** is the pressure difference that drives fluid movement across the capillary membrane. \n* It's calculated by subtracting the **hydrostatic pressure of the interstitial fluid** from the **hydrostatic pressure of the blood** in the capillary.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '(血漿膠體滲透壓+組織液膠體滲透壓)-(毛細血管壓+組織液靜水壓)'], ['B', '(毛細血管壓+組織液靜水壓)-(毛細血管壓+組織液膠體滲透壓)'], ['C', '(毛細血管壓+組織液膠體滲透壓)-(血漿膠體滲透壓+組織液靜水壓)'], ['D', '(毛細血管壓+血漿膠體滲透壓)-(組織液膠體滲透壓+組織液靜水壓)']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "輔酶FAD分子中含有下列邊種B族維生素",
    "llm_output": "答案：**B**\n\n**解释：**\n\nFAD (黄素腺嘌呤二核苷酸) 嘅全名係 **Flavin Adenine Dinucleotide**，它是由 **核黃素 (Riboflavin)** 形成的。 \n\n* **A. 吡哆醛 (Pyridoxal)** 係維生素B6 嘅一部分，參與其他代謝過程，但不是构成FAD的必要成分。\n\n* **C. 异位选择** 选项中，**叶酸 (Folate)** 和 **B. 硫胺素 (Thiamine)** 都是 B 族维生素，但它们不是构成 FAD 的成分。\n\n* **D. 硫代葡萄糖 (B2)** 虽然是 FAD 的组成部分，但不是 FAD 里面 **含有** 的维生素。\n\n所以，正確答案是 **B. \n\n** \n**\n\n**其他信息：**\n\n* 这些選項中，只有 **B. 煙酰胺 (FAD) \n** 选项包含了构成 FAD 腺嘌呤二核苷酸的 **一个** 答案。\n\n* 您的示例答案 **A** 中的公式描述的是 **血液中的压力差**，而不是与FAD相关的任何特定维生素。\n\n希望这个解释能够帮助您理解为什么答案是 **D**。",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '吡哆醛'], ['B', '煙酰胺'], ['C', '葉酸'], ['D', '核黃素']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "體內最重要嘅脫氨基方式係",
    "llm_output": "**D. 氧化脫氨基**\n\nThe correct answer is **D. 氧化脫氨基 (Oxidative deamination)**. \n\nThis is because the question is asking about the \"most important\" way the body gets rid of excess nitrogen from amino acids, and **oxidative deamination** is the primary process for this in the human body. \n\nLet me know if you'd like more examples or have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '氨基轉移作用'], ['B', '聯合脫氨基作用'], ['C', '氧化脫氨基'], ['D', '還原脫氨基']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊啲情況可使心輸出量增加",
    "llm_output": "D. 聯合脫氨基\n\n**Explanation:**\n\nThe correct answer is **D. 心室壁壓力增加** (**Increased ventricular filling volume**)\n\nThe question asks for the answer in terms of the factors that directly increase stroke volume.  \n\n* **Ventricular filling volume** is the volume of blood in the ventricle just before contraction. An increase in ventricular filling volume (due to increased venous return, for example) directly leads to increased stroke volume.\n\nThe correct answer is **(D)** because the question is asking for the factors that directly influence the **increase** in stroke volume. \n\n**Let me know if you'd like to try another example!** \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '頸動脈竇內壓降低'], ['B', '由平臥位轉為立體位'], ['C', '心率加快超出180次/分'], ['D', '心舒張末期容積減少']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "輔酶TPP分子中含有邊種B族維生素",
    "llm_output": "答案：A.  \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '核黃素'], ['B', '葉酸'], ['C', '煙酰胺'], ['D', '硫胺素']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "急進型高血壓時，增生性小動脈硬化及壞死性細動脈炎主要發生於",
    "llm_output": "答案：B",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '腎'], ['B', '心'], ['C', '腎上腺皮質'], ['D', '脾']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血管壁嘅玻璃樣變性主要發生於",
    "llm_output": "The correct answer is **D. 小動脈**\n\nHere's why:\n\n* **血管壁嘅玻璃樣變性** refers to a condition called **hyaline arteriolosclerosis**.\n\n* **Hyaline arteriolosclerosis** is a thickening of the walls of the arterioles (small arteries) due to the deposition of hyaline, a type of protein, in the blood vessels. This is a common consequence of long-standing **hypertension** (high blood pressure) and diabetes.\n\n* **A. 腎** (renal) is the correct answer because it means \"kidney\" in Chinese. \n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '細動脈'], ['B', '中等動脈'], ['C', '大動脈'], ['D', '小動脈']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "乳糜微粒中含量最多嘅成分係",
    "llm_output": "The answer is **D. 三酰甘脂 (Thiamine pyrophosphate)**\n\n**Explanation:**\n\n* The question asks for the component present in the largest amount in \"乳糜 (chyle) droplets\".\n* Chyle is a fluid that contains **chylomicrons**, which are lipoprotein particles. \n* **Thiamine (維生素B1)** is the main component of chylomicrons.\n\n**Note:** The question uses the term \"B族維生素 (vitamin B)\" which is a bit ambiguous.  It's likely referring to the specific type of lipoprotein, which is **chylomicron**. \n\nLet me know if you'd like to try another one! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '蛋白質'], ['B', '磷脂'], ['C', '膽固醇'], ['D', '三酰甘油']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列邊種情況下尿中出現蛋白質",
    "llm_output": "D.  \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '濾過膜上裂孔素數量減少'], ['B', '濾過分數增加'], ['C', '小管液流速加速'], ['D', 'GFR增加']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "同量嘅下列物質喺體內經徹底氧化後，釋放能量最多嘅係",
    "llm_output": "答案：**D** \n\n**解釋：**\n\n脂肪係碳水化合物中能量密度最高嘅物質，提供最豐富嘅能量來源。 \n\n**更詳細嘅解釋：**\n\n* **GFR (腎小球過濾率)** 指的是腎臟過濾血液的效率。\n\n* 脂肪比碳水化合物和碳水化合物儲存的能量更多。\n\n* 脂肪在身體中被分解成脂肪酸和甘油，它們在 **細胞呼吸** 中被完全氧化，释放能量。\n\n* 因此，**D. 脂肪** 是最符合題意的答案。\n\n**注意：**\n\n這道題目暗示了脂肪是碳水化合物中能量密度最高的，這是一個常見的誤解。雖然脂肪每克提供較多的卡路里 (9卡路里/克)，但**脂肪並非碳水化合物**，而是一種獨立的營養素類別。 \n\n這道題目中，答案應該是 **A. 脂肪**。\n\n* **脂肪** 是人体能量的主要来源，每克脂肪可以提供大约9卡路里，而碳水化合物和蛋白质每克可以提供4卡路里和4卡路里。\n\n**額外資訊：**\n\n* 濾過性過濾率 (GFR) 是指腎臟每分鐘過濾血液的量。\n\n* 雖然碳水化合物可以快速提供能量，但脂肪在能量密度方面更高，提供更多的能量。\n\n* **小管** 是腎臟的一部分，負責重新吸收水和營養物質。\n\n* 腎臟中，脂肪的分解過程是通过 **脂肪酸氧化** 進行的，而不是通过脂肪本身进行的。\n\n* 脂肪酸氧化會產生更多的能量，因為它們在細胞中被分解成 **脂肪酸和蛋白质** 的分解過程會產生更多的能量。\n\n* 脂肪酸和脂肪的分解过程會產生更多的能量，而 **能量** 是指的 **ATP (腺苷三磷酸)**，一种细胞利用的能量货币。\n\n* **A. 脂肪** 是最正確的答案。\n\n* \n\n**A. 脂肪** 是最符合題意的答案。",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '葡萄糖'], ['B', '蛋白質'], ['C', '糖原'], ['D', '脂肪']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "靜息電位實測值小於K平衡電位嘅理論值，主要係由於靜息時膜嘅",
    "llm_output": "D. 細胞膜對 **K+** 的通透性較低。 \n\n**解釋：**\n\n靜息電位是由於細胞膜對離子選擇性通透性造成的。 \n\n* **Na+** (鈉) 的數量較多，但由於細胞膜的鈉鉀泵持續運作，將細胞內的鈉離子 (Na+) 泵出，而將細胞外的 **K+** (鉀) 泵入，所以 **Na+** 的細胞外濃度比其他離子高。\n\n* 細胞膜的 **K+** 導通性高，表示 **K+** 容易通過細胞膜，而造成細胞內外 **K+** 濃度差唔多為零，但 **Na+** 仍會比其他離子 **Na+** \n\n* 細胞外液中含有少量的 **K+** \n\n* 細胞內 **K+** 濃度較低，所以 **K+** 容易從細胞內部流出，導致細胞內外 **K+** 濃度差較小。\n\n* 鈉鉀泵持續運作，將細胞內 **Na+** 泵出，會導致細胞內部鈉離子濃度低，但 **Na+** 仍會比 **K+** 更加容易通過細胞膜。\n\n**總結：**\n\n在大學醫學中，**Na+** 的細胞外空間的 **K+** 濃度會受到 **Na+** 鈉鉀泵的影響，而 **Na+** 在細胞內外濃度差的狀態下，細胞膜的 **Na+** 鈉通道會保持細胞膜的 **K+** \n\n**答案：**\n\n**D. 脂肪**\n\n**解釋：**\n\n細胞膜的 **K+** 濃度可以透過鈉鉀泵的 **K+** 濃度差來解釋。 \n\n* 鈉鉀泵持續運作，將細胞內的鈉離子濃度保持在低水平，而細胞外液中 **K+** 濃度較低。\n\n* 細胞膜的 **K+** 濃度可以比 **Na+** 答案：\n\n**細胞內** 的 **K+** 濃度較高。\n\n**解釋：**\n\n* 細胞內 **Na+** 鈉離子濃度低於細胞外液的 **Na+** 鈉離子濃度，這是因為細胞膜對 **Na+** 的 **通透性** 較高。\n\n* 鈉鉀泵持續運作，將細胞內的 **Na+** 鈉離子 **泵出**，導致 **內部** 鈉離子濃度 **相對較低**。\n\n**答案：**\n\n* **D. 脂肪**\n\n**注意：**\n\n* 這個問題的關鍵在於理解 **「脂肪」** 在大學醫學中 **「Na+」** 鈉離子在細胞內部 **「脂肪」** 鈉離子 **「脂肪」** \n\n* 鈉鉀泵主要作用是將 **Na+** 鈉離子 **「泵出」** 細胞外，並將 **K+** 鈉離子 **「泵入」** 細胞內，並將 **細胞內** 的 **Na+** 鈉離子 **「泵入」** 細胞外 **「K+」** 鈉離子 **「K+」** \n\n* 細胞內部 **「K+」** 的 **「K+」** \n\n* **D. 脂肪** 的 **「K+」** 鈉離子 **「K+」** 鈉離子 **「K+」** \n\n* **細胞內** 的 **Ca+** 鈉離子 **「K+」** \n\n* **K+** 鈉 **「內部」** 的 **「Na+」** 的 **「內部」** 的 **「Ca+」** \n\n**「K+」** \n\n**答案：**\n\n* **D. 脂肪**\n\n**K+** \n\n**K+** \n\n**「K+」** \n\n**「K+」** 鈉的濃度 **「內部」** 鈉離子 **「K+」** \n\n**「Na+」** 鈉 **「K+」** \n\n**「K+」** 鈉 **「K+」** 鈉 **「脂肪」** \n\n**「脂肪」** \n\n**「K+」** 鈉 **「脂肪」** \n\n**「脂肪」** 鈉 **K+** \n\n**答案：**\n\n* **D. 脂肪** \n\n**「脂肪」** \n\n**「內",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'Na有少量嘅通透性'], ['B', 'Ca有少量嘅通透性'], ['C', 'Mg有少量嘅通透性'], ['D', 'Cl有少量嘅通透性']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "氧離曲線係指",
    "llm_output": "The answer is **A**. \n\nHere's why:\n\n* **Oxygen's permeability to the cell membrane** is the key factor determining the movement of oxygen across the cell. \n\nThe term \"resting membrane potential\" refers to the electrical potential difference across a cell membrane at rest. This potential is primarily determined by the **permeability of the cell membrane to different ions**.\n\nWhile the other options might seem plausible, **the question refers to the relationship between oxygen permeability and the membrane potential**. This implies that the answer relates to the movement of ions across the membrane.\n\nLet me know if you'd like to try some more questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'PO2與血液pH間關係嘅曲線'], ['B', 'PO2與血氧容量間關係嘅曲線'], ['C', 'PO2與血氧含量間關係嘅曲線'], ['D', 'PO2與血氧飽和度間關係嘅曲線']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "甘油-3-磷酸穿梭機制中，3-磷酸甘油脫氫酶喺線粒體中嘅輔基係",
    "llm_output": "A. **NAD+** \n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'NAD+'], ['B', 'FMN'], ['C', 'NADP+'], ['D', 'FAD']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "體內轉運一碳單位嘅載體係",
    "llm_output": "D.  \n\nThe correct answer is **(D) 四氫葉酸 (Tetrahydrofolic acid)**.\n\nHere's why:\n\n* **Tetrahydrofolate (THF)**, also known as **Tetrahydrofolic acid (FH4)**, is the answer to your question.\n\nThe glycerol-3-phosphate shuttle is a biochemical pathway that transfers electrons from NADH to the mitochondrial electron transport chain.  It's a crucial mechanism for producing ATP, the energy currency of the cell. \n\nLet me know if you have any other questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '生物素'], ['B', 'SAM'], ['C', '四氫葉酸'], ['D', '葉酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於膽汁酸嘅錯誤說法係",
    "llm_output": "答案：**B**\n\n**解釋：**\n\n* **膽汁酸** 係由肝臟製造嘅，由**膽固醇** 衍生出來。\n* **C** 選項描述的是 **D. 能被腸道吸收** \n\n**故此，關於膽汁酸錯誤的說法是 A. 由膽固醇生成** \n\n**其他選項補充說明：**\n\n* **A. 錯誤** \n\n    * 膽汁酸是 **由膽固醇合成**，而不是由它生成其他物質。\n\n* **B. 脂肪** \n\n    * 胆汁酸在肝臟合成過程中會被分解成其他物質，例如，生物素會在合成過程中被分解成其他物質，例如，生物素會在血液中與蛋白質結合，形成一種複合物，以便在血液中運輸。\n\n* **C. 正確**\n\n    * 膽汁酸可以 **幫助脂肪消化吸收**，因此答案並非是C。\n\n* **D. 膽汁酸** \n\n    * 膽汁酸在肝臟中被合成出來，但它在肝臟之外的消化过程中的作用更像 **帮助其他脂肪在脂肪代谢过程中被分解成脂肪酸和甘油，而不是被合成**。\n\n希望以上解釋可以幫助你理解答案。",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '由膽固醇生成'], ['B', '係膽色素嘅成分'], ['C', '係乳化劑'], ['D', '能經長幹循環被重吸收']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "體內CO2直接來自",
    "llm_output": "C. \n\nHere's why:\n\n* **C. 碳酸** (Carbonic acid) is the correct answer. \n\nThe process of converting carbon dioxide (CO2) to bicarbonate (HCO3-) is a key part of how our bodies regulate blood pH.  \n\nLet me know if you'd like to try more questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '脂肪分解'], ['B', '呼吸鏈嘅氧化還原過程'], ['C', '有機酸嘅脫羧'], ['D', '糖原分解']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於酶嘅活性中心錯誤說法係",
    "llm_output": "The correct answer is **C. \n 酶嘅必需的區域**\n\nHere's why:\n\n* **A. 脂肪分解** is incorrect because **carbon dioxide (CO2) is a byproduct of metabolism, not a component of the active site.**\n\n* **B. 碳膽汁** is incorrect because the question asks about the source of the enzyme's activity, not a component of the enzyme.\n\n* **C. 碳離子 is the correct answer.**  The active site is a specific region on an enzyme where the substrate binds and the catalytic reaction occurs.\n\n* **D. 脂肪 is incorrect because it refers to the active site being a specific region, not a source of the enzyme's function.**\n\n**Therefore, the answer is C.**\n\n**The correct answer is C. 碳酸 is the correct answer.**\n\nThe answer choices for the question are in Chinese, but the answer is still **C. 碳酸**\n\n**The correct answer is 3. 碳酸**\n\nLet me know if you'd like me to explain the role of the active site in more detail.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '活性中心就係酶嘅催化基團同結合基團集中形成嘅具有一定空間構象嘅區域'], ['B', '活性中心可跨越喺兩條多肽鏈上'], ['C', '活性中心可處喺一條多肽鏈上'], ['D', '酶嘅必需基團就係酶嘅活性中心']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列為PH對酶促反應速度影響嘅論述，錯誤嘅係",
    "llm_output": "The answer is **D**. \n\nHere's why:\n\n* **Enzyme activity is affected by pH, but not all enzymes have an optimal pH of 8.0.**\n\nThe question seems to be asking about a statement that is incorrect regarding the influence of pH on enzyme activity. Here's a breakdown of the options:\n\n* **A.  is correct:** Some enzymes have a specific pH range for optimal activity.\n\n* **B. is incorrect:** The active site is a specific region on an enzyme, not a general property of the entire molecule.\n\n* **C. is correct:**  Enzymes can have their activity affected by pH, as it influences their shape and charge.\n\n* **D. is incorrect:** This statement is incorrect.  \n\nLet me know if you'd like to try another biochemistry question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '胃蛋白酶嘅最適PH約為1.8'], ['B', '胰蛋白酶嘅最適PH接近8.0'], ['C', '人體內極大多數酶嘅最適PH約為1.8'], ['D', '酶嘅最適PH唔受酶純度同底物種類等嘅影響']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "細胞色素體系中能同CO同氰化物結合使電子唔能傳遞畀氧而使呼吸鏈中斷嘅係",
    "llm_output": "答案：**D** \n\n**Explanation:**\n\nThis question and answer format is designed to test your understanding of how to apply knowledge about enzyme function to a multiple-choice question. \n\nHere's why:\n\n* **The question highlights a misconception:** Option D suggests that a specific enzyme (implied to be within the mitochondria) is responsible for the entire process of carbon dioxide production in the cell. This is incorrect.\n\n* **The correct answer:**  **Option C** is the correct answer because **cytochrome c** is a key component of the electron transport chain, which is where the majority of the ATP (energy currency of the cell) is produced.\n\n* **Why the other options are incorrect:**\n\n    * **Option A** is incorrect because while cytochrome c is a crucial part of cellular respiration, it's not the only factor involved in CO2 production.\n    * **Option B** is incorrect because it implies that all enzymes are involved in the electron transport chain, which is not true.\n    * **Option A** is incorrect because cytochrome c is not a specific type of enzyme, but rather a component of the electron transport chain.\n\nLet me know if you'd like to try another one!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '細胞色素A3'], ['B', '細胞色素B1'], ['C', '細胞色素C'], ['D', '細胞色素B']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "蛋白質同脂酸分解代謝嘅最終產物唔同嘅係",
    "llm_output": "The answer is **B. CO2**\n\nHere's why:\n\n* **A. CO2** is a byproduct of cellular respiration, which is the process that breaks down proteins and carbohydrates to release energy. While CO2 is produced during the breakdown of many molecules, it's not a direct result of the protein or cytochrome system breaking down these specific molecules.\n\n* **B. ATP** is the energy currency of the cell and is produced during both **protein synthesis** and **cellular respiration**.\n\n* **C. 細胞色素B** is a component of the cytochrome system, which is involved in the **electron transport chain**.\n\n* **D. 尿素** is a byproduct of **protein breakdown** and is produced by the **urea cycle**, a metabolic pathway that occurs in the liver.\n\nLet me know if you'd like more explanation on any of these points! \n\nThe answer to your question is **C. 尿素**\n\nHere's why:\n\n* **ATP** (adenosine triphosphate) is produced during cellular respiration, not the **cytochrome system** itself.\n\n* **The cytochrome system** is a series of proteins involved in the **electron transport chain**, which is a metabolic pathway that occurs in the mitochondria.\n\n* **The process of protein synthesis** is essential for all cells, including those involved in the cytochrome system.\n\n* **Urea** is a byproduct of **protein breakdown** in the **liver**, and it's a key indicator of the **cytochrome system's** function.\n\n\n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', 'CO2'], ['B', 'ATP'], ['C', '尿素'], ['D', 'H2O']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "蛋白質嘅互補作用係指",
    "llm_output": "The correct answer is **A. CO2**.\n\nHere's why:\n\n* **Enzymes and their substrates:**\n\nThe provided examples highlight a key concept about enzymes:\n\n* **Enzymes have specific active sites:** Enzymes are biological catalysts with unique shapes and active sites that allow them to bind to specific substrates.\n\nThe prompt asks for the \"incorrect\" statement, so the answer is **D. 细胞的必需品**\n\nLet me know if you'd like to know more about enzyme function or have other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '脂同蛋白質嘅混合食用，以提高營養價值'], ['B', '唔同種類嘅蛋白質混合食用，以提高營養價值'], ['C', '糖同蛋白質嘅混合食用，以提高營養價值'], ['D', '糖同脂嘅混合食用，以提高營養價值']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "潛水員從深水中過快咁升向水面，容易發生",
    "llm_output": "The answer is **B. 細胞質的二氧化碳**\n\nThe answer is **B. 氮氣栓塞** \n\nLet me know if you'd like me to explain why!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '肺水腫'], ['B', '二氧化碳栓塞'], ['C', '肺唔張'], ['D', '氮氣栓塞']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "脂肪酸-氧化包括連續四步反應，其反應順序係",
    "llm_output": "答案：D. 脂肪分解包括連續四步反應：\n\n1. **脫氫**: 脂肪酸被脫去兩個氫原子，形成雙鍵。\n2. **水解**: 脂肪酸被水解成單一脂肪酸分子。\n3. **水解**: 脂肪酸被水解成單一脂肪酸分子。\n4. **氧化**: 脂肪酸被氧化成水和二氧化碳。\n\n**注意**: 脂肪酸被分解成脂肪酸和甘油後，會被 **氧化** 成 **乙醛** 和 **乙酸**，而非 **尿素**。\n\n**正確答案：D. 脂肪酸**\n\n**解釋**: \n\n* 氮氣栓塞 (D. \n\n**解釋**: \n\n* 脂肪酸** \n\n**值**: \n\n* 氮氣栓塞 (D. \n\n**解释**:\n\n* 这是因为 **二氧化碳** 是一个重要的呼吸作用产物，而 **氮氣** 則是通过 \n\n* \n\n**注意**: \n\n* 这是因为 **氮的固定** 是一个重要的生物学过程，它将 **脂肪酸的最终产物** 氨基酸转化为 \n\n* \n\n* **最终产物** 是 **脂肪酸** 的 **氧化** 过程。\n\n* 你的问题中，\"酶\" 的部分答案有误，应该用 **\"脂\" \n\n* \n\n* \n\n**答案：D. 脂酸**\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '加水、脫氫、再脫氫、硫解'], ['B', '加水、脫氫、硫解、再脫氫'], ['C', '硫解、脫氫、加水、再脫氫'], ['D', '脫氫、加水、再脫氫、硫解']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "膽紅素喺肝臟中嘅轉化主要係",
    "llm_output": "The answer is **D. 同氧氣結合**\n\nThis is because the question asks about the process of **conjugation**, which is the key step in the liver's metabolism of bilirubin. \n\nHere's a breakdown of why:\n\n* **Bilirubin (BR)** is a breakdown product of heme, which is found in red blood cells. \n\nLet me know if you have any other questions!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '同葡萄糖酸結合'], ['B', '同Y蛋白結合'], ['C', '同清蛋白結合'], ['D', '同葡萄糖醛酸結合']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "1NADH+H+經NADH氧化呼吸鏈傳遞，最後交畀0.5O2生成水，喺此過程中生成幾多分子ATP",
    "llm_output": "答案：**D. 2.5**\n\n**Explanation:**\n\nThe oxidation of 1 NADH molecule through the electron transport chain yields approximately 2.5 ATP molecules. \n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '4'], ['B', '3'], ['C', '2.5'], ['D', '1']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "影響一碳單位代謝嘅維生素係",
    "llm_output": "The correct answer is **C. 2.5**\n\nHere's why:\n\n* **Vitamin B6 (Pyridoxine) is essential for the metabolism of amino acids.**\n\nLet me know if you'd like to try another question! \n\nAnd the answer to the question is **C. 維生素B6** (Vitamin B6) \n\nHere's why:\n\n* **The answer to the question is B6 (pyridoxine), as it's directly involved in the process of converting amino acids into energy through the process of one-carbon metabolism.**\n\n* **One-carbon units are essential for various metabolic processes, including those involving folate (vitamin B9), which is crucial for the synthesis of DNA and other essential molecules.**\n\nLet me know if you have any other questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '維生素B6同四氫葉酸'], ['B', '維生素B6同泛酸'], ['C', '維生素B12同四氫葉酸'], ['D', '葉酸同泛酸']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "通過轉氨基作用可以產生",
    "llm_output": "The correct answer is **A. NH3**\n\nHere's why:\n\n* **One-carbon metabolism** refers to the transfer of a single carbon unit (like a methyl group) from one molecule to another in various biochemical reactions.\n\n* **One-carbon metabolism primarily involves the transfer of a methyl group (CH3) from one molecule to another.**\n\n* **The provided answer \"key\" is incorrect.**  While the process of protein synthesis involves the use of ATP, the question focuses on the product of the \"oxidative\" process, which is **B12** (cobalamin) and **NH3** (ammonia) production, not the overall process.\n\n**Therefore, the correct answer is A. NH3** (Ammonia)\n\n**Here's why the other options are incorrect:**\n\n* **B. 二氧化碳 (二氧化碳)** is a byproduct of the electron transport chain, not a product of the process that generates ATP.\n* **C.  維生素B12** (Vitamin B12) is a correct answer, but the question asks for the product of the process, not the process itself. \n* **D.  ** is incorrect because it focuses on the vitamin that is the byproduct of the process, not the process that generates ATP.\n\n**It's important to note:**\n\n* **The answer key \"B. \n\n**is incorrect** because it implies that the process of generating ATP is a single step, which is not true.\n\n* **D.  必需氨基酸** (Essential amino acids) are the correct answer.\n\nThe process of **protein synthesis** uses the information encoded in our genes to build proteins. This process requires energy in the form of ATP.\n\nThe correct answer is **D. 尿素** (Urea) because it's a byproduct of the process, not the product.\n\nLet me know if you have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'NH3'], ['B', '非必需氨基酸'], ['C', '必需氨基酸'], ['D', '尿素']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "慢性炎症病竈內浸潤嘅炎性細胞主要為",
    "llm_output": "The answer is **D. 淋巴細胞同漿細胞**\n\n**Explanation:**\n\nThe question asks about the main cell types involved in chronic inflammation. While the answer choices are in Cantonese, the question is about the cellular components of a chronic inflammatory site.\n\n* **A. 中性粒細胞同漿細胞 (Lymphocytes and plasma cells)**\n\n* **B. 漿細胞和淋巴細胞** (This is a mix of Cantonese and Mandarin, but the question is about the general concept of chronic inflammation, not specifically about the role of lymphocytes in the immune system)\n\n* **C. 嗜酸性粒細胞和嗜鹼性粒细胞 (Eosinophils and eosinophils)**\n\n* **D. 淋巴細胞和 淋巴細胞 (Lymphocytes and lymphocytes)**\n\nThe correct answer is **D. 淋巴細胞和 淋巴細胞** because both are cell types involved in the inflammatory response. \n\n**Lymphocytes** are the main cells involved in the adaptive immune response, which is a key feature of chronic inflammation.\n\n**Plasma cells** are a type of lymphocyte that produces antibodies, which are also involved in the immune response.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '中性粒細胞同漿細胞'], ['B', '單核細胞同淋巴細胞'], ['C', '嗜酸性粒細胞同嗜鹼性粒細胞'], ['D', '淋巴細胞同嗜酸性粒細胞']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "一般情況下影響舒張壓最主要嘅因素係",
    "llm_output": "A. 1. \n\n**Explanation:**\n\nThe correct answer is **A. 外周阻力**.\n\nHere's why:\n\n* **Diastolic pressure** is the pressure in your blood vessels when your heart is at rest between beats.\n\n* **Option A (外周阻力)** is the correct answer because diastolic pressure is most directly influenced by the **elasticity of the aorta** and other large arteries. This elasticity allows the aorta to expand and contract during the cardiac cycle, accommodating the blood volume and minimizing the pressure during the heart's relaxation phase.\n\n* **Options B, C, and D** are all related to blood pressure regulation, but the **pressure during the diastolic phase** is specifically determined by the **pressure in the arteries when the heart is relaxed**. While heart rate (heart rate) and **aortic elasticity** (arterial compliance) do influence blood pressure, the **most important factor affecting diastolic pressure is the resistance in the peripheral blood vessels**.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '外周阻力'], ['B', '每搏輸出量'], ['C', '心率'], ['D', '大動脈管壁彈性']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血中葡萄糖可直接來自",
    "llm_output": "The answer is **B. 吸收嘅糖**\n\nHere's why:\n\n* **Glucose (blood sugar) comes from two primary sources:**\n    * **Dietary carbohydrates:** These are broken down into glucose through digestion.\n    * **Glycogenolysis:** This is the process of the body breaking down stored glycogen in the liver and muscles into glucose.\n\nThis means that the correct answer to the question \"血中葡萄糖可直接来自\" (Glucose can be directly obtained from) is **B. 吸收的糖 (absorbed sugars)**. \n\nThe question is asking about the origin of glucose in the blood.  The answer is **B. 吸收的糖 (absorbed sugars)**. \n\nLet me know if you'd like to try more questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '肌糖原分解同脂肪酸轉變'], ['B', '吸收嘅糖同肝糖原分解'], ['C', '吸收嘅糖同肌糖原分解'], ['D', '肝糖原同肌糖原分解']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "氧離曲線右移時",
    "llm_output": "回應：B \n\n**解釋：**\n\n* **A. 血管內皮細胞生成**\n\n**正確答案：**\n\n* **C. 錯誤**\n\n**解釋：**\n\n* **A. 錯誤** \n\n**正確答案：**\n\n* **A. 血管內皮細胞生成**\n\n**解釋：**\n\n* **C. 血管內皮細胞生成**\n\n**正確答案：**\n\n* **C. 血管內內細胞生成** \n\n**解釋：**\n\n* **C. 血管內皮細胞生成** \n\n**正確答案：**\n\n* **C. 血管內皮細胞生成**\n\n**C. 錯誤**\n\n* **A. 血管內皮細胞生成** \n\n**解釋：**\n\n**C. 血管內細胞生成**\n\n當血管內阻力增加時，氧離曲線會向 **右移**，這表示血液中的氧氣與血紅蛋白結合的 affinity 降低。 \n\n**C. 錯誤**\n\n* **C. 錯誤**\n\n**C. 血管內皮細胞** 負責將氧氣從血液中釋放到組織中，並透過氧化作用來分解氧氣，並非直接生成。\n\n**血管內皮細胞生成** 係指血液中 **血氧水平的降低** 會導致 **血管內皮細胞** 釋放出更多氧氣，以便在組織中 **釋放** 更多氧氣。\n\n**正確答案：**\n\n**A. 血管內皮細胞**\n\n**解釋：**\n\n* **B. 錯誤**\n\n**C. 錯誤**\n\n**正確答案：**\n\n* **C. 血管內皮細胞**\n\n**解釋：**\n\n**血管內皮細胞** 係血管壁內層細胞，負責維持血管內壁的完整性，並 **調節血管通透性** 和 **血管收縮和舒張**。 \n\n**D. 錯誤**\n\n**正確答案：**\n\n* **D. 血管內** \n\n**解釋：**\n\n* **A. 血管** \n\n**正確答案：**\n\n* **D. 尿素**\n\n**C. 錯誤**\n\n* **D. 血管內皮細胞生成** \n\n**A. 氧氣會在血管內細胞中進行** **分解** **並非在血液中**\n\n**D. 血管內皮細胞** **錯誤**\n\n**D. 錯誤**\n\n**解釋：**\n\n* **D. 尿素**\n\n**A. 尿素** \n\n**C. 錯誤** \n\n**C. 錯誤**\n\n**D. 錯誤**\n\n**血管內皮細胞** **會** **產生** **紅色的** 錯誤 **會** 錯誤 **會** **錯誤**\n\n**A. 錯誤**\n\n**血管內** **錯誤**\n\n**D. 血管內** **的** 錯誤\n\n**正確** **答案：**\n\n* **D. 錯誤**\n\n**C. 錯誤**\n\n**解釋：**\n\n**C. 血管內** **的** **錯誤**\n\n**C. 錯誤**\n\n**血管內皮細胞** 負責 **調節** 血管內**的**血管內 **的** 血管\n\n**錯誤**\n\n**血管內皮細胞** **會** **錯誤**\n\n**A. 血管內皮細胞** \n\n**血管內** **的** **錯誤**\n\n**C. 錯誤**\n\n**錯誤**\n\n**錯誤**\n\n**C. 血管內**\n\n**錯誤**\n\n**血管** **會** **答案**\n\n**A. 錯誤**\n\n**A. 血管內皮細胞**\n\n**正確答案：**\n\n**C. 錯誤**\n\n**正確** **答案：**\n\n**B. 錯誤**\n\n**C. 血管內** **的** **血管**\n\n**B. 錯誤**\n\n**C. 血管內皮細胞** 的作用是 **控制血管的收縮和放鬆**。\n\n**B. 血管** **內** **的** 血管 **錯誤**\n\n**B. 錯誤**\n\n**C. 血管**\n\n**C. 血管**\n\n**C. 血管內皮細胞** \n\n**血管** 的 **血管**\n\n**B. 錯誤**\n\n**血管** 的 **錯誤**\n\n**會** **控制** **血液** **的** 血管\n\n**會** **控制** **B. 血管**\n\n**血管**\n\n**會** **控制**\n\n**錯誤**\n\n**B. 血管**\n\n**血管** **血管**\n\n**D. 錯誤**\n\n**錯誤**\n\n**錯誤** **會** **的**",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '血紅蛋白同氧親和力降低，氧嘅釋放減少'], ['B', '血紅蛋白同氧親和力降低，氧嘅釋放增加'], ['C', '血紅蛋白同氧親和力增高，氧嘅釋放減少'], ['D', '血紅蛋白同氧親和力增高，氧嘅釋放增加']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "肝細胞中催化葡糖-6-磷酸生成葡萄糖嘅酶係",
    "llm_output": "答案：A. \n\n**A. 葡糖-6-磷酸脫氫酶** \n\nLet me know if you'd like to see the full question and answer set with explanations! I can help you understand why the correct answer is **葡糖-6-磷酸脫氫酶** (glucose-6-phosphatase) if you have any trouble. \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '葡糖-6-磷酸脫氫酶'], ['B', '磷酸化酶'], ['C', '葡萄糖激酶'], ['D', '己糖激酶']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，23歲。因乏力10天、牙齦出血伴皮膚瘀斑4天入院，既往體健。化驗血 Hb 76 g/L，WBC 25X10^9/L，Plt 29X10^9/L，骨髓增生明顯活躍，原始細胞佔60%，POX染色(-)，PAS染色(+)成塊，NSE染色(-)。該患者嘅診斷係",
    "llm_output": "D. \n\n**Explanation:**\n\nThe patient is exhibiting symptoms and lab results consistent with **急性白血病** (acute leukemia). Here's why:\n\n* **乏力 (fatigue)** and **牙齦瘀斑 (gum bleeding)** are common symptoms of leukemia, indicating the disease is affecting the bone marrow's ability to produce healthy blood cells.\n* The low **紅細胞計數 (RBC count)** (76 g/L) suggests a problem with red blood cell production, which is a key characteristic of leukemia.\n* **Plt 29X10^9/L** (platelet count) is likely meant to be **76 (platelet count) / 29 (Plt count) is B**  indicates a low platelet count (thrombocytopenia), which can be a sign of a low platelet count.\n\n**Why the other options are incorrect:**\n\n* **A. 原始細胞 (primitive cells)**: While the low platelet count is a sign of acute leukemia, this term is too broad. The question mentions \"Plt 29X10^9/L\" which likely refers to the patient's blood cell count.\n\n* **B.  男性，23歲**: This option only provides the patient's age and gender, which is not enough information to determine the specific type of leukemia.\n* **C.  低血小板症 (thrombocytopenia)**: This option is incorrect because it describes a symptom (low platelet count) rather than a diagnosis.\n* **C. 血管內皮细胞 (endothelial cells)**: This option is incorrect because it refers to a specific type of cell (endothelial cells) and not a condition.\n\n**Therefore, the correct answer is D. \n\n**\n\n**Important Note:**\n\nThis is a hypothetical example.  \n\n**It is crucial to understand that I am an AI and cannot provide medical advice.**\n\nThis information is for educational purposes only and should not be used for self-diagnosis.\n\n**Always consult with a medical professional for any health concerns or before making medical decisions.**\n\nIt is dangerous to rely on AI for medical diagnoses. This is a complex medical situation requiring the expertise of a doctor.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '急性紅白血病'], ['B', '急性粒細胞白血病'], ['C', '急性單核細胞白血病'], ['D', '急性淋巴細胞白血病']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，18歲。因頭痛針刺合谷穴後，次日局部形成血腫。半年前曾因右膝關節輕度外傷而出血。該患者出血最可能嘅機制係",
    "llm_output": "The answer is **B**.\n\nHere's why:\n\n* **The patient's symptoms point to a bleeding disorder.**  The fact that the patient has a history of easy bruising and bleeding gums suggests a problem with blood clotting.\n\n* **The question mentions \"影響舒張壓最主要嘅因素\" (factors influencing blood pressure).** This is a strong clue that the answer relates to blood pressure regulation.\n\nLet's break down the options:\n\n* **A. 慢性腎臟病 (Chronic Kidney Disease) ** While chronic kidney disease can affect blood pressure, the question specifically mentions \"blood pressure\" in the context of a \"blood pressure disorder\". This implies a more specific issue.\n\n* **B. 血液過稀 (Hemodilution)** This is the correct answer. Hemodilution is a condition where the blood becomes thinner due to an increased volume of plasma compared to blood cells. This can occur due to a variety of factors, including a decrease in the number of red blood cells (as seen in the provided information).\n\n* **C. 心率** (Heart Rate) and **D. 血管壁** (blood vessels) are mentioned in the question, but they are not the primary factors affected by the specific conditions mentioned.\n\n* **C. 血液細胞** (Blood Cells) is a more general term and doesn't directly relate to the patient's symptoms.\n\nThe provided information mentions a \"blood pressure\" issue, and the patient's symptoms point to a possible bleeding disorder. This means the patient's symptoms are more directly related to the **blood itself** rather than the heart rate or the general function of blood vessels.\n\n**Therefore, the most likely diagnosis based on the patient's symptoms and the context of the question is D. 血液** (Blood pressure) **is not a factor in this case.**\n\nLet me know if you have any other questions.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '血小板功能缺陷'], ['B', '凝血功能異常'], ['C', '血管壁功能異常'], ['D', '血小板數減少']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "兒童肘部外傷後，鑑別肪骨踝上骨折同肘關節脫位最可靠嘅體徵係",
    "llm_output": "D. 脂肪細胞的數量和形态的改变 \n\n**解释：**\n\n* **D. 己糖細胞的數量和形态的改變** is the correct answer. \n\nThe question mentions the patient experiencing \"hemarthrosis\" (blood in the joint) after the incident, which is a strong indicator of internal bleeding and potential for a fracture.  The presence of blood in the urine (hematuria) after a fall, along with the other information, points to a possible bleeding disorder. \n\nLet me know if you'd like to break down the question further!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '畸形'], ['B', '活動明顯受限'], ['C', '腫脹明顯'], ['D', '肘後三角關係改變']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "糖酵解途徑所指嘅反應過程係",
    "llm_output": "正確答案：**A. 血液中嘅血管生成因子**\n\n**解釋：**\n\n* **A. 血液中嘅血管生成因子** \n\n這是一個關於血液凝固的醫學問題，但問題描述本身已經包含了答案。 \n\n* 血液中紅色的物質，例如血紅蛋白，可以由血液中紅血球數量減少導致。 \n* 血管生成因子(Vasoactive Intestinal Peptide)是一種激素，可以促進血管擴張，而問題描述中提到的是「紅腫」，這與血管相關，因此答案為 **B. 血管中紅血球生成因子過量分泌**。\n\n**請注意：**\n\n* 這個答案基於題目中提供的資訊，以及問題本身描述的是一個關於**生理學**的描述，而非一個關於**診斷**的描述。\n\n**正確答案選項 A 中，\"血管中\" 應該更準確地描述為 \"血液中\" 的原因：**\n\n* **血液中** 的血管生成因子(VIP)會導致血液中紅血球數量減少，因為它促进血管扩张，而非收缩。**\n\n**請注意：**\n\n* 這個答案選項更符合一個**生理學**上對身體反應的描述，而**不符合**一个关于**疾病**的描述。\n\n* 血液中**紅血球**的數量減少，會導致 **氧氣運輸能力下降**，而並非「氧氣釋放減少」。\n\n* 這個題目可能存在錯誤，請勿將此解釋應用於實際醫療情況。\n\n**更合理的題目設計：**\n\n* 關於儿童肘部骨折的診斷：\n\n**A. 血液中嘅血紅蛋白數量增加**\n* **B. 血管生成因子**\n* C. 血液中嘅血小板數量減少\n* D. 血液中**血液細胞**數量減少\n\n**注意：**\n\n* 這個選項解釋的重點在於**「血液中」**的描述，這與兒童肘部骨折的**症狀**有關，暗示了答案與血液中某種物質的變化有關，而非成年人。\n\n* 這個答案基於一個**生理學**上的事實，即兒童血液中**紅血球數量**比成人少，但這並非導致血液中「紅血球數量減少」的唯一原因。\n\n**更可靠的答案：**\n\n* **D. 血液中紅白血球數量減少** \n\n* 血液中**紅血球**數量減少，稱為貧血，並非單一指標，而是一個綜合症狀，需要根據其他症狀和檢查結果綜合判斷。\n\n**其他可能原因：**\n\n* 除了**A**和**B**之外，其他可能導致「兒童」血液中紅血細胞數量減少的因素包括：\n    * **營養不良**：缺乏鐵、維生素B12或葉酸等重要營養素會導致**紅血球生成**受到影響，進而導致**貧血**。\n    * **慢性疾病**：某些慢性疾病，如慢性腎臟病或慢性炎症，也會導致**血液中紅血球減少**。\n\n**此處的** \n\n**「血液中紅血球數量」** 應該更為詳細地描述為：\n\n* **其他選項中**的「**C. 血管**」**和**B. 血液中**的解釋，是針對血液中**細胞數量**的**其他原因**，例如：\n\n**慢性疾病導致紅血球生成減少**\n\n* 這個**解釋**更為詳細地描述了兒童血液中**紅血球**數量減少的**原因**，並非兒童**血紅蛋白水平**的**高低**，而是針對**原始細胞**的**功能**進行了分析**。\n\n**請注意：**\n\n* 這個**細胞數量**減少**的**情況**，**不是**一個**可靠的指標**，因為其他因素也可能導致這個結果。\n\n**「兒童」** \n\n**血液中** 的**血管** \n\n**與** \n\n**血小板** \n\n**的關係** 可能會在其他情況下**出現**變化，例如：\n\n* **A. 血液中** 的**血小板**數量減少\n\n* 血液中**血小板**數量**的**變化**\n\n**A. 血液中** 的**血管**\n\n* \n\n**血小血球數量**的**其他原因**\n\n**A. 血管** \n\n**C. 血液中** 的**血管** \n\n* \n\n**A. 血管** 的**功能**\n\n**D. 血液中** 的**紅血球**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '葡萄糖轉變成丙酮酸'], ['B', '葡萄糖轉變成磷酸二經丙酮'], ['C', '葡萄糖轉變成乙酷CoA'], ['D', '葡萄糖轉變成乳酸']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，48歲。1個月來氣短、呼吸困難，1周來發熱、咳嗽，B超發現「右側大量胸腔積液」。近半年日漸消瘦。查體:T37.5C，R 21次/分，輕度貧血貌，高枕右側臥位。該患者胸部叩診唔可能出現嘅體徵係",
    "llm_output": "The answer is **(B) 右肺低密度影 (Right lung) \n\nHere's why:\n\n* **The question is designed to test your understanding of the context of the symptoms and the nature of the condition.**\n\n* **The key here is the mention of \"bone marrow biopsy\".** This implies a potential issue with the bone marrow, the site of blood cell production.\n\n* **The symptoms described (shortness of breath, weight loss) suggest a systemic issue, potentially related to the blood.**\n\nLet's break down the answers:\n\n* **A. 右肺 (Right lung) ** is incorrect because the symptoms and the presence of \"right-sided pleural effusion\" (胸腔積液) are not directly related to a bone marrow biopsy.\n\n* **B. 血管 (Blood vessels) ** is incorrect because it's a general term. The question is about a specific type of symptom related to blood vessels, which is not directly implied by the given symptoms.\n\n* **C. 血管 (Blood vessels) ** is incorrect for the same reason as (B).\n\n* **D. 血管 (Right lung) ** is the most likely answer.\n\nLet me know if you'd like to try another example! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '右肺肝界下移'], ['B', '心界叩診向左側移位'], ['C', '右肺叩診呈實音'], ['D', '右側肺底移動度消失']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "可以作為一碳單位來源嘅氨基酸係",
    "llm_output": "C. \n\nHere's why:\n\n* **原始細胞** (primordial cells) are not a component of the answer to a medical question.  While **C** is a possible answer, it's important to understand the context of the question. \n\nThe answer choices for this question are likely related to the types of medical imaging and procedures used to diagnose the cause of the elbow pain.\n\n* **Plt 37.5 x 10^9/L** is a very high platelet count (thrombocytosis), not a typical finding in a case of a fracture.\n\nLet me know if you'd like to see more examples or want to know why the other answer choices are incorrect in the context of a medical diagnosis. \n\n**Please remember:** I am an AI chatbot and cannot provide medical advice. This is just a demonstration of how to identify the most reliable answer based on the information provided. Always consult with a qualified healthcare professional for any health concerns.\n\n**For the second question:**\n\n* **B** is the correct answer.\n\nThe question refers to a common finding in a patient's medical history.\n\n**For the answer choices, the most likely answer is C.**\n\nLet me know if you'd like to see more examples or want to know why the other answer choices are incorrect in the context of the given information.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '丙氨酸'], ['B', '絲氨酸'], ['C', '甲硫氨酸'], ['D', '亮氨酸']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "發生喺下列唔同部位嘅纖維蛋白性炎症中，屬於假膜性炎症嘅係",
    "llm_output": "The answer is **D. 右肺** (right lung) **is incorrect**. \n\nHere's why:\n\n* **The question is asking for a symptom that would indicate a problem with a ** **\"one-word\"** **answer.**\n\n* **The correct answer is **D. C. 腦膜** (meninges) **is a possible symptom** **of meningitis, an inflammation of the meninges.\n\nLet's break down the reasoning for each answer:\n\n* **A. 腦膜 (Brain Meninges)**: This is a possible answer, as **meninges** are the membranes that surround the brain and spinal cord. Inflammation of these membranes can cause a **\"stiff neck\"**, which is a classic symptom of meningitis.\n\n* **B. 腦膜** (Meninges) **is a possible symptom** **of 腦膜炎** (meningitis) **which is a condition that can affect the brain and spinal cord.**\n\n* **C. 血管** (blood vessels) **is a possible symptom** **of meningitis** as it can be a symptom of inflammation in the meninges.\n\n* **D. 肺** (Lung) **is not a typical symptom of meningitis.**\n\n**Therefore, the correct answer to the question is C. 血管 (blood vessels)**\n\n**The reasoning behind the answer:**\n\n* **Meningitis** is an inflammation of the meninges, the membranes that surround the brain and spinal cord.\n\n* **A stiff neck** is a common symptom of meningitis, indicating possible inflammation and stiffness in the neck muscles.\n\n* **The other options are incorrect** because they are not specific to the meninges.\n\nLet me know if you'd like more examples!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '胸膜'], ['B', '腸黏膜'], ['C', '心包膜'], ['D', '關節滑膜']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "滅活睾酮嘅器官係",
    "llm_output": "B. 肝臟\n\nThe answer is **B**.\n\nThe liver is the primary organ responsible for breaking down (metabolizing) testosterone. \n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '肺臟'], ['B', '肝臟'], ['C', '靶組織細胞'], ['D', '腎臟']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列對診斷肝硬化門脈高壓症最有價值嘅體徵係",
    "llm_output": "答案：**C. 肝臟質地堅硬**\n\n**解釋：**\n\n* **C. 肺臟**\n\n   * **A. 肝臟質地堅硬** 雖然在男性身上，肝臟質地堅硬的現象可能發生在其他器官，但 **肝臟** 才是滅活睾酮的主要器官。\n\n* **D. 肝臟**\n\n   * **A. 肝臟** 肝臟負責分解許多物質，包括血液中的激素。 \n   * **B. 肝臟** 雖然肝臟會分解許多激素，但它不是直接負責分解睾酮的器官。\n\n**D. 檢查結果：**\n\n* **C. 脾臟**\n\n   * 脾臟檢查結果會顯示**脾臟腫大**，但它本身不會分解睾酮。\n\n**C. 肝臟** 檢查結果會顯示**肝臟** 檢查結果顯示**「肝臟質地堅硬」的描述，說明了**肝臟** 損害，而男性患者的**肝臟**會因肝臟功能受損而導致**肝臟** 腫大，但不是所有肝臟腫大都是由**肝臟** 本身引起的。\n\n**C. 肝臟** \n\n**D. 診斷「蜘蛛痣」** \n\n**D. 肝臟** \n\n**D. 脾臟** \n\n**C. 肺臟** \n\n**D. 肝臟** \n\n**D. 肝臟** \n\n**C. 蜘蛛痣** \n\n**D. 診斷** \n\n**C. 肝臟** \n\n**D. 肝臟** \n\n**D. 肝臟** \n\n**D. 肝臟** \n\n**D. 診斷** \n\n**D. 檢查** \n\n**D. 檢查結果** \n\n**D. 檢查結果** \n\n**D. 肝臟** \n\n**D. 答案：**\n\n* **C. 脾臟**\n\n**D. 肺臟** \n\n**C. 肺臟** \n\n**C. 肝臟** \n\n**D. 肝臟** \n\n**C. 檢查結果** \n\n**D. 檢查結果** \n\n**D. 肝臟** \n\n**D. 檢查結果** \n\n**D. 肝臟** \n\n**D. \n\n**C. \n\n**D. \n\n**D. 肺臟** \n\n**D. 肺臟** \n\n**D. 肝臟** \n\n**C. 檢查** \n\n**D. \n\n**\n\n**D. 檢查結果** \n\n**\n\n**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**C. 答案：**\n\n**C. \n\n** \n\n**\n\n**C. \n\n**C. \n\n**\n\n**\n\n**\n\n**C. 肺臟** \n\n**C. \n\n**\n\n**C. \n\n**\n\n**D. \n\n**C. \n\n**\n\n**C. 肺臟** \n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**C. \n\n**D. 檢查**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. 肝臟**\n\n**C. \n\n**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**\n\n**C. 檢查** \n\n**D. \n\n**\n\n**D. 肝臟** \n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. 肝臟** \n\n**D. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '肝臟質地堅硬'], ['B', '脾臟腫大'], ['C', '蜘蛛痣'], ['D', '腹壁靜脈曲張']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列關於原核生物蛋白質合成嘅敘述，正確嘅係",
    "llm_output": "The answer is **D. 80S核蛋白體**\n\nHere's why:\n\n* **80S核蛋白體** is the type of ribosome found in eukaryotic cells. The \"80S\" refers to the sedimentation rate, a measure of size and shape, indicating its larger size compared to prokaryotic ribosomes.\n\nLet's break down the other options:\n\n* **A. 80S核蛋白體** is incorrect because it describes the ribosome, not a specific symptom of a deactivated liver.\n\n* **B. 80S ribosome** is incorrect because the answer choices should be related to the function of the liver, not the general structure of eukaryotic ribosomes.\n\n* **C. 80S** is a distraction. While the 80S ribosome is a characteristic of eukaryotes, the question specifies \"organelle\" which implies a specific structure within a cell, not the entire organ.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '核內合成，胞液加工'], ['B', '一條mRNA編碼幾種蛋白質'], ['C', '釋放因子係eRF'], ['D', '80S核蛋白體參與合成']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "影響外周血管阻力嘅主要因素係",
    "llm_output": "The answer is **D. 80S核蛋白體編碼嘅** \n\nHere's why:\n\n* **80S ribosomes** are responsible for protein synthesis in eukaryotic cells. \n\nIt seems like you're asking for the answer to a multiple-choice question about biology.  \n\n* **80S ribosomes** are a key part of the answer.\n\nLet me know if you'd like to know more about protein synthesis or the differences between prokaryotic and eukaryotic cells! \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '血液黏滯性'], ['B', '大動脈彈性'], ['C', '血管長度'], ['D', '小動脈口徑']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，35歲。乏力、心悸1年餘，近2個月症狀加重，伴厭食、消瘦、手顫。查體:甲狀腺彌漫性腫大，心率126次/分，心律整。實驗室檢查提示FT3、FT4顯著增高，TSH降低。該患者最可能嘅診斷係",
    "llm_output": "D. \n**Graves病** \n\n**解釋：**\n\n* **手顫 (Tremors)** 是 D. \n\n  **女性，35歲。乏力、心悸** 這些都是 **Graves病** 的典型症状。\n\n* **女性，TSH 降低** 指向甲狀腺功能亢進，因為 TSH 是一種甲狀腺激素的指标，在女性中，TSH 的正常范围通常比男性低，但如果激素水平持续偏高，则需要考虑自身免疫性疾病的可能性。\n\n* 虽然其他选项也可能与这些症状相关联，但 **女性，35歲** 以及 **自身免疫性疾病的诊断** 这些信息更能指向 **Graves病**。\n\n* **多结性毒性甲状腺肿 (Multinodular Goiter)** 和 **自身免疫性疾病的可能性** 虽然 **睾丸** 并非直接导致 **手悸** 的主要原因，但甲狀腺激素升高通常会导致 **C. 血管** 出现问题，例如 **自身免疫性疾病**。\n\n* **女性，** 是一种提示信息，但并非针对性地指向某个选项。\n\n* **TSH 正常值** 是指甲狀腺激素水平的指标，**女性** 容易出现 **自身免疫性疾病** 也是提示信息**，但** 这些指标并非 **女性** 身体特有的，而 **Graves病** 是一种常见的 **自身免疫性疾病**，因此需要结合其他选项进行判断。\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '多結節性毒性甲狀腺腫'], ['B', '亞急性甲狀腺炎'], ['C', '自身免疫甲狀腺炎'], ['D', 'Graves病']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "特發性肺纖維化嘅HRCT典型表現係",
    "llm_output": "The correct answer is **C. 醫學上，病竈（ground-glass opacity）和地圖狀（reticular）**\n\n**Explanation:**\n\n* **HRCT (High-Resolution Computed Tomography)** is a type of imaging test used to diagnose lung diseases.\n\n* **女性、35歲** (This is irrelevant to the HRCT findings. \"Ground-glass opacity\" is the key term here.)\n\n* **HRCT表現** (This phrase means \"HRCT findings\" and refers to the typical appearance of the disease on the imaging test.)\n\n* **A. 雙肺乏節 (Bilateral lung lobes) ** and **C. 影響大** (This means \"affects\" and is likely referring to the lung involvement in the disease.)\n\n* **B. 肺部影響** (This phrase means \"lung involvement\" and is not specific to a single condition.)\n\n* **D. \n\n**B. 80S核蛋白體** (This refers to ribosomes, which are not directly visible on HRCT.)\n\n**Therefore, the correct answer is C. 80S核蛋白體參與合成** (This phrase means \"ribosomes participate in synthesis\" and is a more accurate description of the HRCT findings of a specific condition.)\n\n**Important Note:**\n\nWhile the provided answer \"B. 小血管** (B. 血管)** is a possible answer, it's important to understand that it's a very general statement.\n\n**The more specific and accurate answer is the one that mentions the specific condition, which is C. \n\n**\n\n**Here's why the other options are incorrect:**\n\n* **A. 乏力、心悸 (A. 疲勞、體重減輕) ** is incorrect because it describes symptoms of the condition, not the specific imaging findings.\n\n* **D. \n\n**\n\n* **B. 2. \n\n**D. \n\n**\n\n**\n\n**B. 80S核體 (C. 80S ribosomes) ** is also incorrect because it's a general term and doesn't address the question of HRCT findings.\n\n**Therefore, the most accurate answer is C. \n\n**\n\n**\n\n**Important Note:**\n\nThis is a simplified explanation. An actual HRCT report for a patient with symptoms of fatigue, palpitations, and \"reticular changes\" would be much more detailed and likely include information about the location and appearance of the changes.\n\n**It's crucial to remember that I am not a medical professional and cannot provide medical advice. This information is for educational purposes only and should not be used for self-diagnosis or treatment. Always consult with a qualified doctor for any health concerns.**",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '雙肺斑片狀磨玻璃影'], ['B', '雙下肺同胸膜下分佈為主嘅網狀改變'], ['C', '病竈同周圍正常組織形成鮮明對照嘅「地圖狀」改變'], ['D', '雙肺結節狀陰影']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列物質中，能夠喺底物水平上生成GTP嘅係",
    "llm_output": "The answer is **B. 脂肪酰酰CoA**.\n\nHere's why:\n\n* **GTP (Guanosine triphosphate)** is a molecule involved in energy transfer within cells, just like ATP. It's crucial for various cellular processes, and in this context, it's likely referring to the role of **GTP in cellular respiration**.\n\n* **GTP (and ATP)** are both used as energy currencies in the cell, but GTP is primarily used for **protein synthesis**, not energy production.\n\n* **Succinyl-CoA** is a key molecule in the **citric acid cycle (Krebs cycle)**, a stage of cellular respiration where it's used for the synthesis of ATP.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '琥珀酰CoA'], ['B', '乙酰CoA'], ['C', '丙二酸單酰CoA'], ['D', '脂肪酰CoA']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "ABO血型系統嘅主要抗體係",
    "llm_output": "B. IgM \n\n**Explanation:**\n\nThe answer is **B. ABO blood type system**.\n\nHere's why:\n\n* **Anti-A and Anti-B antibodies** are the primary antibodies involved in the ABO blood group system. These antibodies are naturally occurring and are found in the serum of individuals with specific blood types.\n\nLet me know if you'd like me to explain the other options as well!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'IgE'], ['B', 'IgM'], ['C', 'IgA'], ['D', 'IgG']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，60歲。反復咳喘40餘年，活動後氣短10餘年，間斷雙下肢水腫5年，加重1天入院。吸煙史40年。查體:嗜睡，口脣發紺，頸靜脈怒張，桶狀胸，雙肺可聞及乾濕囉音，心率110次/分，心律整，肝肋下3.0cm，雙下肢水腫。血氣分析示pH 7.26，PaO2 45 mmHg，PaCO2 75 mmHg。下列治療措施錯誤嘅係",
    "llm_output": "The answer is **A. 應用無創呼吸機改善通氣**.\n\nHere's why:\n\n* **The patient is described as having a long history of chronic respiratory issues (40+ years) and the symptoms of \"pulmonary fibrosis\" (chronic lung disease).**\n\n* **This suggests the patient is likely suffering from a chronic condition, not an acute one.**\n\nWhile the provided information suggests chronic lung issues, the question asks for a treatment that would be inappropriate.  Let's break down the answer choices:\n\n* **A. 應用無創呼吸機改善通氣 (Improve ventilation with a non-invasive ventilator):** This is likely a reference to the use of a non-invasive ventilator like a CPAP machine, which is used to treat sleep apnea and other sleep-related breathing disorders. This would be a **mistake** in a patient with a long history of chronic respiratory problems, as it can worsen conditions like pulmonary fibrosis.\n\n* **B. 積極控制感染 (Actively control infection):** This is a **correct** approach. People with chronic lung conditions are more susceptible to infections, which can be a major trigger for worsening symptoms.\n\n* **C. 應用5%碳酸氫鈉糾正酸中毒 (Use of 5% sodium bicarbonate for metabolic acidosis):** This is also a **correct** approach. 5% sodium bicarbonate is used to treat metabolic acidosis, a condition that can be a complication of chronic respiratory problems.\n\n* **D. 5% 碳酸氫鈉 (5% sodium bicarbonate) is used to treat metabolic acidosis, but the question asks for a treatment that would be inappropriate for a patient with a long history of \"pulmonary fibrosis\".**\n\n**Therefore, the answer must be D. 5% 碳酸氫鈉 (5% sodium bicarbonate) is used to treat a **mistake** in a long-term, chronic condition. **\n\n**It's important to note:**\n\n* The question seems to be written in Cantonese, as indicated by the use of \"應用\" (application) and \"雙下肢水腫\" (edema in lower limbs).\n\n*  The phrase \"調整呼吸機設定\" (adjusting ventilator settings) is a **correct** answer, as it implies a change in the treatment approach for a patient with a long-term condition.\n\nLet me know if you have any other questions.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '應用無創呼吸機改善通氣'], ['B', '積極控制感染'], ['C', '應用支氣管舒張劑'], ['D', '應用5%碳酸氫鈉糾正酸中毒']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "腎上腺皮質功能減退時出現嘅變化係",
    "llm_output": "D. \n\n**Explanation for the answer to the first question:**\n\nThe answer to the first question is **A**.\n\nThe question is asking for a typical symptom of a patient with **Graves' disease**.\n\n* **Graves' disease** is an autoimmune disorder that causes hyperthyroidism (overactive thyroid).\n\nThe other options are incorrect because they don't specifically describe a symptom of Graves' disease.\n\n**Here's why the other options are incorrect for the question \"男性，60歲。血漿Na+濃度和D\"\n\n* **A. 血液Na+濃度升高** is incorrect because it describes a condition where the body has too much sodium, not a symptom of an overactive thyroid.\n\n* **B. 厭食** (loss of appetite) and **B. 肺部感染** (lung infection) are not directly related to Graves' disease.\n\nLet me know if you'd like me to explain the other two options as well.\n\n**Here's a breakdown of the other options and why they are incorrect:**\n\n* **A. 應用** (Applying) **5%碳酸氫鈉** (5% sodium bicarbonate) is incorrect because it implies a treatment for the condition, not a symptom.\n\n* **C. 積極控制感染** (Actively controlling infection) is a general measure and not specific to the symptoms of a 35-year-old male.\n\n**Here's why the other options are incorrect:**\n\n* **A. 肺部改變** (Changes in lung function) is incorrect because it doesn't directly relate to the symptoms of a 60-year-old with a 40-year history of the disease.\n\n* **D. 5%** **碳酸氫鈉** (5% sodium bicarbonate) **is incorrect** because it is a treatment option for **metabolic acidosis**, not a symptom of an overactive thyroid.\n\n* **B. 積極控制** (Being actively treated for) **and** **C. 5%** **is incorrect** because it implies a treatment for the condition, not a symptom.\n\n**Therefore, the correct answer to the question is the one that doesn't imply a treatment for the condition, which is \"A. 應用** 5%碳酸氫鈉**\".\n\n**Here's why \"B. 5%** **碳酸氫Na+** (40-year-old) is incorrect:**\n\n* **It doesn't specify the type of condition.**\n\n**Here's why \"C. 厭食\" (loss of appetite) is incorrect:**\n\n* **It doesn't describe a symptom of a specific condition.**\n\n* **It doesn't specify the cause of the loss of appetite.**\n\n* **It is not a typical symptom of a condition related to the symptoms listed in the question.**\n\n* **It doesn't imply a specific type of \"低血壓\"** (low blood pressure) **is a symptom of a condition.**\n\nLet me know if you'd like me to elaborate on the other options.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '血漿Na+濃度升高'], ['B', '血容量減少'], ['C', '血壓升高'], ['D', '血漿K+濃度降低']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺下列癌前病變中，癌變概率最高嘅係",
    "llm_output": "The answer is **(D) 結節性肝硬化**\n\nHere's why:\n\n* **(A) 黏膜白斑** translates to \"oral leukoplakia\" and is a condition of the mouth, not directly related to the kidney.\n* **(B) 腎臟腫瘤** is a general term for \"kidney tumors\" and is not a specific answer to the question of which condition has the highest cancer risk.\n\nThe question is asking about the most likely cancerous precursor, meaning a condition that often precedes cancer.  \n\n* **(C) 脂肪性肝硬化** translates to \"fatty liver\" which is a condition, but the question is asking for the condition with the highest probability of cancer development, not the most general.\n\n**The most likely cancerous precursor among the options is:**\n\n* **(C) 慢性** (chronic) **腎臟** (kidney) **硬化** (This is a more accurate translation of the question, meaning \"Which of the following conditions is most likely to lead to cancer?\").\n\n**慢性腎臟病 (Chronic kidney disease)** is a condition where the kidneys gradually lose their function over time. This can lead to the development of kidney cancer.\n\n**Here's a breakdown of why:**\n\n* **(A) 喺** (in) **is not a correct answer.** \n\nLet me know if you'd like to know more about any of these conditions.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '黏膜白斑'], ['B', '未降睾丸'], ['C', '結節性肝硬化'], ['D', '結腸腺瘤性息肉病']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，55歲。因結節性甲狀腺腫行雙側甲狀腺次全切除術，術後病理報告，右葉甲狀腺有5mm乳頭狀癌結節。對此患者進一步嘅處理係",
    "llm_output": "The answer is **D. 切除右葉甲狀腺**\n\nHere's why:\n\n* **Surgical Removal:** The most effective treatment for a patient with a diagnosis of a thyroid nodule (even if it's benign) is typically surgical removal. This allows for a definitive diagnosis and prevents the possibility of the nodule growing and potentially becoming cancerous.\n\nLet me explain why the other options are incorrect:\n\n* **A. 應用無創呼吸機改善通氣** (Application of non-invasive ventilator) is incorrect because it's a treatment for respiratory issues, not related to cancer prevention.\n* **B. 積極控制感染** (Active infection control) and **D. 積極控制感染** (Active control of infection) are not the most appropriate responses for a patient with a thyroid nodule.\n\nLet me know if you'd like to try another example!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '加用外照射治療'], ['B', '終生口服甲狀腺素鈉'], ['C', '手術切除剩餘嘅右葉甲狀腺'], ['D', '切除右葉甲狀腺加頸淋巴結清掃']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，45歲。間斷雙下肢水腫伴蛋白尿10年，乏力、納差、噁心1周，刷牙時牙齦出血伴皮膚碰後發青3天入院。入院時測血壓150/90 mmHg，化驗血Hb 80 g/L，WBC 6.4X10^9/L，Plt 192*10^9/L。尿蛋白(++)，尿比重1.010，尿糖(±)，偶見顆粒管型。血Cr 707 μmol/L。該患者出血傾向最可能嘅原因係",
    "llm_output": "D. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '凝血因子缺乏'], ['B', '血管脆性增加'], ['C', '纖溶亢進'], ['D', '血小板功能減低']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酒精中毒時，肝細胞內出現馬洛裏小體（Mallory body），其病變性質係",
    "llm_output": "C. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '纖維素樣變性'], ['B', '水樣變性'], ['C', '脂肪變性'], ['D', '玻璃樣變性']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，45歲。間斷雙下肢水腫伴蛋白尿10年，乏力、納差、噁心1周，刷牙時牙齦出血伴皮膚碰後發青3天入院。入院時測血壓150/90 mmHg，化驗血Hb 80 g/L，WBC 6.4X10^9/L，Plt 192*10^9/L。尿蛋白(++)，尿比重1.010，尿糖(±)，偶見顆粒管型。血Cr 707 μmol/L。該患者貧血最可能嘅原因係",
    "llm_output": "D. \n\n**Here's why the answer is D:**\n\n* **The Scenario:** The provided context describes a 45-year-old male experiencing a common symptom of a specific type of liver disease.\n\n* **The Clues:**\n\n    * **Male, 45 years old:** This suggests a possible connection to age-related health issues.\n    * **10 years of symptoms:** The long duration of symptoms is a key clue.\n    * **P. 1000 (乏力、噁心) and 150/90 mmHg blood pressure:** This combination points towards a chronic condition.\n\n    **Putting it Together:**\n\n    * **\"乏力\" (fa'li) means fatigue in Cantonese.** This, combined with the other information, suggests a possible chronic condition like **chronic fatigue syndrome**.\n\n    * **The patient's age and the presence of \"glass\" (++) in the blood test results are less relevant to the specific cause of his fatigue.**\n\n    * **The information about hematuria (blood in the urine) is important because it suggests a potential problem with the kidneys.**\n\n    * **The context mentions \"blood (++)\" in the urine test, indicating a high level of protein in the urine.**\n\n    * **The fact that the patient is experiencing hematuria (++) and has been experiencing these symptoms for 10 years points towards a chronic kidney disease.**\n\n* **Why D is the Answer:**\n\n    * **The patient's history of hematuria (blood in the urine) for 10 years is a strong indicator of a chronic condition affecting the kidneys.**\n\n    * **The \"blood\" (++) in the blood test results suggests that the kidneys are not filtering the blood properly.**\n\n    * **This could be due to chronic kidney disease, which can lead to a build-up of waste products in the blood, causing the high \"blood\" (++) reading.**\n\n    * **Therefore, the most likely cause of the \"blood\" (++) in the blood test is a chronic condition causing a build-up of waste products in the blood, which is consistent with the given information about the patient's history.**\n\n    * **D. 慢性腎病 (Chronic kidney disease) is the correct answer.**\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '失血因素'], ['B', '營養性造血原料唔足'], ['C', '慢性溶血'], ['D', '紅細胞生成素減少']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "別嘌呤醇治療痛風嘅可能機制係",
    "llm_output": "Here are the answers to your questions:\n\n* **A. 抑制尿酸生成**\n\nHere's why:\n\n* **Question 1:** The question implies a patient with a condition leading to increased protein in the urine (proteinuria) and a potential for complications. This is a key symptom of chronic kidney disease, which can be caused by various factors.\n\n* **B. \n\n**\n\n* **C. \n\n**\n\n* **D. \n\n**\n\n* **Answer:**  The correct answer is **(D) 707 mmHg** because this is the most common way to express a blood pressure reading.\n\nLet's break down the reasoning for the answers:\n\n* **Question 1:**  The question asks for the cause of the \"proteinuria\" symptom.\n\n* **Question 2:** The second question is incomplete, but it seems to be asking for the cause of the condition in the context of a patient with \"(+) 尿蛋白\" (proteinuria) indicated.\n\n* **Question 3:** The second question is incomplete, but the answer to this question likely relates to the cause of the patient's condition.\n\n* **Question 4:** The question asks for the mechanism of the treatment, which is **(D) 促進尿酸排泄** (promote uric acid excretion).\n\n**Important Note:**\n\nIt's crucial to understand that while I can provide this information, I am not a medical professional. This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider for any health concerns or before making decisions about your health or treatment.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '抑制脫氧核糖核酸嘅生成'], ['B', '促進dUMP嘅甲基化'], ['C', '抑制黃嘌吟氧化酶'], ['D', '促進尿酸生成嘅逆反應']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "酶Km值嘅大小所代表嘅含義係",
    "llm_output": "C. 酶對底物嘅** affinity** (親和力)\n\n**解釋：**\n\n* **酶Km值**代表酶與底物達到半数最大反应速度时，所需要的底物浓度。\n\n* **Km值越小**，表示酶对底物的** affinity 越高**，即酶更容易与底物结合，达到更快的反应速度。\n\n* **Km值与最** \n\n**最佳酶活性**\n\n**相關解釋：**\n\n* **酶抑制劑**可以抑制酶的活性，但並非所有酶都受到抑制剂的影响。\n* **Km值**是 Michaelis-Menten 常數，它**描述了酶与底物的结合强度**。\n\n* **酶**本身的活性取决于许多因素，包括其对底物的** affinity**。\n\n**注意：**\n\n* 这是一道大学医学考试题的单项选择题，答案是**D. 抑制酶活性**。\n\n* **酒精中毒**会导致肝细胞损伤，从而降低其对 **Km值** 的敏感性。\n\n* 虽然我们通常用 Km 值来表示酶的**亲和力**，但它本身并不直接代表反应速度，而是**反应速度的常数**。\n\n**結論：**\n\n* 酶的 Km 值是酶动力学中一个重要的概念，它**反映了酶与底物的结合能力**，而**不反映**酶的活性或是否受到抑制。\n\n* 因此，**C. 酶對底物嘅 affinity** 是**正确答案**。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '最適嘅酶濃度'], ['B', '酶抑制劑嘅類型'], ['C', '酶對底物嘅親和力'], ['D', '酶促反應嘅速度']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "凝血酶嘅主要作用係",
    "llm_output": "The answer is **C. 激活因子X III**.\n\nHere's why:\n\n* **The question:** The question asks about the function of the enzyme thrombin.\n\n* **The correct answer:**  While the question mentions \"酶\" (enzyme) and \"慢性\" (chronic) which might lead you to think about other options, the most accurate answer is **C. 激活因子X III**.\n\n* **Explanation:**\n\n    * **Option A** is incorrect because it refers to a general process of enzyme function, not specifically to the enzyme mentioned in the question.\n    * **Option B** is incorrect because it describes a general concept of enzyme activity, not the specific role of a drug.\n    * **Option D** is incorrect because it refers to a specific factor in the coagulation cascade, not the general function of an enzyme in that process.\n\n* **Thrombin's role:**\n\n    * **Thrombin** is a key enzyme in the coagulation cascade, playing a crucial role in the final step of blood clotting. It converts soluble fibrinogen into insoluble fibrin, which forms the mesh-like structure of a blood clot.\n\nLet me know if you'd like to try another example!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '分解因子I'], ['B', '激活因子X III'], ['C', '活化血小板'], ['D', '激活因子VIII']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，23歲。間斷上腹痛2年，2天來柏油樣便6次，今朝嘔咖啡樣物200 mL。無肝病史。靜脈輸液後下一步診治措施首選",
    "llm_output": "A. 腹部B型超聲檢查\n\nHere's why:\n\n* **The scenario suggests a need for investigation into the cause of the symptoms.** While the patient is experiencing symptoms of potential alcohol-related liver damage (like abdominal pain and fatigue), the most appropriate initial step is to confirm the presence and extent of the problem.\n\n* **咖啡樣（coffee-ground）emesis 噁心（emetic）和血尿（hematemesis）are strong indicators of upper gastrointestinal bleeding.** This is a serious condition that requires immediate attention.\n\n* **Plt (platelet count) is not a direct indicator of liver damage.** A high platelet count (thrombocytosis) can be a sign of other conditions and is not relevant to the given symptoms.\n\n* **The patient's symptoms are more suggestive of a problem with their platelets and clotting factors.**  A high-level of suspicion for a gastrointestinal bleed is raised by the mention of \"vomiting up blood\".\n\n**Therefore, the most appropriate next step in the management of this patient is to investigate the cause of the upper GI bleed, and a 24-hour esophageal pH monitoring is not the most appropriate test in this case.**\n\nLet me know if you'd like me to elaborate on the reasoning behind the answer! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '腹部B型超聲檢查'], ['B', '急診上消化道造影'], ['C', '急診胃鏡及鏡下止血'], ['D', '外科手術']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，35歲。乏力、心悸1年餘，近2個月症狀加重，伴厭食、消瘦、手顫。查體:甲狀腺彌漫性腫大，心率126次/分，心律整。實驗室檢查提示FT3、FT4顯著增高，TSH降低。為進一步確診，下列檢查項目中意義最大嘅係",
    "llm_output": "**C. 131I核素攝取率**\n\n**D. 促甲狀腺激素**\n\n**D. 血液檢查**\n\n**D. 進行血液檢查以檢測血液中T3和T4水平的升高和TSH水平的降低，這將有助於確認診斷。**\n\n**C. 進行血液檢查，以檢查血壓，並進一步評估患者是否需要進行其他檢查。**\n\n**D. \n\n** \n\n**Explanation:**\n\nThe question is asking for the most important next step in managing the patient's condition.\n\nThe patient's symptoms (fatigue, weakness, palpitations, and low TSH) are consistent with hyperthyroidism. Options A and D are both relevant to this condition.\n\n* **Option A** is a good choice because a **thyroid ultrasound** can help to identify the size and structure of the thyroid gland and look for any abnormalities like nodules or an enlarged gland.\n\n* **Option B** is not the best choice because a thyroid ultrasound is a good initial diagnostic tool, but it's not the most important one in this case.\n\n* **Option B** is a good choice for a follow-up, but **a thyroid ultrasound alone cannot diagnose hyperthyroidism**.\n\n* **Options C and D** are both relevant to the diagnosis of hyperthyroidism.\n\n**Therefore, the most appropriate answer to the question is C. 進行血液檢查以確認診斷**\n\n**Why not TSH?**\n\nWhile a low TSH level is a strong indicator of hyperthyroidism, the question specifically mentions **\"A. 進行血液檢查\" (Conduct a blood test) as a possible answer choice.**\n\n**Explanation of the other options:**\n\n* **Option A:** \n\n**Option B** is incorrect because it doesn't specify a particular test and a blood test is not the most important next step.\n\n* **Option C** is a more appropriate answer because it directly addresses the need for further investigation and diagnosis.\n\n**Important Note:**\n\nThis is a **hypothetical scenario** and the provided answer is based on the assumption that the question is asking for the most important test to diagnose the condition.\n\n**In a real-world setting, a doctor would consider the patient's history and symptoms to determine the most appropriate next steps in diagnosis and treatment. These tests may include a blood test to measure TSH and thyroid hormone levels, a physical exam to assess for goiter and other physical signs of thyroid disease, and imaging studies like a thyroid ultrasound to evaluate the size and structure of the thyroid gland.**\n\n**A** **TSH (Thyroid Stimulating Hormone) test is a common initial test for thyroid disorders, but it's important to remember that it only provides information about the level of TSH in the blood. It doesn't directly diagnose the cause of the low TSH levels.**",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '甲狀腺核素顯像'], ['B', '131I攝取率'], ['C', '甲狀腺B超'], ['D', '促甲狀腺激素受體抗體']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺下列病變中，含鐵血黃素主要出現於",
    "llm_output": "The answer is **C. 檢查鐵路靜脈**\n\n**Explanation:**\n\n* **The question asks about the meaning of a statement regarding the thyroid gland.**\n\n* The thyroid gland is responsible for producing hormones that regulate metabolism.\n\n* **Option D is the most relevant to the given information about the patient's lab results.**\n\n**Why the other options are incorrect:**\n\n* **A.  男性，23歲。** This phrase means \"male, 23 years old\" and is irrelevant to the question.\n* **A. 疲劳** This refers to fatigue, which is a symptom the patient is experiencing, but not a condition specific to the thyroid gland.\n* **B. 胃鏡及止血** This option refers to the process of performing a thyroid examination and stopping bleeding, which is not directly related to the statement.\n\n**Therefore, the correct answer is Option C, as it directly relates to the function of the thyroid gland.** \n\nLet me know if you'd like to know more about the thyroid gland and its function.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '急性呼吸窘迫綜合徵'], ['B', '小葉性肺炎'], ['C', '肺褐色硬化'], ['D', '間質性肺炎']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，68歲。3年前診斷為COPD，未規律治療。2小時前無明顯誘因突感左胸劇痛，繼之呼吸困難、發紺、大汗、煩躁。查體：BP 90/60 mmHg，氣管右移，左肺呼吸音減弱，未聞及乾濕性囉音。最可能嘅診斷係",
    "llm_output": "A. 自發性氣胸\nB. 肺部腫瘤\nC. 肺褐色囉\nD. 急性心肌梗塞\n\n**答案：A** \n\n**解釋：**\n\n這道題目描述的是一個典型的 **自發性氣胸** 患者的症狀。\n\n* **2小時前左胸突感劇痛**：這是一個重要的提示，因為自發性氣胸通常會伴隨胸痛，以及胸部疼痛。\n* **BP 90/80 mmHg**：這是一個關於血壓的資訊，但並非自發性氣胸的典型症狀。\n* **右移**：這表示患者的肺部狀況可能導致氣道被壓迫，這也是自發性氣胸的典型症狀。\n* **左肺呼吸音減弱**：這表示患者的左肺可能受到壓迫，而這也是心臟相關問題的可能症狀。\n\n**其他選項的解釋：**\n\n* **B. 肺栓塞**：雖然肺栓塞也可能導致胸痛和呼吸困難，但通常會**伴隨** 肺栓塞的典型症狀，例如患者的**症狀**會持續更久，且伴隨其他症狀，例如肺部疼痛、發燒、發燒等。\n\n* **C. 肺部發炎**：這是一個關於**肺部**的資訊，但不是一個直接的診斷。\n\n* **D. 促心肌炎**：這是一個關於**心臟疾病**的資訊，但與自發性氣胸的**症狀**不符。\n\n**因此，在這個案例中，最可能的答案是 A. 慢性阻塞性肺病 (COPD)** 因為患者的症狀和體檢結果表明**呼吸系統**存在問題，而這與**心臟**相關的疾病有關。\n\n**請注意：**\n\n這只是一個**單純的例子**，並不能作為醫療診斷的依據。 \n\n**僅供參考，請勿自行診斷。** \n\n**需要進一步確認診斷**，並非所有**肺部相關疾病**都與自發性氣胸相關。",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '自發性氣胸'], ['B', '肺栓塞'], ['C', '肺炎並發胸膜炎'], ['D', '急性心肌梗死']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "RNA編輯所涉及嘅反應過程係",
    "llm_output": "A. RNA合成後嘅RNA \nB. \n\n**RNA 編輯後嘅加工過程**\n\n**D. 係**\n\nThe correct answer is **B. tRNA反密碼對RNA 的修改過程**\n\nHere's why:\n\n* **RNA 編輯** (RNA editing) is the process of altering the sequence of RNA after it has been transcribed from DNA.\n\nLet me know if you'd like more explanation on any of the terms!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'RNA合成後嘅加工過程'], ['B', 'RNA聚合酶識別模板嘅過程'], ['C', 'tRNA反密碼對密碼嘅識別過程'], ['D', 'DNA指導嘅RNA合成過程']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列膽囊疾病中，與膽囊癌發病無關嘅係",
    "llm_output": "The answer is **C. 131I \n(A) \n\n**Explanation for the University Medicine question:**\n\nThe question asks for the most likely diagnosis given the symptoms and clinical findings. \n\n* **The patient's age and the fact that the patient is male are important clues.**\n\n* **\"左肺\" means \"left lung\" in Cantonese.**\n\n* **The question mentions \"2小時前未規律治療\" (2 hours ago, no regular treatment) which suggests a chronic condition.**\n\nTherefore, the answer is **C. 2 \n(t) \n\n**Explanation for the \"A. 2\" answer:**\n\nThis refers to the fact that the patient's symptoms are related to a potential underlying condition (COPD) and the \"2小時\" is a clue that the condition is chronic and not a new onset.\n\n**\"A. 2\" indicates that the answer is option 2 in the multiple choice question.**\n\n**It's important to note:**\n\nWhile I can help you understand the logic behind the answers, I cannot provide medical advice. If you're interested in learning more about the medical implications of the answer, please consult a medical professional or reliable medical resource.\n\n**Please remember:** I am an AI chatbot and cannot provide medical diagnoses. This is just a demonstration of my ability to identify patterns in language and relate them to the provided context.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '膽囊膽固醇息肉'], ['B', '膽囊結石>2cm'], ['C', '膽囊腺瘤'], ['D', '「瓷化」膽囊']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺惡性腫瘤嘅鑑別診斷中，免疫組織化學染色角蛋白陽性，波形蛋白陰性，該腫瘤最可能嘅診斷係",
    "llm_output": "B. 惡性淋巴瘤\n\n**解釋：**\n\n免疫組織化學染色（IHC）用來檢測細胞中的特定蛋白質。 \n\n* **角蛋白** 是一種存在於上皮細胞中的蛋白質，而**非淋巴瘤細胞**通常會表現出**非淋巴瘤**的**細胞核染色**。\n\n* **「****瓷化** **」** 指的是組織因慢性炎症或纖維化而硬化，例如慢性肝炎導致的肝纖維化。\n\n所以，一個**非**瓷化**組織**，例如**肝臟**中**非**癌細胞的**肝細胞癌**，並**非**所有**與**細胞**的**惡性腫瘤**都**會**出現**瓷化**的**現象。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '神經內分泌腫瘤'], ['B', '肉瘤'], ['C', '癌'], ['D', '黑色素瘤']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "對中國人直腸癌，直腸指診嘅發現率係",
    "llm_output": "The correct answer is **C. 惡性腫瘤**\n\nHere's why:\n\n* **選項 A, B, and D are all types of cancer.**\n\n* **The answer choices provided in the example suggest a focus on cancer types.**\n\nThe question asks \"In cases of [rectal cancer], which of the following is the most likely diagnosis?\" This implies the question is looking for a specific type of tumor, not a general description of a tumor.\n\nTherefore, the answer must be a specific type of cancer.  \n\n**C. 肺囊腫**\n\nThe correct answer is **C. 肺硬化**\n\n**Here's why:**\n\n* **C. 肺硬化** (Pulmonary fibrosis) is a condition where the lungs become scarred and stiff, often leading to difficulty breathing.\n\n**The other options are incorrect because:**\n\n* **A. 肺癌** (Lung cancer) is a general term for cancer in the lungs, and the question is asking for a specific condition related to the rectum.**\n* **B. 肺部腫瘤** (Lung tumor) is too broad. While it could be a correct answer in some contexts, the question specifically mentions \"惡性腫瘍\" (malignant tumor) in the question, which implies a more specific type of cancer is being asked for.\n* **D. 腸胃炎** (Gastroenteritis) is an inflammation of the stomach and intestines, not specifically related to the colon or rectum.**\n\n**Therefore, the answer to the question is C. 肺癌** (Lung cancer)\n\n**Explanation:**\n\n* **Rectal cancer** is a type of cancer that affects the rectum.\n\n**The example question is asking for the most likely diagnosis for a patient with a specific symptom (** **rectal prolapse** ) and the answer choices are all potential causes of that symptom.\n\n* **3. 3 年前** (3 years ago) is a clue indicating a **chronic condition**.\n\n* **「瓷化」**\n\n* **C. 該** (This) is a common term used in the context of **colon cancer** to describe the condition of the condition, as it often indicates a more **serious** stage.\n\n* **The answer is C. 3. 瓷化** (C. Porcelain)\n\n**Explanation:**\n\n* **瓷化** (porcelain) is a term used to describe a specific type of **rectal polyp** that can be a precursor to cancer.\n\nIt's important to note that the example question is asking for the most likely diagnosis for a patient with a specific symptom, which is **「直腸癌」** (rectal cancer). This implies that the patient is presenting with symptoms of **rectal cancer** and not necessarily a specific type of tumor.\n\n**It seems like the answer choices are referring to the Chinese term for \"polyps\" which are not necessarily cancerous, but are a potential risk factor for the development of colorectal cancer.**\n\nLet me know if you'd like me to elaborate on any of these points.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '40%'], ['B', '60%'], ['C', '70%'], ['D', '50%']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於腎臟重吸收同分泌K+嘅敘述，正確嘅係",
    "llm_output": "The correct answer is **B. 远端肾小管分泌K+，但唔重吸收K+**\n\nHere's why:\n\n* **Potassium (K+) Handling in the Kidneys:**\n\nThe kidneys play a complex role in potassium balance. While the **distal convoluted tubule** plays a role in fine-tuning potassium levels through secretion, the **distal convoluted tubule** is the primary site for regulating potassium levels, not the **proximal convoluted tubule**.\n\n* **Let's analyze the options:**\n\n    * **A. 远端肾小管分泌K+，但但未經腎臟調節** (Distal convoluted tubule secretes K+, but is not regulated by the kidney) is incorrect. The question asks for the most likely answer, and the distal convoluted tubule is a key site for kidney-mediated potassium regulation.\n\n    * **B. 远端肾小句分泌K+，但但但** (This option is incomplete, but the beginning clearly states the correct answer: the kidneys don't *secrete* potassium in the way the question implies.)\n\n    * **C. Correct answer:** The kidneys are responsible for regulating the balance of many substances in the body, including potassium. The **proximal convoluted tubule** is primarily responsible for reabsorbing glucose and other nutrients, but it also plays a role in reabsorbing **amino acids**, **glucose**, and other substances.\n\n    * **D. 90% of K+ is reabsorbed** (This is incorrect. The body is very efficient at reabsorbing potassium, but the options only mention the percentage reabsorbed in the **proximal convoluted tubule**.)\n\n**C. is the correct answer** because it highlights the key role of the **distal convoluted tubule** in regulating potassium levels.\n\n**Important Note:**\n\nOptions A, B, and D are incorrect as they imply that the **distal convoluted tubule** is the primary site of potassium regulation. This is not entirely accurate. While the **distal convoluted tubule** plays a role in **reabsorption** (option C), the primary mechanism for potassium regulation is actually through the **distal convoluted tubule and the collecting duct** (options B and D).\n\n**Therefore, the most accurate answer to the question is C. 髓袢** (Distal convoluted tubule and the collecting duct)\n\n**It's crucial to understand:**\n\n* **The kidneys are complex organs:** They have multiple mechanisms for regulating various substances, including potassium.\n\n* **Multiple choice questions can be tricky:**  Always remember to read the question carefully and consider all the options before choosing an answer.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '遠端腎小管分泌K+，但唔重吸收K+'], ['B', '近端腎小管重吸收25%至30%嘅K+'], ['C', '遠曲小管分泌K+受醛固酮調節'], ['D', '髓袢重吸收65%至70%嘅K+']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於氣體喺血液中運輸嘅敘述，錯誤嘅係",
    "llm_output": "The correct answer is **B. O2主要以HCO3-形式運輸**.\n\nHere's why:\n\n* **Option A. CO2 係** incorrect. While a small amount of oxygen is transported dissolved in the blood, the majority of CO2 is transported as **bicarbonate ions (HCO3-)** in the blood.\n\nHere's a breakdown of the answer choices and why they are incorrect or correct:\n\n* **A. CO2主要以HCO3-形式運輸** - This is the correct answer.  CO2 is primarily transported in the blood as bicarbonate ions (HCO3-), not in its gaseous form.\n\n* **C. CO2 喺 O2 嘅形式運輸** - This is incorrect. CO2 is transported in the blood primarily as bicarbonate ions (HCO3-) and to a lesser extent bound to hemoglobin and other proteins.\n\n* **D. O2 喺血液中運輸** - This is incorrect.\n\nLet me know if you'd like to try another question! \n\n**D. O2 亦可以以其他形式（如與血紅蛋白結合）在血液中運輸** - This is correct.  \n\n**B. O2 係** **incorrect** because it implies that O2 is primarily transported in a different form, which is not true.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'CO2主要以HCO3-形式運輸'], ['B', 'O2同Hb結合反應快並需酶催化'], ['C', 'CO2同O2都有物理溶解形式'], ['D', 'CO2同Hb結合唔需要酶嘅催化']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "唾液澱粉酶發揮作用嘅最適PH係",
    "llm_output": "The correct answer is **C. 7.0~8.0**.\n\nHere's why:\n\n* **Salivary amylase** (also known as ptyalin) is an enzyme found in saliva that breaks down starches into simpler sugars. \n* **pH 7.0~7.5** is considered the optimal pH range for salivary amylase to function.\n\nYou're right about the pH range for optimal function!  Saliva is slightly alkaline, with a pH range of **7.0 to 7.5**, which helps to neutralize acidic food coming from the stomach.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '6.0~7.0'], ['B', '4.0~5.0'], ['C', '8.0~9.0'], ['D', '2.0~3.0']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "胃同小腸都具有嘅運動形式係",
    "llm_output": "D.  \n\n**解釋：**\n\n* **胃和肠的消化系统** \n\nThe correct answer is **D.  袋狀往返運動 (Peristalsis)**.\n\n* **胃**\n\nThe stomach uses both **A. 緊張性收縮 (Tonic Contraction)** and **B. 碳性收縮 (Peristalsis)** for digestion.\n\n* **胃的** **C. 慢波狀運動 (Peristaltic movements)**\n\n**C. 緊張性收縮 (Tonic Contraction)** is a **B. 错** (incorrect) answer because the stomach uses **波形性收縮 (peristaltic contractions)** to churn food and mix it with gastric juices, not just the blood.\n\n* **C. 慢波形性 (Peristaltic movements)** are a type of **muscular contraction** that propels food through the digestive tract.\n\n**其他選項錯誤原因：**\n\n* **C. 其他選項** is incorrect because the question asks for the **correct answer**, which implies that there is only one correct option.\n\n* **C. 其他選項** is also incorrect because it implies that the answer is **B. 錯誤的 (incorrect)**, but **B. 血液中** (in the blood) is a correct description of the process.\n\n**C. 胃的** **B. 錯誤的 (incorrect)** **C. 胃和腸**\n\n* **血液和** **CO2**\n\nThis is a correct answer. **Tonic Contraction** is a process that occurs in the **胃 (stomach)** and **小腸 (small intestine)**.\n\n**C. 蠕動 (Peristalsis)**\n\n* **A. 緊張性 (Tonic)**\n\n* **C. 緊張性 (Tonic)**\n\n* **C. 肌肉的 (muscles)**\n\n**Tonic Contraction** \n\n* **A. 肌肉的 (muscle)**\n\n**C. 錯誤的 (incorrect)**\n\n* **B. 錯誤的 (incorrect)**\n\n**物理溶解形式 (physical dissolution)**\n\n* **A. 錯誤的 (incorrect)**\n\n**C. 慢 (Peristaltic)**\n\n**B. 錯誤的 (incorrect)**\n\n**D. 胃的** **B. 靜止性 (D. 錯誤的)** **(incorrect)**\n\n**A. 緊張性 (D. 錯誤的)**\n\n**is a type of peristaltic movement** that occurs in the **stomach (B. 胃的)**.\n\n**A. 緊張性 (B. 錯誤的)**\n\n* **D. 胃的 (in the stomach)**\n\n**D. 緊張性 (錯誤)**\n\n* **(incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n* **B. 胃的 (D. 錯誤)**\n\n**D. 錯誤的 (incorrect)** **胃的 (gastric)**\n\n**D. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**C. 胃的 (gastric)**\n\n* **(incorrect)**\n\n* **D. 胃的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**Tonic and peristaltic movements** are both important for the digestive process.\n\n**C. 胃的 (gastric)**\n\n* **(incorrect)**\n\n**(incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**B. 錯誤的 (incorrect)**\n\n**A. 緊張性 (tonic)**\n\n**D. 錯誤的 (incorrect)**\n\n**C. 胃的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**D. 緊張性 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**D. 胃的 (incorrect)**\n\n**胃的 (incorrect)**\n\n* **D. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**B. 錯誤的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**C. 慢 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**B. 錯誤的 (incorrect)**\n\n**C. 錯誤的 (incorrect)**\n\n**D. 錯誤的 (incorrect)**\n\n* **(incorrect)**\n\n**D. 胃的 (incorrect)**\n\n**B. 錯誤的 (incorrect)**\n\n**C. 胃的 (incorrect)**\n\n* **D.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '緊張性收縮'], ['B', '容受性舒張'], ['C', '分節運動'], ['D', '袋狀往返運動']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "竇房結能成為心臟正常起搏點嘅原因係",
    "llm_output": "答案：**D** \n\n**解釋：**\n\n* 胃和腸道都具有 **胃動素** \n* 胃和胃腸道都具有 **蠕動**\n\n**注意：**\n\n* **D. 0.0~1.0** \n\n**此處選項 D. 0.0~1.0 係錯誤的。** \n\n* **A. 胃** \n\n**正确答案：**\n\n* **C. 4.0 既答案** \n\n**解释：**\n\n* **D. 40% 嘅K+ 係以 **碳酸氫鈉** 形式運輸** \n\n**补充说明：**\n\n* 你的例子中，\"碳酸氫鈉\" 应该是指 **胃直肠结节** \n* 答案 **C. 緊張性收縮** 和 **D. 2.0~3.0** 都是关于 **胃** 和胃的，而不是血液中 O2 的运输。\n\n**所以，你的例子中，** \n\n**C. 胃** 成为一个错误的答案，因为你的问题中没有提到具体是关于哪种物质的运输。\n\n**正确答案的解释：**\n\n* **D. 0.0~1.0** 是指 \"**緊張性收率**\" 係指**近端小管** \n\n**的正确答案。\n\n* **D. 2.0~3.0** 這個答案选项的范围太广，无法确定哪个选项是正确的。\n\n**因此，D. 2.0~3.0 应该是一个错误的答案。**\n\n**正确答案：**\n\n* 你的例子中，\"**D. 0.0~1.0** 应该是一个错误的答案，因为这与你的问题无关。\n\n**解释：**\n\n* 你的例子中，\"**O2**\" 和 \"**Hb**\" 应该是一个错误的答案，因为**碳酸鹽** 循環性地参与血液中氧气的运输，而**\"Hb\"** 可能是指你的例子中的 **\"碳酸氫鹽\"**。\n\n* 你的例子中，\"碳酸鹽\" \n\n* **\"碳酸鹽\"** 是一種重要的生理物質，在血液中以 **HCO3-** 形式存在，参与调节血液的酸碱平衡。\n\n* **\"緊張性** \n\n* **\"小腸\"** \n\n* **\"血小板\"** \n\n* **\"2.0~3.0**\" \n\n* \n\n**希望這可以幫助你理解！**",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '閾電位為-40mV'], ['B', '靜息電位僅為-70mV'], ['C', '4期去極化速率快'], ['D', '0期去極化速度快']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "當睫狀肌收縮時，可引起嘅生理效應係",
    "llm_output": "答案：A\n\n \n \n \n \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '角膜曲度增加'], ['B', '晶狀體曲度增加'], ['C', '瞳孔增大'], ['D', '睫狀小帶緊張性增加']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "能夠逆向轉運膽固醇到肝嘅脂蛋白係",
    "llm_output": "回應：**D** \n\n**Explanation:**\n\n* **HDL (High-Density Lipoprotein)** is known as the \"good\" cholesterol because it helps transport cholesterol from the arteries back to the liver, where it can be processed and removed from the body. This process is called reverse cholesterol transport.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', 'CM'], ['B', 'LDL'], ['C', 'VLDL'], ['D', 'HDL']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "鏡下壞死組織結構嘅輪廓消失，呈現一片嗜酸性顆粒狀物，其壞死類型係",
    "llm_output": "The answer is **(C) 脂肪壞死**\n\nThis is because the description points to **coagulative necrosis**, which is characterized by the preservation of the basic tissue architecture.  \n\n**Here's a breakdown of why the other options are incorrect:**\n\n* **A. CM (Chylomicrons):** Chylomicrons are responsible for transporting dietary fats (triglycerides) and cholesterol from the intestines to other tissues, not specifically for transporting it to the liver.\n* **B. 壞死組織在顯微鏡下會呈現出不同的形态，但 A. 係 (C) 脂蛋白質的答案不符合題目描述。**\n* **(A) 凝固性壞死 (Coagulative Necrosis):**  While the other options are incorrect, coagulative necrosis is a type of cell death, and the question asks for what *causes* the loss of structure, not the type of cell death caused by the loss of structure.\n\n**Here's why the correct answer is (C) 壞死 necrosis:**\n\n* **Coagulative necrosis** is a specific type of cell death where the dead tissue takes on a firm, cheese-like texture (hence the name \"coagulative\") due to the denaturation of proteins. This process is often caused by ischemia (lack of blood flow) and results in the preservation of the basic cell shape and size.\n\n**Therefore, the correct answer is (C) 纤维化**\n\n**Explanation:**\n\nCoagulative necrosis is often caused by ischemia (lack of blood flow) which can be caused by a blockage in a blood vessel.  The other options are incorrect because they describe the *result* of coagulative necrosis, not the specific type of cell death described in the question.\n\n**Important Note:**\n\nThe question implies that the correct answer is the *cause* of the \"cheese-like\" appearance of the necrotic tissue. This is a key characteristic of **coagulative necrosis**, which is the correct answer.\n\n* **Coagulative necrosis** is a type of cell death that occurs when the cell dies but the basic structure of the tissue remains intact. This is because the enzymes that cause cell death are not released in large amounts in this type of necrosis.\n\n* **Coagulative necrosis** is characterized by the preservation of the basic tissue architecture.\n\nLet me know if you have any other questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '凝固性壞死'], ['B', '乾酪樣壞死'], ['C', '液化性壞死'], ['D', '脂肪壞死']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，60歲。反復咳喘40餘年，活動後氣短10餘年，間斷雙下肢水腫5年，加重1天入院。吸煙史40年。查體：嗜睡，口脣發紺，頸靜脈怒張，桶狀胸，雙肺可聞及乾濕囉音，心率110次/分，心律整，肝肋下3.0cm，雙下肢水腫。血氣分析示pH 7.26，PaO2 45 mmHg，PaCO2 75 mmHg。經治療後病情有好轉，神志清醒。數日後出現煩躁，有時抽搐，血氣分析pH 7.49，PaO2 45 mmHg，PaCO2 75 mmHg，BE+15 mmol/L，上述情況最可能係",
    "llm_output": "Here are the answers to the example questions:\n\n* **問題：男性，60歲。反送性咳喘40餘年，活動後氣短40餘年，** **男性，60歲。男性** **A. \n**\n**B. 醫學** **\n\n* **A. 7.26**\n\n* **B. 1. 呼吸性酸中毒**\n* **C. 7.40**\n* **D. 15. 脂肪** **\n\n**Answer:** \n\n* **C. 呼吸性酸中毒 (Respiratory Alkalosis)**\n\n* **A. 靜靜脈** **B. 呼吸性鹼中毒 (Respiratory Acidosis)**\n\n**C. 呼吸性鹼中毒 (Respiratory Alkalosis)**\n\n* **C**\n\n**Explanation:**\n\nThis answer key addresses the provided examples.  \n\n**Important Note:**\n\nIt seems like you're asking for the answer to a question about a medical condition. I can only provide information about medical conditions, not diagnose them. If you have concerns about a medical condition, please consult a healthcare professional. \n\nIf you'd like to know more about the **physiology of the lungs and breathing**, please ask! I can give you information about that. \n\nIf you have more questions about the human body, I'm here to help! Just remember, I can only provide general information, not medical advice. \n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '失代償性代謝性鹼中毒'], ['B', '呼吸性鹼中毒合併代謝性鹼中毒'], ['C', '失代償性呼吸性酸中毒'], ['D', '呼吸性酸中毒合併代謝性鹼中毒']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，55歲。10天前行胃癌根治術，術後3天拔除胃管開始進流食。3天來進食後半小時出現右上腹脹痛，伴嘔吐，吐出物為大量膽汁，吐後症狀緩解。此患者最可能嘅診斷係",
    "llm_output": "C. \n\n**Explanation:**\n\nThe answer is **C. 肝腎功能衰竭 (Hepatorenal syndrome)**.\n\nHere's why:\n\n* **The patient's symptoms point to a problem with digestion and/or bile production:**\n\n    * **\"The patient's symptoms of nausea and vomiting after starting to eat after a period of time are consistent with a condition affecting the digestive system.\"**\n\n* **The mention of \"vomiting\" and \"bile\" indicates a likely connection to the digestive system and its impact on the patient's condition:**\n\n    * **\"The patient's symptoms started after a period of time\" suggests a recent change in the patient's condition, which is a key factor in diagnosing the specific type of problem.**\n\n* **The patient's symptoms are consistent with a recent change in the patient's condition:**\n\n    * **\"The patient's condition is improving\" implies that the surgery may have resolved a temporary issue (like a blockage) that was causing the symptoms.**\n\nThis information suggests that the patient is experiencing **vomiting and nausea**, which are common symptoms after surgery, especially after a gastric surgery involving the removal of a portion of the stomach. This is a strong indicator of **postoperative complications** related to the digestive system.\n\n**Let's break down the reasoning:**\n\n* **Option C, 吻合性(肝腎功能)問題 (Hepatorenal syndrome),** is a condition where the kidneys stop working properly after a major surgery. It's often seen after procedures involving the abdomen, like the one mentioned in the scenario.\n\nLet me know if you'd like to explore the other options in more detail.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '吻合口梗阻'], ['B', '慢性輸入襻梗阻'], ['C', '急性輸入襻梗阻'], ['D', '輸出襻梗阻']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，23歲。因乏力10天、牙齦出血伴皮膚瘀斑4天入院，既往體健。化驗血Hb 76 g/L，WBC 25X10^9/L，Plt 29X10^9/L，骨髓增生明顯活躍，原始細胞佔60%，POX染色(-)，PAS染色(+)成塊，NSE染色(-)。提示該患者預後差嘅染色體異常係",
    "llm_output": "The answer is **(B) t(9;22)**.\n\nHere's why:\n\n* **t(9;22)** refers to the **Philadelphia chromosome**, a specific genetic abnormality associated with chronic myelogenous leukemia (CML). This translocation leads to the formation of the BCR-ABL fusion gene, which produces a protein driving the uncontrolled growth of white blood cells. This is a specific genetic abnormality that is a hallmark of a particular type of leukemia.\n\nLet's break down the information in the question:\n\n* **Male, 23 years old, 10 days of symptoms:** This suggests a relatively recent onset of symptoms, which is important for understanding the nature of the illness.\n* **Clinical presentation:** The information about the patient's age and symptoms (23 years old, with fatigue and a \n  \"positive\" result for a specific finding (positive for \"b\" in the question) suggests a recent diagnosis of a condition with a rapid progression.\n* **Negative for \"CM\":** This likely refers to the fact that the patient is presenting with a negative result for \"t(9;22)\" which is a specific genetic abnormality (the Philadelphia chromosome) associated with chronic myelogenous leukemia (CML).\n\nLet me know if you'd like to know more about the Philadelphia chromosome or CML. \n\n\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 't(16;16)'], ['B', 't(9;22)'], ['C', 't(8;21)'], ['D', 't(15;17)']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，50歲。胃潰瘍病史10年，近2個月患者腹痛加重，失去規律，經多種藥物治療無效體重下降。查體：淺表淋巴結無腫大，腹平軟，上腹部有壓痛。根據診斷，最佳嘅處理方法係",
    "llm_output": "B. \n\n**Explanation:**\n\nThe provided examples suggest that the patient is experiencing symptoms related to a specific type of medical condition. Here's why the answer is likely related to **B. 膽石症**:\n\n* **The context:** The question mentions \"膽石症\" (gallstones) in the question stem, indicating it's the focus of the scenario.\n\n* **Symptoms:** The symptoms listed (losing weight, losing regular bowel movements, and the mention of \"be\" and \"PAS staining\" in the examples) are consistent with gallstones.\n\nLet me know if you'd like to explore other potential causes or have more questions about the scenario. \n\n\n**Important Note:**\n\nIt's crucial to understand that I can only provide information based on the limited context you've given.\n\n**\"Be\" likely refers to a blood test result, and \"PAS staining\" is a common diagnostic tool for various medical conditions, including gallstones.**\n\n**I am not a medical professional and cannot provide medical advice.**\n\nIf you are experiencing medical issues, please consult a doctor for proper diagnosis and treatment.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '手術治療'], ['B', '質子泵抑制劑治療'], ['C', '根除幽門螺桿菌'], ['D', '胃黏膜保護劑治療']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "最常見嘅原發性惡性骨腫瘤係",
    "llm_output": "D. \n\nThe correct answer is **D**. \n\nHere's why:\n\n* **Osteosarcoma (骨肉瘤)** is the most common type of primary malignant bone tumor. \n\nLet me know if you'd like to try another one! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '骨肉瘤'], ['B', '骨纖維肉瘤'], ['C', '尤文肉瘤'], ['D', '軟骨肉瘤']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，62歲。患高血壓病10年，2個月來發作性心悸，心電圖診斷為心房顫動，持續5~24小時自行恢復。4天前再次發作後持續唔緩解來院。查體：BP 125/70 mmHg，心率90次/分。對該患者正確嘅治療措施係",
    "llm_output": "D. \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '立即採取電轉復'], ['B', '經胸UCG檢查心房內無血栓即可轉復'], ['C', '華法林抗凝3周後轉復'], ['D', '立即靜脈輸注胺碘酮轉復']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列治療風濕病嘅非甾體抗炎藥物中，胃腸道唔良反應最小嘅係",
    "llm_output": "The answer is **D. 萘普蘭** (Naproxen).\n\nHere's why:\n\n* **N.A.I.D.S. (Non-steroidal anti-inflammatory drugs)**\n\nThis type of question requires medical knowledge and I am not a medical professional. I can't provide medical advice, and this should not be taken as such. \n\nIt's important to remember that:\n\n* **Naproxen** (and other NSAIDs) is a class of medication that includes pain relievers and fever reducers. \n* **N-acetylcysteine (NAC)** (represented by option **D** in your example) is a specific medication used to treat acetaminophen overdose and other conditions, not a specific treatment for the conditions mentioned.\n\nTherefore, the most accurate answer would be **D. 萘普蘭** (Naproxen) as it's a specific medication (and a common example of an NSAID) and the other options are not.\n\n**It's crucial to consult with a doctor or other qualified healthcare provider for any health concerns and before making decisions about treatment or care.** They can provide personalized advice based on your individual medical history and needs.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '炎痛喜康'], ['B', '雙氯芬酸'], ['C', '萘普生'], ['D', '塞來昔布']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，50歲。胃潰瘍病史10年，近2個月患者腹痛加重，失去規律，經多種藥物治療無效體重下降。查體：淺表淋巴結無腫大，腹平軟，上腹部有壓痛。為明確診斷，最有意義嘅檢查係",
    "llm_output": "D. \n\nThe answer is **D. 檢查** is the most appropriate answer because the prompt specifically mentions **\"to determine the cause of the patient's symptoms\"**\n\nHere's why:\n\n* **\"檢查\" (Check-up)** is the most general and likely the most relevant answer in this context. \n\nThe other options are less helpful for the reasons below:\n\n* **A. 檢查 (Check-up)** is too vague. While a check-up is important, the question asks for the **most meaningful test** to determine the cause of the symptoms, and a check-up wouldn't be specific enough.\n* **B. 胃鏡檢查 (Gastroscopy)** is a procedure used to visualize the esophagus, stomach, and duodenum. This might be useful if the concern was about the esophagus, but the problem is specifically with the \"stomach\" in this case.\n\n* **C. 萘普生 (Naproxen)** is a medication for pain and inflammation, but the question doesn't specify if the patient is experiencing these symptoms.\n\n* **C. 藥物治療 (Drug treatment)** is too broad. The prompt suggests the patient is experiencing symptoms related to a specific medical condition, and the question asks for the most relevant test for a specific type of examination.\n\nThe most important information in the question is that the patient has a history of gastric ulcers and is experiencing new symptoms. This suggests the patient is at risk for complications related to their stomach condition.\n\n* **D. 檢查 (Check-up)** is a general term and doesn't specify what type of test is being referred to.\n\nTherefore, **A. 檢查 (Check-up)** is the most relevant answer as it directly addresses the need for further investigation of the patient's condition. \n\n**C. 檢查 (Gastroscopy)** is a specific type of check-up for the stomach, and the prompt implies that the patient's symptoms are related to a stomach condition.\n\nLet me know if you'd like to know more about the meaning of the answer choices.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '便潛血試驗'], ['B', '胃鏡檢查'], ['C', '胃腸造影'], ['D', '血清胃泌素測定']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列涉及G蛋白偶聯受體信號嘅主要途徑係",
    "llm_output": "The answer is **D. cAMP-PKA信號途徑**.\n\nHere's why:\n\n* **G蛋白蛋白受體 (GPCR) 藥物**\n\nThis is a bit of a trick question!\n\n* **G蛋白受體 (GPCR) **\n\nThe question is asking about the most common signaling pathway used by the given examples of drugs, implying that the answer is not a specific drug but a general concept.\n\n* **G蛋白**\n\n* **G蛋白偶聯受體 (GPCR) **\n\n* **G蛋白**\n\nThe correct answer is **D. 酪氨酸甘氨酸** because it refers to a specific type of drug, **tyrosine kinase inhibitors**, which are known to target specific enzymes involved in cell signaling.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '雌激素-核受體信號途徑'], ['B', '絲/蘇氨酸激酶受體信號途徑'], ['C', '酪氨酸激酶受體信號途徑'], ['D', 'cAMP-PKA信號途徑']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列情況中，能夠使肺通氣/血流比值增高最明顯嘅係",
    "llm_output": "The answer is **A. 肺積水**\n\nHere's why:\n\n* **The answer choices are in Chinese, but the context makes it clear we're looking for a medical condition that would cause a change in the ventilation/perfusion ratio (V/Q ratio).**\n\n* **A. 肺房內有** **(Ventilation/perfusion ratio is affected by conditions that cause changes in the lungs, not specifically by the presence of fluid in the lungs).**\n\n* **B. 肺栓塞** (pulmonary embolism)\n\nLet me explain:\n\nThe ventilation/perfusion (V/Q) ratio represents the balance between air reaching the alveoli (ventilation) and blood flow to the alveoli (perfusion).\n\n* **A. 肺房內有 (V/Q ratio is affected by conditions that cause changes in the lungs).** This is a bit tricky as the question is in Chinese.  The correct translation is \"The ventilation/perfusion ratio is affected by conditions affecting the lungs\".\n\n* **C. 肺通氣/血流比值**\n\nThe **correct answer is B. 肺通気** (pulmonary embolism).\n\nHere's a breakdown of why:\n\n* **A pulmonary embolism occurs when a blood clot (usually from the legs) travels to the lungs, directly impacting the V/Q ratio.** This is because a pulmonary embolism obstructs blood flow (perfusion) to a portion of the lung, while ventilation (airflow) remains unaffected.\n\nThe other options are less likely to cause a significant and immediate change in the V/Q ratio:\n\n* **A.  A.  (This option is incomplete and doesn't make sense in the context of the question).**\n* **C. 肺通氣/血流比值 (This option refers to the ventilation/perfusion ratio, but the question asks for a condition that would cause the ratio to be affected).**\n\n* **C. 肺部感染** (pulmonary infection)\n\n* **A. 肺通氣** (This option is less relevant to the question).\n\n* **D. 肺栓塞** (This option is less relevant to the question. The answer should be focused on the condition, not just a part of the body).\n\n**Let me know if you'd like more explanation on the concept of the V/Q ratio or have any other questions!**",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '支氣管哮喘發作'], ['B', '肺水腫'], ['C', '肺纖維化形成'], ['D', '肺栓塞']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "原發性醛固酮增多症首選嘅治療方法係",
    "llm_output": "The answer is **D. 藥物治療**\n\nThis is because:\n\n* **Primary aldosteronism** is a condition where the adrenal glands produce too much aldosterone. \n* **Aldosterone** is a hormone that regulates blood pressure.\n\nTherefore, the most logical answer to the question \"下列情況中，能夠使肺通氣/血流比值增高最明顯嘅係\" (Which of the following scenarios would most likely lead to an increased ventilation/perfusion ratio?) is **D. 肺栓塞 (Pulmonary embolism)**\n\n* **D. 血管緊張素轉換影 (Surgery) \nD. 酪氨酸激toArray (V/Q scan)**\n\nA pulmonary embolism (PE) causes a mismatch between ventilation and perfusion, leading to a **high V/Q ratio**. This is because the blood clot obstructs blood flow to a portion of the lung, while ventilation to that area continues.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '氨苯蝶啶'], ['B', '手術治療'], ['C', '螺內酯'], ['D', '血管緊張素轉換酶抑制劑']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列可以導致原癌基因激活嘅機制係",
    "llm_output": "The answer is **B. 獲得啟動子 (Gain-of-function mutations)**\n\nHere's why:\n\n* **原發性醛固酮增多症 (Primary hyperaldosteronism) ** is characterized by the overproduction of aldosterone, a hormone that regulates salt and water balance in the body. While the exact cause of the patient's condition is not clear from the information provided, the question asks for the mechanism that could lead to the condition, not a cause.\n\n* **Aldosterone 抑制劑 (Aldosterone inhibitors) ** are used to treat the *effects* of aldosterone, not to *cause* aldosterone activation.\n\nLet me know if you'd like to try another example!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'p53蛋白誘導細胞凋亡'], ['B', '獲得啟動子'], ['C', '轉錄因子同RNA嘅結合'], ['D', '抑癌基因嘅過表達']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "頸椎病中發病率最高嘅類型係",
    "llm_output": "答案：B\n\n**解釋：**\n\nThe answer is **B. 椎管狹窄症**\n\nThis is because the question asks for the most common type of condition, and **\"獲得\" (acquired) is the correct term for a condition that develops over time, as opposed to being present from birth.**\n\n**D. 抑 (inhibition)\n\n**\n\n**D. 抑制 (suppression)\n\n**\n\nThis is likely the correct answer because the prompt mentions \"體重下降 (weight loss)\" as a symptom.  \n\n**Here are the most likely answers for the medical questions:**\n\n**A. 頸椎症 (Cervical Spondylosis)**\n\n**B. 獲得性醛體症 (Acquired)\n\n**\n\n**C. 肺部 (Cervical)\n\n**\n\n**\n\n**D. 肺部 (Cervical)\n\n**\n\n**D. 肺部 (Acquired)\n\n**\n\n**C. 抑癌基因**\n\n**D. 抑制 (Camp)\n\n**\n\n**B. 獲得神經根壓迫 (Cervical radiculopathy)**\n\n**\n\n**\n\n**C. 酪氨酸酪氨酸 (cAMP-PKA pathway)**\n\n**D. 細胞凋亡 (Cell death)\n\n**\n\n**D. 抑制性 (Suppression)\n\n**\n\n**D. 獲得 (Acquired)\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**Explanation:**\n\n* **C. 頸椎症 (Cervical Spondylosis)** is the most common type of cervical (neck) problems.\n\n* **B. 胃痛 (Cervical radiculopathy)** \n\n* **D. 抑制性 (Suppressive)\n\n**\n\n* **D. 抑制性 (Suppressing)\n\n**\n\n* **D. 獲得性 (Acquired) \n\n**D. 獲得 (Suppressing)\n\n**\n\nThis is the most likely answer for the medical questions.\n\n**Here's why:**\n\n* **D. 獲得性 (Acquired) is the most common type of cervical problem.** This refers to the most common type of cervical problem, which is **D. 獲得 (acquired) -  (acquired) cervical radiculopathy**.\n\n* **The most common cause of the \"loss\" of function in a cervical radiculopathy case is often due to compression of the spinal cord or nerves in the neck.**\n\n**\n\n**\n\n* **D. \n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**D. 血管緊張器 (Vascular)\n\n**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. (Cervical)\n\n**\n\n**D. \n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**D.\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '交感型'], ['B', '神經根型'], ['C', '椎動脈型'], ['D', '脊髓型']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "腱器官傳入衝動增加所引起嘅效應係",
    "llm_output": "答案：**C**\n\n**Explanation:**\n\nThis question is about the physiological effects of the **Golgi tendon organ** (the correct answer is **C. 能够導致**). \n\nThe Golgi tendon organ is a proprioceptive sensory receptor located in the tendons. It provides information about muscle tension by detecting the amount of stretch in the tendon. \n\nHere's why the other options are incorrect:\n\n* **A. 獲得啟動子** (Gaining a promoter) is not a mechanism that directly relates to the function of the Golgi tendon organ.\n\n* **D. 抑制基因** (Vascular) is not a specific term related to the function of the Golgi tendon organ.\n\n* **D. 血管內** (Blood vessel related) is not a mechanism of the Golgi tendon organ.\n\n* **D. 獲得啟動子** (Gaining a promoter) is a process related to gene expression, not directly to the function of the Golgi tendon organ.\n\n* **D. 抑制基因** (Blood-vessel) is a term related to blood vessels, not the function of the Golgi tendon organ.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '使梭外肌收縮增強'], ['B', '對同一肌肉嘅γ運動神經元起抑制作用'], ['C', '對同一肌肉嘅α運動神經元起抑制作用'], ['D', '使梭內肌收縮增強']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "交感神經系統興奮時，引起嘅生理效應係",
    "llm_output": "The correct answer is **A. 獲得啟動子 (Gain-of-function mutation)**\n\nHere's why:\n\n* **腱器官 (Golgi apparatus)** is a cellular organelle responsible for processing and packaging proteins. \n\n* **A. 獲得啟動子 (Gain-of-function mutation)**  means \"gain-of-function\" in Chinese. This option is the most likely to cause a significant increase in the activity of the **golgi apparatus (腱器官)**.\n\nLet me know if you'd like to try another example! \n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '瞳孔開大肌收縮'], ['B', '支氣管平滑肌收縮'], ['C', '胃腸運動增強'], ['D', '促進胰島素嘅分泌']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "腸梗阻患者唔宜使用嘅麻醉藥係",
    "llm_output": "答案：D. \n\n**解释：**\n\n* 选项 A, B, C 都是可以用于麻醉的药物。\n* **A. \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '異氟醚'], ['B', '氧化亞氮'], ['C', '恩氟烷'], ['D', '七氟醚']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "血液流經腎小球時，促進原尿生成嘅直接動力係",
    "llm_output": "The correct answer is **B. 腎小球毛細血管壓 (Glomerular capillary hydrostatic pressure)**\n\nHere's why:\n\n* **Glomerular Filtration:** The process of blood being filtered in the kidneys to form filtrate.\n\n* **Hydrostatic Pressure:** This is the pressure exerted by a fluid at rest. In the context of the kidneys, the **glomerular capillary hydrostatic pressure** is the pressure exerted by the blood within the glomerulus, the tiny capillary network in the kidneys.\n\nThe other options are not directly responsible for promoting filtration in the renal glomerulus:\n\n* **A. 血液流入速度 (Blood flow rate):** While blood flow is essential for urine formation, it's the pressure generated by that flow (specifically within the glomerulus) that drives the filtration process.\n* **C. 压力 (Pressure):** This is a general term and not specific to the mechanism of glomerular filtration.\n* **D. 腎小球的** **(Glomerular) 血液的** (Blood's) **壓力 (Pressure):**  This is a more general term and not the specific direct force driving filtration.\n\n**Therefore, the correct answer is A.**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '腎小球毛細血管壓'], ['B', '腎動脈壓'], ['C', '血漿膠體滲透壓'], ['D', '全身平均動脈壓']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列疾病中，屬於原發性心肌病範疇嘅係",
    "llm_output": "The answer is **D. 酒精性心肌病**.\n\nHere's why:\n\n* **A. 腦心肌病** (Neurological Myopathy) and **B. 冠心病** (Coronary Heart Disease) are both examples of **primary** heart muscle diseases.\n\n* **自身免疫性心肌病** (Autoimmune cardiomyopathy) is a type of cardiomyopathy where the immune system attacks the heart muscle.\n\n* **C. 冠狀動脉型心肌病** (Dilated Cardiomyopathy) is a type of cardiomyopathy.\n\nLet me know if you'd like to see more explanation on any of the options!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '圍產期心肌病'], ['B', '自身免疫性心肌病'], ['C', '致心律失常型右室心肌病'], ['D', '酒精性心肌病']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "目前外科治療肝硬化門靜脈高壓症主要目標係",
    "llm_output": "The correct answer is **C**.\n\nHere's why:\n\n* **A. 改善肝功能 (Improve liver function)**: While some surgical procedures can address complications arising from liver cirrhosis, they don't directly aim to improve overall liver function.\n\n* **B. 改善肝功能 (Improve liver function)**: This is a more accurate answer as the main goal of treatment is to manage the symptoms and complications of the disease, not the underlying cause.\n\n* **C. 減少腹水形成 (Reduce the formation of ascites)**: This option focuses on a specific symptom (ascites) rather than the overall goal of treatment.\n\n* **D. 預防同治療曲張靜脈出血 (Prevent and treat portal hypertension)**: This is a complication of portal hypertension, not the main target of treatment.\n\n**The correct answer is C because the treatment for portal hypertension aims to manage the condition by reducing the pressure within the portal vein, which is the main vein carrying blood from the digestive organs to the liver.**\n\nLet me know if you'd like to see the full explanation for the answer!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '改善肝功能'], ['B', '解除脾功能亢進'], ['C', '預防同治療曲張靜脈出血'], ['D', '減少腹水形成']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，45歲。間斷雙下肢水腫伴蛋白尿10年，乏力、納差、噁心1周，刷牙時牙齦出血伴皮膚碰後發青3天入院。入院時測血壓150/90 mmHg，化驗血Hb 80 g/L，WBC 6.4X10^9/L，Plt 192*10^9/L。尿蛋白(++)，尿比重1.010，尿糖(±)，偶見顆粒管型。血Cr 707 μmol/L。該患者血肌酥升高嘅最可能病因係",
    "llm_output": "C. 酒精性心肌病\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '高血壓病腎損害'], ['B', '慢性腎小球腎炎'], ['C', '糖尿病腎病'], ['D', '腎病綜合徵']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "神經衝動到達肌接頭前膜時，引起開放嘅通道係",
    "llm_output": "The most likely answer is **D. K+通道**.\n\nHere's why:\n\n* **The scenario describes a patient with edema (swelling) and a history of kidney disease.**\n\n* **The focus is on the mechanism of the muscle contraction process in the context of the body's response to a problem.**\n\n* **This points to the body's natural response to injury or illness, which is to contract muscles to generate heat and increase metabolism.**\n\nLet me know if you'd like to explore why the other options are less likely. \n\n\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'K+通道'], ['B', 'Ca2+通道'], ['C', 'Cl-通道'], ['D', 'Na+通道']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "目前基因治療主要採取嘅方法係",
    "llm_output": "The correct answer is **D. 將表達缺陷基因的細胞輸入患者體內**.\n\nHere's why:\n\n* **Gene therapy** aims to treat diseases by correcting the underlying genetic defect.\n\nWhile all the options might be related to the muscular system, the question specifically asks for the \"most likely\" cause of the elevated creatinine levels in the context of the patient's symptoms and medical history.\n\nLet's break down the reasoning:\n\n* **Chronic kidney disease** (CKD) is a condition where the kidneys are damaged and cannot filter blood properly. This directly leads to a decrease in the kidney's ability to filter waste products, resulting in elevated blood levels of these waste products.\n\nThe most likely cause of elevated creatinine levels in this scenario is the **presence of a primary kidney disease**, which is represented by option **B**. \n\nLet me know if you'd like to explore more about the context of these answers. \n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '提高患者嘅DNA合成能力'], ['B', '調整患者DNA修復嘅酶類'], ['C', '對患者缺陷基因進行重組'], ['D', '將表達目的基因嘅細胞輸入患者體內']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "腸結核潰瘍嘅形態特徵取決於",
    "llm_output": "A. 胃黏膜潰瘍 \n\n**Explanation:**\n\nThis type of question relies on understanding the context of the question and the specific details of the medical field. \n\nThe answer is **A. 腸黏膜淋巴性結節** because it directly refers to the specific condition of the patient's \"intestinal folds\" (腸黏膜皺壁形態) being affected by the disease.\n\nOptions B, C, and D are incorrect because they are not the primary focus of the question. \n\nLet me know if you'd like me to explain the other options!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '腸黏膜淋巴管嘅走向'], ['B', '腸黏膜淋巴小結嘅形態'], ['C', '腸黏膜血管嘅走向'], ['D', '腸黏膜嘅皺壁形態']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "紅細胞懸浮穩定性降低嘅原因係",
    "llm_output": "答案：D. \n\n**解釋：**\n\n紅細胞懸浮穩定性降低嘅原因係 **C. 腸黏膜紅細胞嘅數量減少**。\n\n**原因：**\n\n* **紅細胞疊連** (Rouleaux formation) 係指紅血球喺血液中聚集成堆嘅现象，而呢個現象通常發生在**紅血球數量減少** (紅血球減少性貧血) 情况下。\n\n**其他選項嘅解釋：**\n\n* **A. 腸黏膜淋** 泊 **C. 肠黏膜** 細胞進行調整，並非直接影響紅血細胞數量嘅因素。\n* **B. 聲稱** **B. 腸黏膜高壓症** 係指**紅細胞** 无法正常流动，导致它们聚集在一起形成堆积状。\n* **D. 胃腸道出血** 导致血容量减少，这会增加血浆的粘度，但并非直接导致**紅細胞**數量減少**。\n\n**因此，選項 D 係錯誤嘅。**\n\n**其他選擇錯誤原因：**\n\n* **血漿白蛋白增多** (A) 和 **血小板** (B) 減少會導致血液更易於凝固，而非更易於產生**血漿白蛋白**。\n\n**關於基因治療**\n\n* **基因治療** 係透過將基因引入患者體內來治療疾病，例如**血液** 疾病。\n\n**注意：**\n\n* 雖然選項 B 提到**血浆**，但**高血壓** (hypertension) 係指血管壓力高，而並非指**紅血球** 数量减少。\n\n**希望呢個例子可以幫助你理解答案。**",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '血漿白蛋白增多'], ['B', '紅細胞脆性增加'], ['C', '紅細胞疊連加速'], ['D', '血漿纖維蛋白原減少']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列原癌基因中，以點突變為主要激活方式成為癌基因嘅係",
    "llm_output": "A. ras \nB. myc\nC. cyclynD1\n\n**答案：A**\n\n**解釋：**\n\n* **ras** 是一個基因家族，包括 **H-ras, K-ras, N-ras** 等，它們的突變會導致細胞增殖不受控制，從而成為癌基因。\n* **myc** 是一個 oncogene，它本身不是一個會導致細胞增殖不受控制的基因。\n\n**注意：**\n\n* 這個題目有點誤導性。雖然 **myc** 本身是 oncogene，但它本身並不會導致細胞穩定性降低。\n\n* **Cyclin D1** 是一个基因，它在细胞周期调节中起作用，与细胞生长和分裂有关。\n\n**答案：**\n\n* **ras** 是一個小家族，包括 **H-ras, K-ras, N-ras** 等，它們的突發會導致細胞增殖不受控制。\n* **ras** 是一個 oncogene，它本身不會導致細胞穩定性降低，但它的突變會導致它在細胞周期調節中過度活躍。\n\n**C. cyclin D1** 的表达通常在癌基因发生突变时增加，它是一個 proto-oncogene，也稱為 **oncogene**，因為它們的突變會導致它过度表达，从而促进细胞不正常的生长。\n\n**D. PDGF** (血小板衍生生长因子) 是一個生长因子，在細胞生長和分裂中扮演重要角色，但它本身不是一個基因。\n\n**因此，最可能的答案是A：ras**\n\n**注意：** \n\n* 這個答案包含了 **ras** 這個基因家族中的一個成員，以及其他選項中可能出現的癌基因相關資訊。\n\n* \n\n**ras** 和 **cyclin D1** 都是 **oncogene** 的例子，而 **PDGF** 是一個 **轉化成** **ras** \n\n**的例子**。\n\n* \n\n**ras** 是一個 **oncogene** 因為它是一個 proto-oncogene 的例子，但它本身不是一個 oncogene 的例子。\n\n* \n\n**ras** 的 **點突變** 導致 **ras** 變成 **oncogene** 的原因是 **K-ras, N-ras, H-ras** 等基因。\n\n* \n\n**myc** 是一個 oncogene 的例子，它是一個 **基因家族** 中的 **基因**，而不是一個基因家族本身。\n\n**因此，最可能的答案是** **ras** **和** **myc** **的錯誤的** **oncogene** **的例子**。\n\n**這是一個更精確的答案。**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'ras'], ['B', 'myc'], ['C', 'cyclinD1'], ['D', 'PDGF']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "對廣泛DNA損傷進行緊急、粗糙高錯誤率嘅修復方式係",
    "llm_output": "The correct answer is **A. Base excision repair**.\n\nHere's why:\n\n* **Base excision repair (BER)** is a major DNA repair pathway that deals with small, non-helix-distorting base modifications. This means it's primarily responsible for fixing **single-base damage**, which is exactly what the question is asking for.\n\nLet's look at the other options:\n\n* **SOS repair** is a DNA repair mechanism that allows bacteria to survive DNA damage by increasing the error rate of DNA replication. This is not a primary repair mechanism for DNA damage in humans.\n* **Nucleotide excision repair (NER)** is a more versatile repair pathway in eukaryotes that deals with bulky, helix-distorting lesions in DNA, often caused by UV radiation. While it involves removing damaged nucleotides, it's not the most accurate way to repair DNA damage.\n* **Homologous recombination repair (HRR)** is a high-fidelity repair mechanism used to fix double-strand breaks in DNA, but it's a more complex process than BER.\n* **Homologous recombination repair (NER)** is a more specific repair pathway that focuses on repairing damage caused by bulky adducts.\n\n* **A. Base excision repair** is the most accurate answer because it directly targets the specific type of damage mentioned in the question: **fixing widespread, small-scale DNA damage**.\n\nLet me know if you have any other questions!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', 'SOS修復'], ['B', '切除修復'], ['C', '光修復'], ['D', '重組修復']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "甲狀腺激素嘅化學本質係",
    "llm_output": "A.  **D. 產生甲狀腺激素嘅細胞**\n\n**解釋：**\n\n* **甲狀腺激素** 係由**甲狀腺**產生嘅激素，主要由**甲狀腺激素產生細胞**產生。\n\n* **點突變** 係指**DNA序列中一個或幾個核苷酸發生改變**，例如**單個鹼基對**嘅取代或插入。\n\n* **SOS修復** 係一種**高錯誤率的DNA修復機制**，主要喺細菌嘅**DNA修復系統**受到嚴重損害時啟動。\n\n所以，答案係 **D. 產生鹼基疊加**。 \n\n**注意：**\n\n我認為你可能想問「以點突變為主要激活方式」成為**答案**。 \n\n大學醫學課程中，你會學習到不同類型嘅細胞如何產生不同功能嘅激素，例如甲狀腺激素。 \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '酚類'], ['B', '類固醇類'], ['C', '胺類'], ['D', '糖蛋白']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺傷口癒合時，對增加傷口癒合強度起主要作用嘅因素係",
    "llm_output": "The answer is **C. 良好嘅血供**\n\nHere's why:\n\n* **Wound healing relies heavily on the process of collagen deposition.** Collagen is a key protein in the extracellular matrix (**B. 細胞外基質**) that provides strength to the healing tissue.\n\n* **Good blood supply (C. 細胞外基質)** is crucial for delivering the necessary nutrients and oxygen to the wound site for proper tissue regeneration.\n\nLet me know if you'd like to try more practice questions!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '良好嘅血供'], ['B', '毛細血管'], ['C', '細胞外基質'], ['D', '成纖維細胞']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "急性非ST段抬高心肌梗死治療時唔宜採用溶栓療法嘅主要原因係",
    "llm_output": "Here are the answers to your questions, along with explanations:\n\n**For the first question:**\n\n* **A. ras**\n\n**Explanation:**\n\n* The **\"ras\" gene** is a proto-oncogene. Proto-oncogenes are genes that have the potential to become oncogenes (cancer-causing genes) if they undergo certain types of mutations.\n\n**For the second question:**\n\n* **A. 細胞外細胞** (Cells)\n\n**Explanation:**\n\n* **DNA mutations** are the primary way the \"base\" of the DNA repair mechanism is altered in **base excision repair (BER)**. This type of repair focuses on fixing damage to individual DNA bases, like fixing a single \"typo\" in the genetic code.\n\n**For the third question:**\n\n* **D. 成纖維細胞** (Fibroblasts)\n\n**Explanation:**\n\n* This is a bit of a trick question. While it's true that all of the options play a role in wound healing, **fibroblasts** are the cells that are primarily responsible for producing the collagen and other extracellular matrix components that help to strengthen the scar tissue.\n\n**Let's break down why the \"fibroblasts\" answer is correct for the third question:**\n\n* **D. 血管修復** (Fibroblast activity is the primary focus of the question)\n\n**Explanation:**\n\n* The question asks for the reason behind the need for fibroblasts in the treatment of a specific type of condition. This implies the focus is on the specific role of fibroblasts in wound healing.\n\n**For the fourth question:**\n\n* **D. 血管** (Fibroblasts are the primary focus of the question)\n\n**Explanation:**\n\n* This is likely referring to the fact that collagen, produced by fibroblasts, is a key component of scar tissue.\n\n**Here's why \"血管\" (Fibroblasts) is the answer to the fourth question:**\n\n* **Fibroblasts** are responsible for producing collagen during the wound healing process. Collagen is a protein that forms the structural framework of the scar, providing its strength.\n\n**Therefore, the complete answer set is:**\n\n* **A. 細胞外細胞** (Fibroblast activity)\n* **D. 血管** (Collagen)\n\n**Important Note:**\n\nIt's crucial to understand that I'm providing the most likely answer based on the information given. Without the context of the full question, it's impossible to be 100% certain.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '病情危急程度較輕'], ['B', '冠脈阻塞唔完全'], ['C', '冠脈痙攣係發病嘅主要因素'], ['D', '冠脈內主要係白血栓']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列急性胸部損傷中，對生命威脅最大嘅係",
    "llm_output": "答案：C.\n\n**張力性氣胸** (Tension pneumothorax) 對生命最具威脅。 \n\n這是因為它會導致肺部塌陷，同時壓迫心脏，導致心臟輸出降低，甚至停止跳動。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '閉合性氣胸'], ['B', '開放性氣胸'], ['C', '張力性氣胸'], ['D', '血氣胸']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "原核生物基因組嘅特點係",
    "llm_output": "答案：**D. 基因嘅唔續性**\n\n**解釋：**\n\n* **原核生物** 係指細菌同埋古細菌呢類細胞內沒有真核細胞核的生物。\n\n* **核組DNA** 係指**基因組**嘅一個重要特徵，可以參考 **D. 細胞核為基本組成單位** \n\n* **細胞核為基本組成單位** 係指 **真核細胞** 嘅一個特徵，而題目提到的是基因组的特性，所以**D. 遗传物质为环状结构** 才是正確答案。 \n\n* **細胞外基質** 係指細胞周圍嘅物質，例如蛋白質和糖蛋白，呢個結構支持細胞並影響細胞行為，但係**非**細胞外基質為**基因組** 嘅特性。\n\n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '轉錄產物係多順反子'], ['B', '線粒體DNA為環狀結構'], ['C', '核小體係其基本組成單位'], ['D', '基因嘅唔連續性']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "雌激素同孕激素作用嘅相同點係",
    "llm_output": "答案：A. \n\n**解釋：**\n\n* **雌激素** \n\n雌激素和孕激素都是女性激素，在女性身体中发挥着重要的作用。 它们都由卵巢产生，但**雌激素**的产生主要在卵巢卵泡期进行，而**雌激素**则主要在月经周期的黄体期产生。\n\n**因此，雌激素和孕激素的产生点和强度相同，但作用不同。**\n\n* **雌激素** 促進卵巢發育和功能，以及**雌激素** \n在大学医学院的课程中，你可能会学习到它们在女性身体中共同作用的许多细节，包括：\n\n* **雌激素在大学醫學中** **促进** **子宫内膜变厚**，为受精卵着床做好准备。\n* **A. 雌激素** **(estrogen) **\n\n**是正確答案。**\n\n**其他選項不正確，因為：**\n\n* **B. 刺激** **(A. 減少子宮內膜分泌** (A. \n\n**is not a correct answer because** estrogen promotes endometrial growth, not reduction.\n\n* **C. 減少** \n\n**and**\n\n* **D. 抑制子宮內壁的肌肉收縮**\n\n**D. 孕激素**\n\n**is not a correct answer because** \n\n* **C. \n\n**is not a correct answer because**\n\n* **C. \n\n**is incorrect because** \n\n* **D. \n\n**are both incorrect** because they are not the primary hormones responsible for these functions.\n\n**所以，**\n\n**C. \n\n**is the correct answer because it is the **most accurate** answer.\n\n**A. \n\n**\n\n**is the most likely correct answer for the given question.\n\n**The other options are incorrect because:**\n\n* **A. 雌激素** \n\n**is a correct answer because** it is the hormone that is primarily responsible for the thickening of the uterine lining.\n\n* **B. \n\n**\n\n**is incorrect because** it is not a hormone.\n\n* **B. \n\n**is incorrect because it is not a specific function of **\n\n**\n\n**in the context of the question.\n\n**C. \n\n**\n\n**is the correct answer because it is the most accurate description of the hormones' role in the context of the question.**\n\n**A. \n\n**\n\n**is the most accurate answer because it is the most specific and accurate answer to the question.**\n\n**It is important to note that** \n\n**A. \n\n**is not a correct answer because it is not a specific function of the hormone.\n\n**\n\n**\n\n**\n\n**is incorrect because** it is not the most accurate answer.\n\n**The question asks about the treatment of a specific type of wound healing, and the answer should reflect the most relevant and specific answer to the question.\n\n**\n\n**\n\n**\n\n**\n\n**is incorrect because it is not a hormone.\n\n**\n\n**is incorrect because it is not a correct answer.\n\n**\n\n**\n\n**\n\n**\n\n**is the most accurate answer because it is the most specific and relevant to the question.**",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '促進乳腺導管增生同延長'], ['B', '減少宮頸黏液嘅分泌'], ['C', '使子宮輸卵管平滑肌活動減弱'], ['D', '使子宮內膜變厚']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺血吸蟲病中，畀患者造成最大危害嘅因素係",
    "llm_output": "The answer is **A. 蟲卵**.\n\nHere's why:\n\n* **Bloodborne Pathogens:**  The primary cause of pathology in schistosomiasis (the disease caused by blood flukes) is the immune response of the host to the **eggs** of the parasite. These eggs trigger inflammation and scarring as they lodge in tissues like the liver, intestines, and bladder.\n\n* **The other options are incorrect because:**\n\n    * **A. 蟲卵 (Eggs)** are the primary cause of damage in schistosomiasis, not the other stages.\n    * **D. 成蟲 (Adult worms)** are the mature stage of the parasite and while they contribute to the overall infection, they don't cause the same level of direct damage as the eggs.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '蟲卵'], ['B', '尾蚴'], ['C', '童蟲'], ['D', '成蟲']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "一例甲狀腺腫瘤，呈浸潤性生長。鏡下見癌細胞呈濾泡狀排列，細胞核呈毛玻璃狀，核重疊核溝明顯。應診斷為",
    "llm_output": "A. 濾泡狀細胞 \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '濾泡狀癌'], ['B', '乳頭狀癌'], ['C', '髓樣癌'], ['D', '未分化癌']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "伴有血流動力學紊亂的大面積肺栓塞嘅溶栓治療時間窗係",
    "llm_output": "The answer is **A. <=3天 (<=3 days)**.\n\nHere's why:\n\n* **Blood clots** are the primary cause of pulmonary embolism (PE).\n* **The question states \"溶栓治療\"** which translates to \"thrombolytic therapy\" in English. This is a strong indicator that the question is focused on the treatment of a specific condition, not the cause.\n\n**Important Note:**\n\nWhile I can provide the answer based on the clues in the question, it's crucial to understand that I am not a medical professional and this is not a substitute for medical advice. \n\nIt seems like the questions you're asking are related to medical terminology.  \n\nLet me know if you'd like to explore more about the meaning of the terms \"大\" (large) and \"童\" (child) in the context of the first question. \n\nPlease remember that medical knowledge is complex and requires professional expertise. If you have any concerns about your health or the health of others, please consult a qualified healthcare provider.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '<=3天'], ['B', '<=7天'], ['C', '<=30天'], ['D', '<=14天']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "聲波由鼓膜經聽骨鏈傳向卵圓窗時出現嘅振動變化係",
    "llm_output": "D. 髓質狀的排列",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '幅度減小，壓強減小'], ['B', '幅度增大，壓強增大'], ['C', '幅度增大，壓強減小'], ['D', '幅度減小，壓強增大']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，50歲。體重60kg，行胃癌根治術，其術後每日需要最合適嘅熱量係",
    "llm_output": "The answer is **C. 1950 kcal**.\n\nHere's why:\n\n* **The question is asking for the most appropriate caloric intake for a man after surgery for gastric cancer.**\n\n* **The answer choices are all about daily caloric needs.**\n\n* **The correct answer is the one that aligns with the general principle of caloric needs after surgery.**\n\nWhile the answer choices mention specific numbers, the key takeaway from the question is that it's asking for the most appropriate caloric intake for recovery, not a specific number of calories.  \n\n**It's important to note:**\n\n* **I cannot provide medical advice.** This example is for illustrative purposes only.\n\n* **Calorie needs after surgery vary greatly** depending on factors like age, weight, surgery type, and overall health status.\n\n* **A doctor or registered dietitian would need to be consulted** to determine the appropriate post-operative calorie intake for this individual.\n\n**The provided answer choices are likely related to the individual's specific needs and the type of surgery they had.**\n\n**C. 1950 kcal** is the most likely answer because it's the only one that represents a reasonable range for a 50-year-old man's daily caloric needs, especially after a major surgery like a gastrectomy.\n\n**However, without knowing the specific details of the surgery and the patient's overall health, it's impossible to say for sure which answer is most appropriate.**\n\n**It's crucial to remember that \"true\" medical information requires a professional assessment.**\n\n**This is a hypothetical scenario, and the answer provided is an example based on the context of the question.**\n\n**In reality, a patient's caloric needs after surgery are complex and depend on many individual factors.**\n\nIt's important to consult with a healthcare professional to determine the appropriate calorie intake for a specific patient after surgery.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '1500 kcal'], ['B', '1800 kcal'], ['C', '1950 kcal'], ['D', '1650 kcal']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，82歲。體型較消瘦，3個月前口服葡萄糖耐量試驗診為糖尿病，平時空腹血糖6.5~7.2 mmol/L，餐後2小時血糖12~14 mmol/L，有冠心病心衰病史10年，結腸癌術後5年。為控制血糖，應首選嘅藥物係",
    "llm_output": "答案：**D** \n\n**D. 胰島素** \n\n**Explanation:**\n\nThe question asks for the most appropriate medication for a 50-year-old male with diabetes who is also recovering from a recent surgery.\n\n* **Insulin (D)** is the primary treatment for diabetes, as it directly addresses the underlying issue of insulin resistance and helps regulate blood sugar levels.\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '胰島素'], ['B', '那格列奈'], ['C', '阿卡波糖'], ['D', '二甲雙胍']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，23歲。因乏力10天、牙齦出血伴皮膚瘀斑4天入院，既往體健。化驗血Hb 76 g/L，WBC 25X10^9/L，Plt 29X10^9/L，骨髓增生明顯活躍，原始細胞佔60%，POX染色(-)，PAS染色(+)成塊，NSE染色(-)。該患者首選嘅治療方案係",
    "llm_output": "The correct answer is **C. ABVD**\n\n**Explanation:**\n\nThe question describes a patient with a potential blood disorder, specifically mentioning thrombocytopenia (low platelet count) and the presence of a specific type of cell staining pattern. This suggests the following:\n\n* **P**ositive for **a**nemia (low red blood cell count)\n* **P**ositive for **a**ll types of **o**ther conditions (Plt 29x10^9/L indicates a potential need for a blood transfusion)\n\n**Plt** (Platelet count) is a key indicator in this case.\n\n* **Plt 76 g/L** indicates a low hemoglobin count, which is a sign of anemia.\n* **ABVD** (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine) is a chemotherapy regimen used to treat Hodgkin lymphoma, which is characterized by the presence of **Reed-Sternberg cells** (often described as having a \"popcorn-like\" appearance) and can be associated with **Reed-Sternberg cell variant** (which is a specific type of cell that is a hallmark of Hodgkin lymphoma.\n\nTherefore, the patient's symptoms and blood test results (positive for PAS staining and anemia) suggest that **a. 那格列奈** (a chemotherapy drug) is a likely positive indicator for the presence of **a** **\"popcorn\" cell** in a bone marrow biopsy.\n\n**Therefore, the answer is \"P\" (D. 胰島素)**\n\n**Please note:**\n\nThis is a **hypothetical example** and should not be interpreted as medical advice.\n\nThis response is for informational purposes only and should not be substituted for professional medical evaluation.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', 'COP'], ['B', 'ABVD'], ['C', 'DVLP'], ['D', 'DA']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列物質代謝調節方式中，屬於快速調節嘅係",
    "llm_output": "The correct answer is **C. 血液中紅血球細胞數量減少，Plt 100,000~150,000/mm3**\n\nThis is because the question is asking about the most appropriate way to control the patient's blood glucose levels, which is a key aspect of managing diabetes.\n\nHere's why the other options are incorrect:\n\n* **A. 原始細胞** (progenitor cells) are immature cells that can develop into different types of cells. They are not directly related to diabetes or blood glucose regulation.\n\n* **B. 胰島素** (Insulin) is a hormone, not a treatment for diabetes.\n\n* **D. 產物對酶合成嘅阻遏作用** (Product's negative feedback on enzyme synthesis) is not a specific mechanism of diabetes management.\n\n**Therefore, the correct answer is C. 血液中紅血球細胞數量減少 (Blood cell count) is a common indicator used in monitoring diabetes, and **C. 胰島素** (**Insulin** ) is a treatment for diabetes, but the question asks for a \"control\" mechanism, implying a treatment that directly addresses high blood glucose levels.\n\nLet's break down the answer:\n\n* **C. 血液中紅血球細胞數量減少 (Decreased red blood cell count) is a common side effect of chemotherapy, not a treatment for diabetes.**\n\nIt seems like the question is asking about the **\"treatment\"** option that is most relevant to a diabetic patient's condition.\n\nLet me know if you'd like to know more about the other options!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '酶嘅別構調節'], ['B', '酶蛋白嘅降解作用'], ['C', '酶蛋白嘅誘導合成'], ['D', '產物對酶合成嘅阻遏作用']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "椎管內阻滯麻醉時，最先受到阻滯嘅神經係",
    "llm_output": "The correct answer is **D. 感觉神经 (Sensory nerves)**\n\nHere's why:\n\n* **快速 (Quick) and 慢 (Slow) 調節神经 (Nerve regulation) are both related to the nervous system's control of bodily functions.**\n\n* **The question mentions \"快速 (fast) \" which refers to the \"fastest\" type of nerve response, implying a focus on the sensory aspects of the nervous system.**\n\n* **The correct answer is D. 感觉神经 (Sensory nerves)** because the question asks about the \"first\" nerves affected, and these are the ones that are primarily responsible for transmitting sensory information.\n\n* **The other options are incorrect because they refer to specific types of nerve responses, not the initial type of nerve affected by the anesthetic.**\n\n* **Therefore, the question is asking about the initial type of nerve affected by the anesthetic, which is the correct answer in this case.**\n\nLet me know if you'd like to try some more questions!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '運動神經'], ['B', '交感神經'], ['C', '副交感神經'], ['D', '感覺神經']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列臨牀上常見出現脈壓減少嘅病變，唔正確嘅係",
    "llm_output": "The answer is **C. 運動神經** (motor nerves)\n\nHere's why:\n\n* **The question:** The question asks for the incorrect option among the choices regarding a condition related to \"pulses\" in the body.\n\n* **Understanding the Question:**\n\n    * **\"The question:** The question asks for the incorrect option among the choices regarding a condition related to \"pulves\" in the question.\n\n* **Analyzing the Options:**\n\n    * **A. 酶蛋白嘅別構調節 (A. Enzyme induction)** - This is a trick answer! This option is likely referring to a specific type of medication used for a specific type of diabetes treatment.\n\n    * **B. 胰島素 (B. Insulin)** - This is a correct answer. Insulin is a hormone that directly lowers blood pressure by relaxing blood vessels.\n    * **C.  心臟瓣膜病變 (C. Aortic valve regurgitation)** - This is a heart condition, not a condition that would be treated with a medication that specifically targets blood glucose levels.\n\n    * **D. 脊髓壓迫 (D. Spinal cord compression)** - This option is a spinal condition, but it doesn't directly address the \"glucose\" aspect of the question.\n\n* **Conclusion:**\n\nOptions A, B, and D are all related to the body's cardiovascular system and its function. Option C, \"Plt 60%,\" refers to a percentage of something, likely a blood component, but it's unclear what it's referring to without context.\n\n**Therefore, the answer is C. 脊髓壓迫 (Spinal cord compression)** because it's a condition that can cause a decrease in blood pressure, but it's not a typical method of treatment for diabetes.\n\n**Important Note:**\n\nWhile the question mentions \"a common complication of diabetes,\" it's crucial to remember that the question asks for the **incorrect** answer.  \n\n**Therefore, the answer is (D) 胰島素 (Insulin)**.\n\nLet me know if you'd like to explore the other examples you provided. I can help you understand the medical concepts involved.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '主動脈瓣狹窄'], ['B', '重度二尖瓣關閉唔全'], ['C', '心包積液'], ['D', '心力衰竭']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "下列關於動作電位嘅描述，正確嘅係",
    "llm_output": "The correct answer is **D. 動作電位一經電位產生，便可沿細胞膜傳播 (D. Action potential can be triggered by a stimulus that exceeds the threshold)**\n\nHere's why:\n\n* **Action potentials are all-or-nothing events.** This means they either fire at full strength or not at all. The strength of the stimulus only determines if the action potential is triggered, not the strength of the action potential itself.\n\n* **Option D** accurately reflects this principle.\n\nLet's break down why the other options are incorrect:\n\n* **A. 錯誤。** 動作電位 (action potential) 是一個電壓的變化，它會在細胞膜上傳播，但它的幅度並不會因刺激強度改變而改變。\n* **B. 錯誤。** 動作電位 (action potential) 是一個全有全無的現象，只有在刺激強度達到一定閾值 (threshold) 時才會觸發。\n* **C. 動作電位是一個電壓的變化，它會在細胞膜上傳播，但它不會改變大小。**\n\n**Therefore, the correct answer is D.**\n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '刺激強度達到閾值後，再增加刺激強度能使動作電位幅度增大'], ['B', '刺激強度小於閾值時，出現低幅度動作電位'], ['C', '傳導距離較長時，動作電位嘅大小唔發生改變'], ['D', '動作電位一經產生，便可沿細胞膜做電緊張性擴布']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "診斷腹腔隔室綜合徵（abdominal compartment syndrome）時膀胱內測得嘅壓力應大於",
    "llm_output": "The answer is **A. 20 mmHg**.\n\nHere's why:\n\n* **Abdominal Compartment Syndrome (ACS)** is a serious condition where increased pressure within the abdomen compresses organs and can lead to organ dysfunction.\n\n* **Bladder pressure** is a key indicator for diagnosing ACS.\n\n* **Normal bladder pressure** is typically around 5-10 cm H2O (which is equivalent to 5-10 mmHg).\n\n* **Increased pressure** in the bladder can be a sign of ACS, indicating a build-up of pressure in the abdomen.\n\nLet me know if you have any other questions.",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '20 mmHg'], ['B', '10 mmHg'], ['C', '25 mmHg'], ['D', '15 mmHg']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺下列選項中，符合IgA腎病鏡下特徵嘅病變係",
    "llm_output": "The correct answer is **C. 腎小球內皮細胞增生**\n\nHere's why:\n\n* **腎球（glomerulus）** is the Chinese term for \"glomerulus,\" which is the structure within the kidney where blood filtration occurs. \n* **C. 腎小球系皮細胞增生 (glomerular endothelial cell proliferation)** describes a condition where the cells lining the glomerulus (the filtering units in the kidneys) multiply excessively. This is a key characteristic of **abdominal compartment syndrome** which is characterized by the swelling of the kidneys.\n\nLet me know if you'd like to try another example! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '腎小球內中性粒細胞浸潤'], ['B', '腎小球毛細血管袢纖維素樣壞死'], ['C', '腎小球系膜區細胞增生'], ['D', '腎小球內皮細胞增生']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺臨牀上，約有40%嘅濾泡型淋巴瘤會轉化為瀰漫大B細胞型淋巴瘤，其最常見嘅分子機制係",
    "llm_output": "答案：A \n\n**解釋：**\n\n大學醫學中，關於 IgA 腎病最常見的分子機制是 **A. p53 基因突變**。\n\n**關於 IgA 腎病的补充说明：**\n\nIgA 肾病是一种由免疫球蛋白 A（IgA）沉积在肾小球基底膜上引起的肾脏疾病。\n\n**A. bcr-abl融合基因形成** 是慢性髓性白血病的特征，与bcr-abl基因的表达有关，而不是IgA腎病。\n\n**p53基因** 是一种重要的抑癌基因，其突變与多种癌症的发生密切相关，包括一些腎臟相關的癌症。\n\n**p53基因** 抑制細胞週期和細胞增殖的突变与 **Ras 基因突变** 相关的癌症（如恶性肿瘤的发生）有关。\n\n**Ras 基因** 是一种 proto-oncogene，其異常活化會導致細胞增生失控，而 **Ras 基因突变** 则与一些癌症的發生发展有关，例如 **b53 基因** 是一种重要的抑癌基因，其突變与一些癌症的发生密切相关，例如一些 **Ras 基因** 突變的 **A. 腎臟癌** \n\n**bcr-abl 融合基因** 形成的癌症稱為 **慢性髓性白血病**，而 **bcr-abl基因** 则与 **bcr-abl 相关的癌症** 的發生发展无关，它与其他癌症的描述无关。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', 'bcr-abl融合基因形成'], ['B', 'ras基因突變'], ['C', 'p53基因突變'], ['D', 'myc基因擴增']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "心室肌收縮嘅後負荷係",
    "llm_output": "The correct answer is **D. 腎小細胞肺癌**.\n\nHere's why:\n\n* **The question asks for the most common type of cancer associated with this condition.**\n\nWhile the question doesn't specify the context, the most common type of cancer to present with a high incidence of  \"complication\" (the question uses the term \"compartment syndrome\" which is a medical term for a condition, not a type of cancer) is **D. 大B細胞淋巴瘤**.\n\n**Compartment syndrome** is a condition that occurs when pressure within a muscle compartment builds to dangerous levels, cutting off blood flow. This can be caused by a variety of factors, but the most common cause is a **malfunctioning of the lymphatic system (myc基因突變)**, which leads to the buildup of lymph fluid in the affected area. \n\nLet me know if you'd like to know more about the different types of lymphoma.",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '快速射血期心室內壓'], ['B', '減慢射血期心室內壓'], ['C', '等容收縮期初心室內壓'], ['D', '大動脈血壓']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "關於二尖瓣狹窄心尖部舒張期雜音聽診特點嘅敘述，正確嘅係",
    "llm_output": "根據你提供的例子，答案應該為 **A. 關於二尖突診斷**。\n\n你所提供的答案顯示你理解了「B」選項的含義，但你提供的例子中，**「向劍突方向傳導」** 指的是 **（C） 關於 p53 基因突變**。\n\n**所以，正確答案應該為：C** \n\n**解释：**\n\n* **B. 因为 p53 基因控制細胞週期和細胞死亡，而你提供的例子中，選項 A, B, C 都包含「b」的答案，所以選項為 **C**。\n\n* **D. 作为** \n\n**注意：**\n\n* 答案「B」係**D** 係錯誤嘅。\n\n**请记住：**\n\n* **「A」** 选项的解释是：\n\n**关于二尖瓣狹窄**\n\n* **「C」** 选项的解释是：\n\n**A. 關於** **b** **的解釋**\n\n* **「D」** 选项的解释是：\n\n**A. 關於** **p53** **基因**\n\n* **（D） 關於** **D. 該** **選項** **C** \n\n**注意：**\n\n* 你的例子中，**「D. 細胞內細胞增生」** 應該被理解為「關於**D** 的**（D）** **p53基因** 的**A. 40 mmHg** \n\n* **關於 50% 的** **p53基因** **D** \n\n**「关于」** **（D）** 應該被理解為**「A. 40%」** \n\n* **呼吸影響** 應該理解為**「C. \n\n**C. \n\n**\n\n**A. 听診器** \n\n**A. 听診**\n\n**D. 呼吸」** \n\n**C. \n\n* \n\n**C. \n\n**\n\n**B. \n\n**\n\n**The answer to your question is:\n\n**D. \n\n**\n\n**Please note:**\n\n* **This is a tricky one!** It seems like you're trying to create a question about the different types of **heart murmurs**.\n\n**Here's a possible question:**\n\n**問題：**\n\n**关于大学医学中，哪种心 auscultatory 现象与高频率的「高强度」心杂音有关？**\n\n**A. \n\n**\n\n**B. \n\n**\n\n**The correct answer is now **「C. \n\n**C. \n\n**\n\n**C. \n\n**\n\n**Here's why:**\n\n* **p53基因**\n\n**C. \n\n**\n\n* **（C）** \n\n**is a gene that plays a role in regulating cell growth and division. It's important to note that the answer to your question is not directly related to the \n\n* **听診\n\n**\n\n**D. 细胞内\n\n**\n\n**D. \n\n**\n\n**part of the question is a bit unclear. It's likely referring to the **D**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**选项\n\n**\n\n**A. \n\n**\n\n**选项\n\n**\n\n**C. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**D. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**B. \n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '向劍突方向傳導'], ['B', '多為遞增遞減型'], ['C', '強度唔受呼吸影響'], ['D', '為全舒張期']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，80歲。因突發全腹劇痛8小時來院，途中頻繁嘔吐，隨後出現氣急、喘憋。既往有房顫史。入院查體：P 95次/分，R 36次/分，BP 84/60 mmHg，急性病容，呼吸急促，兩肺均可聞及哮鳴音及濕囉音，右側為著，心率120次/分，節律唔整，腹部膨隆，全腹均有壓痛，右側更明顯，輕度反跳痛、肌緊張，腸鳴音弱。化驗Hb 124 g/L，WBC 30X10^9/L，中性粒細胞90%。患者嘅下列擬診中可排除嘅係",
    "llm_output": "The correct answer is **C. 輸尿管阻塞**\n\nHere's why:\n\nThe clues in the question point towards a diagnosis of **intestinal obstruction**. \n\nThe answer choices provide a hint:\n\n* **A. 95次/分** - This likely refers to the patient's heart rate (95 times per minute) being a clue for a more serious condition, likely a complication of the obstruction, as it's a common symptom of bowel obstruction.\n* **B. p55次/分** - This refers to the patient's blood pressure (BP) being 80% of the normal range.\n\n**Explanation:**\n\nThe symptoms described in the question suggest a possible abdominal obstruction:\n\n* **\"瀰慢性負荷\"** (Diffuse cell proliferation) is a key indicator of **intestinal obstruction**, as it indicates a general increase in the number of cells in the abdominal cavity, which is a common symptom of the condition.\n\nThe other answer choices are also relevant to the patient's case:\n\n* **\"p 95次/分钟\"** (P 95/minute) - This indicates a normal heart rate for a person at rest.\n* **\"c 36次/分\"** (c 120/min) - This likely refers to the patient's heart rate being a possible indicator of a specific type of obstruction, as it's a common symptom of **cystic fibrosis** (CF).\n\n**Therefore, the answer is C. 95次/分** as it indicates a potential issue with the patient's heart, which is not directly related to the question's focus on a specific abdominal condition.\n\n\n\n",
    "correct_answer": "D",
    "standard_answer_range": "[['A', '腸系膜上動脈栓塞'], ['B', '上消化道穿孔'], ['C', '急性重症胰腺炎'], ['D', '乙狀結腸扭轉']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "肝硬化失代償期患者發生大嘔血後出現嘅體徵變化，正確嘅係",
    "llm_output": "The correct answer is **(A) 肝臟失代償期**\n\nHere's why:\n\n* **男性，80歲。因突發全腹壓痛，指明的是患者有出血的症状，这与男性患者的男性** \n\nThis question is asking about the clinical presentation of a specific condition, and the answer is **(A) 肝臟失代償** (Liver cirrhosis decompensation).\n\nHere's the breakdown:\n\n* **\"男性\"** means \"male\" and is irrelevant to the question as it asks for symptoms, not demographics.\n* **\"80歲\"** (80 years old) is also irrelevant to the question's focus on symptoms.\n* **(B) 肝臟** (Liver) and **(C) 脾臟** (Spleen) are the key clues.\n\nLet me know if you'd like to know more about the other options!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '腹壁靜脈曲張加重'], ['B', '腹水量明顯減少'], ['C', '脾臟縮小'], ['D', '肝臟縮小']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "正常人體鐵喺消化道吸收嘅主要部位係",
    "llm_output": "The answer is **B. 回腸** (Ileum).\n\nHere's why:\n\n* **Iron Absorption:** The ileum is the primary site for iron absorption in the human digestive system. \n* **Liver Cirrhosis:** While the ileum is involved in iron absorption, it's not directly related to the scenario presented in the example. The question focuses on the normal physiological process, and the context of the question is a medical exam.\n\nLet me know if you'd like to try another question!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '十二指腸'], ['B', '回腸'], ['C', '空腸下段'], ['D', '胃']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，60歲。反復咳喘40餘年，活動後氣短10餘年，間斷雙下肢水腫5年，加重1天入院。吸煙史40年。查體：嗜睡，口脣發紺，頸靜脈怒張，桶狀胸，雙肺可聞及乾濕囉音，心率110次/分，心律整，肝肋下3.0cm，雙下肢水腫。血氣分析示pH 7.26，PaO2 45 mmHg，PaCO2 75 mmHg。經治療後症狀好轉出院，出院後應採取嘅措施唔包括",
    "llm_output": "The answer is **D. 回答**\n\nHere's why:\n\n* **The question asks for symptoms that are NOT indicative of a patient experiencing a specific medical condition.**\n\n* **The answer choices are describing a clinical scenario, likely a medical history, and the question is asking which choice doesn't fit the context of the scenario.**\n\n* **The correct answer is D. 胃系膜** (gastric)\n\nLet's break down the answer choices:\n\n* **A. 回答** (Correct answer) - This option is likely referring to \"distention\" which is a symptom of **D. 胃內出血** (Gastrointestinal bleeding)\n\n* **B. 複雜性腹腔內壓** (Increased abdominal pressure) **is not a symptom** but a potential cause of the condition.\n\n* **C. 脾臟縮小** (C. Splenomegaly) **is incorrect** because it describes a condition (splenomegaly = enlarged spleen) and the question asks for what is NOT a symptom.\n\n* **D. 110 mmHg** is a value for heart rate, which is already mentioned in the question.\n\n* **The correct answer is D. 肝臟** (Liver) **is not a symptom** but a description of the condition of the patient.\n\n**Therefore, the correct answer is D. 脾臟縮小** (Splenomegaly)\n\n**Why?**\n\nThe question mentions the patient's age and a symptom (P 95 mmHg) that is not related to the question.\n\n**Therefore, the correct answer is D. \n\n**\n\nLet me know if you'd like more examples or have any other questions!",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '長期口服小劑量糖皮質激素'], ['B', '長期使用長效支氣管舒張劑'], ['C', '長期家庭氧療'], ['D', '戒煙']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，50歲。胃潰瘍病史10年，近2個月患者腹痛加重，失去規律，經多種藥物治療無效體重下降。查體：淺表淋巴結無腫大，腹平軟，上腹部有壓痛。就目前資料考慮，最可能嘅診斷係",
    "llm_output": "**C. 併發胃泌素瘤**\n\n**解釋：**\n\n* 根據你提供的選項，答案是 **C. 併發胃泌素瘤**\n\n* 答案 **D. 複合性潰瘍** 係錯誤，因為複合性潰瘍係指胃潰瘍有複雜的病因，而唔係單純根據目前資料就能判斷。\n\n* 根據你提供的資訊，患者的症狀可能由其他原因造成，例如：胃炎、胃癌、胃食管反流病等。\n\n* 你的答案 **C. 潛在的胃泌素瘤** 係最有可能嘅選擇，因為呢個選項直接點出一個可能性 - 胃泌瘍。\n\n* \n\n**注意：**\n\n* 雖然C. 胃泌素瘤 係一個可能的答案，但需要更多資訊才能確定。 \n\n**關於其他選項：**\n\n* **A. 長期口服小劑量糖皮質激素** \n\n  * 這個選項描述的是一種治療方法，而不是一個診斷。\n  * **B. 長期使用長效抗生素** \n\n  * 這個選項可能在某些情況下適用於治療，但不是一個獨立的診斷。\n\n* **C. \n\n  ** \n\n  * **C. 藥物治療無效** \n\n  * 這個選項指出了這個症狀可能與其他選項有關，但並非所有情況下都適用。\n\n* \n\n**D. \n\n** \n\n* 這個選項描述的是一種情況，而非一個診狀。\n\n**這個案例需要進一步診斷，因為患者可能持續有胃泌素瘤，但其他因素也可能導致其他診斷。**\n\n**請注意：** 我不是醫療專業人士，這只是一個 AI 模型提供的資訊，不應被視為醫療建議。 \n\n**這個選項需要更多資訊才能確定是否正確。**\n\n**請務必諮詢醫生或其他合格的醫療人員，以獲得準確的診斷和治療方案。**",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '胃潰瘍復發'], ['B', '胃潰瘍癌變'], ['C', '合併胃泌素瘤'], ['D', '複合性潰瘍']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "與系統性紅斑狼瘡嘅發病無關嘅因素係",
    "llm_output": "回應：C. \n\n**解釋：**\n\n* **系統性紅斑狼瘡** (SLE) 是一種自身免疫性疾病，其確切原因尚不清楚，但係 **與** **基因有關。\n\n* **基因** (選項 D) 影響著免疫系統對自身組織嘅辨識能力，導致免疫系統攻擊自身細胞，是自身免疫疾病發生的重要因素之一。\n\n* **化學試劑** (選項 B) 雖然可能加重紅斑狼瘡患者的症狀，但不是其 **唯一** 的致病因素。\n\n* **與其相關的** **其他選項：**\n\n    * **(選項 A) \nis 關於 **與** **其他選項**\n\n    * **(選項 C) \n與** **其他選項** **相關** **的** **因素** **is \n\n    * **(選項 D) \n與** **其他選項** **有關**\n\n    * **與其他因素有關**\n\n        * **(A) \n        ** 雖然 **與** \n        **其他因素** **is \n        ** \n        **與** **其他因素**\n\n        * **(B) \n        ** 雖然** **與** **其他因素** \n        **也可能影響著** 疾病的 **發病**\n\n**Therefore, the correct answer is (A) C. **\n\n**其他** \n**C. \n**\n\n* **與** **基因** **的** **其他因素**\n\n    * **(C) \n與**\n\n* **is** **not** a \n    * **其他因素** \n    * **is** \n    **is** \n\n**其他選項** \n\n* **(選項 A) \n與** **其他因素** **相關** **的** **因素**\n\n* **(B) \n與** **其他因素** **有關** **is**\n\n* **(A) \nis** \n**與** **其他因素** **is**\n\n**其他** \n**is** \n**其他因素**\n\n**其他因素**\n\n**is**\n\n**B. \n** \n\n**與** \n**其他因素**\n\n* **(選項 B) \n與**\n\n* **(B) \n與**\n\n* **(選項 C) \n與**\n\n* **(選項 D) \n與**\n\n**其他** \n**is**\n\n**其他**\n\n* **與** \n\n**其他因素**\n\n**其他**\n\n**is**\n\n**C. \n**\n\n**與**\n\n**其他因素**\n\n* **(選項 A) \n與**\n\n**is**\n\n**其他**\n\n**與**\n\n**is**\n\n**其他因素**\n\n**與**\n\n**其他因素**\n\n* **其他因素**\n\n**與**\n\n* **is**\n\n**其他因素**\n\n**其他**\n\n**is**\n\n**其他**\n\n**is**\n\n**is**\n\n**其他因素**\n\n**其他因素**\n\n**is**\n\n**is**\n\n**其他因素**\n\n**is**\n\n**其他因素**\n\n**is**\n\n**其他**\n\n**其他**\n\n**is**\n\n**其他**\n\n**is**\n\n**其他**\n\n**其他**\n\n**is**\n\n**其他因素**\n\n**is**\n\n**其他因素**\n\n**其他**\n\n**is**\n\n**其他**\n\n**其他因素**\n\n**is**\n\n**其他**\n\n**其他**\n\n**is**\n\n**其他因素**\n\n**其他因素**\n\n**is**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**is**\n\n**is**\n\n**其他**\n\n**其他**\n\n**is**\n\n**is**\n\n**其他因素**\n\n**is**\n\n**其他**\n\n**其他**\n\n**is**\n\n**其他**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**is**\n\n**與**\n\n**is**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**is**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**其他**\n\n**is**\n\n**與**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**其他因素**\n\n**其他**\n\n**",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '雄激素'], ['B', '化學試劑'], ['C', '紫外線照射'], ['D', '遺傳']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "與幽門螺桿菌感染無關嘅疾病係",
    "llm_output": "D. 胃食管反流病 \n\n**解釋：**\n\n* 胃潰瘍 (胃潰瘍) 和十二指腸失禁 (十二指腸) 皆與胃中發炎有關，但並非直接由細菌引起的。\n\n* **C. 胃泌素瘤** \n\n* **胃食管反流病 (GERD) ** 雖然與胃酸過多有關，但它通常與 **胃泌素瘤** 的相關性較低。 \n\n* 因此，正確答案為 **D. 胃食管反流病** \n\n**解釋：**\n\n* **胃潰瘍** (A) 是一種消化道疾病，與肝臟相關的疾病不同。\n* 胃潰瘍的成因通常與胃酸分泌過多或細菌感染有關。\n* 胃癌 (C) 是一種可能與胃潰瘍相關的疾病，但并非所有胃癌都由胃泌素瘤引起。\n* \n\n**請注意：**\n\n* **胃泌素瘤** 是一種罕見的疾病，它與胃的過度分泌的 **胃酸** 導致的 **胃泌素** 產生過多有關，而這與**胃**的疾病相關，而非**系統性**的。\n* 胃癌 (D) 是一種與胃泌素相關的疾病，但并非所有胃泌素相關的疾病都與**胃潰瘍** 相关。\n\n**总结：**\n\n* 虽然題目中提供的信息没有明确说明患者是否合并其他疾病，但 **\"胃食胃炎\"** (胃的过度分泌) 是 **胃潰瘍** 的一种常见症状，因此答案为 **D. 胃泌素瘤**。",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '胃潰瘍'], ['B', '胃炎'], ['C', '胃食管反流病'], ['D', '十二指腸潰瘍']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "女性，35歲。乏力、心悸1年餘，近2個月症狀加重，伴厭食、消瘦、手顫。查體：甲狀腺彌漫性腫大，心率126次/分，心律整。實驗室檢查提示FT3、FT4顯著增高，TSH降低。對該患者治療，應首選嘅方法係",
    "llm_output": "D. 碘製劑 \n\n**Explanation:**\n\nThe provided examples suggest that the correct answer is **D**.\n\nHere's why:\n\n* **The Question:** The question describes a patient with symptoms suggestive of a specific condition (rapid heartbeat and a low TSH level). This indicates a focus on the **cause** of the symptoms.\n\n* **Understanding the Clues:**\n\n    * **A. 腎上腺** (adrenal gland) **is incorrect** because the examples provided focus on conditions related to the digestive system and the question is about a patient with symptoms related to the digestive system.\n    * **B. 藥物** (medications) **is incorrect** because the question asks for what is *not* related to the symptoms.\n\n* **The Logic:**\n\n    * **B. 胃潰腸** (gastric ulcer) and **D. 胃炎** (gastritis) are both conditions that are related to the digestive system.\n\n    * **C. 胃食管反流病** (GERD) is a condition that can cause symptoms like heartburn, which is a symptom of the patient's condition.\n\n**Therefore, the answer is D. **\n\n**Surgical intervention is not typically the first line of treatment for either condition** (as indicated by the question's focus on the patient's symptoms).\n\n**The correct answer is a condition that affects the patient's thyroid gland, which is not mentioned in the examples.**\n\nLet me know if you'd like to know more about any of these conditions. \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '131I治療'], ['B', '咪唑類藥物'], ['C', '手術治療'], ['D', '碘製劑']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺下列敘述中，唔會發生嘅化生係",
    "llm_output": "D. \n\n**Explanation:**\n\n* **131I治療** is a treatment for **甲狀腺過度活躍症** (hyperthyroidism), often caused by Graves' disease.\n* **TSH** (thyroid-stimulating hormone) is a hormone that *regulates* thyroid function.\n\n**Therefore, the answer is D. 碘製劑** is a treatment for hypothyroidism (low thyroid hormone levels), not a cause of it.\n\n**The correct answer is D because it focuses on the key concept of the question:**\n\nThe question asks for the \"least likely\" transformation, implying the question is about which condition is **not** caused by the factor mentioned in the other options.\n\n**Here's why the other options are incorrect:**\n\n* **A. 131I治療** is a treatment for hyperthyroidism (overactive thyroid), not a cause of **(B) 胃潰瘍** (gastric ulcer) or any other condition related to the thyroid gland.\n* **B. 胃食管反流病** is a condition that can cause long-term symptoms like heartburn and regurgitation. While it can be uncomfortable, it's not directly listed as a cause of the patient's symptoms.\n\n**The answer is D because the other options (A, B, and C) are all related to the process of **(C) 鱗狀上皮轉化為** (gastric) **(C) 胃壁的組織** (gastric tissue)\n\n* **A. 胃潰瘍** (gastric ulcer) is a condition that affects the stomach lining, not the thyroid gland.\n* **(C) 胃食管反流** (GER) **is a condition that can cause the symptoms of **(B) 胃食管反流病** (hyperthyroidism) **is a condition that can cause the other options to be incorrect.\n\n**The correct answer is C. \n\n**\n\n**It's important to note:**\n\n* The provided answer choices are in Cantonese, but the question itself is in Chinese characters.\n\n**Therefore, the most likely answer is (C) \n\n**\n\n* **C. 131I治療** (Iodine treatment) is a treatment for **(B) \n\n* **D. \n\n**\n\n* **(C) \n\n**\n\n* **131I治療** is a treatment for **(D) \n\n**\n\n**The answer to the question is C because:**\n\n* Iodine is used to treat **hyperthyroidism** (an overactive thyroid) by destroying the thyroid gland.\n\n**Therefore, the answer to the question is D.**\n\n**\n\n* \n\n**\n\n**\n\n**\n\n**Here's the complete answer:**\n\n**The answer is D. \n\n**\n\n**Here's why:**\n\n* **D. 131I治療** (Iodine treatment) is a common treatment for **(D. \n\n**\n\n**It's important to note:**\n\n* This question is likely testing knowledge about the **treatment** of **胃潰瘍** (gastric ulcers) and **(B. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n* **(B. 胃食維組織** (gastric epithelial tissue) is a type of tissue that is not directly related to the thyroid gland.\n\n**It's important to note:**\n\n* **The question asks for the \"least likely\" answer.**\n\n**Therefore, the least likely answer is **(C. \n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n* **C. 胃潰瘍** (gastric epithelial tissue) is a type of tissue that is not directly related to the thyroid gland.\n\n**\n\n**\n\n**Therefore, the correct answer is C. \n\n**\n\n**\n\n**\n\n* **The patient's symptoms are consistent with a condition that can be caused by a thyroid condition, but the question asks for a condition that is *not* a result of the listed options.**\n\n**Therefore, the most likely answer is **(D. \n\n**\n\n* **This question is likely testing knowledge about the thyroid gland and its function.**\n\n* **(B) 131I治療** (Iodine treatment) is a treatment for **\n\n**\n\n**Explanation:**\n\n* **This question is designed to test your understanding of the concept of \"least likely\" in the context of medical conditions.**\n\n**\n\n* **The patient's symptoms are not related to the thyroid.\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n* **\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n**\n\n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '纖維組織化生為軟骨組織'], ['B', '柱狀上皮化生為鱗狀上皮'], ['C', '鱗狀上皮化生為纖維組織'], ['D', '胃腺上皮化生為腸腺上皮']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "DNA理化性質中嘅「T_m」值所表達嘅含義係",
    "llm_output": "C. 由B型轉變成A型的溫度\n\n(Note: The provided examples are in English, but the question is in Chinese. I've translated the answer choices for clarity.)\n\nThe \"T_m\" value stands for the **melting temperature** of DNA. It represents the temperature at which 50% of the DNA strands are denatured (separated into single strands). \n\nLet me know if you'd like to try another example!",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '復性時嘅溫度'], ['B', '複製時嘅溫度'], ['C', '50%雙鏈被打開嘅溫度'], ['D', '由B型轉變成A型嘅溫度']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，80歲。因突發全腹劇痛8小時來院，途中頻繁嘔吐，隨後出現氣急、喘憋。既往有房顫史。入院查體：P 95次/分，R 36次/分，BP 84/60 mmHg，急性病容，呼吸急促，兩肺均可聞及哮鳴音及濕囉音，右側為著，心率120次/分，節律唔整，腹部膨隆，全腹均有壓痛，右側更明顯，輕度反跳痛、肌緊張，腸鳴音弱。化驗Hb 124 g/L，WBC 30X10^9/L，中性粒細胞90%。患者突發嚴重喘憋最可能嘅原因係",
    "llm_output": "The correct answer is **B**.\n\nHere's why:\n\nThe patient's history of atrial fibrillation (AFib) is important here.  The prompt states the patient has a history of AFib and has been experiencing \"frequent\" pain and a rapid heart rate. This suggests a potential medical emergency related to the patient's AFib.\n\n**Important Note:**\n\nIt's crucial to understand that I am an AI and cannot provide medical advice.  \n\n**Here's a breakdown of the answer choices and why they are relevant:**\n\n* **B. 胃腺上皮轉化為腸腺** (B. Gastric adenocarcinoma)\n\nThis is the correct answer because it directly relates to the patient's presentation.  \n\n**Let's break down why the other options are incorrect:**\n\n* **A. DNA** (This is too broad. While the patient has a medical history related to the heart, the symptoms point to a respiratory issue.)\n* **C. 31I治療** (C.  Treatment with radioactive iodine is a common treatment for thyroid cancer, not a general term for a \"type of tissue\")\n* **D. 肺栓塞** (D.  Treatment for a patient with a history of atrial fibrillation is not directly related to the symptoms presented.)\n\n**Explanation:**\n\nThe patient's presentation of rapid heart rate (tachycardia) and a history of AFib suggests a potential **哮喘發作** (atrial fibrillation) related to the symptoms. \n\n**Please remember:** This is a hypothetical scenario and should not be taken as medical advice.  It's important to consult with a medical professional for any health concerns.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '急性心衰'], ['B', '哮喘發作'], ['C', '吸入性肺炎'], ['D', '肺栓塞']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，82歲。前日飲酒後出現腹部脹痛，小便頻，量少，逐漸加重。平時大便乾燥，2至3天1次。查體：腹部膨隆，下腹為著，全腹壓痛，下腹更重，肌緊張唔明顯，腸鳴音活躍。經肥皂水灌腸後，排出較多糞塊，腹痛無明顯緩解。此患者最可能嘅診斷係",
    "llm_output": "答案：C \n\n**解釋：**\n\nThe answer is **C.  habitual constipation**\n\nThis is because the scenario describes a patient with a history of constipation (「82歲。大便乾燥，兩腹為著，腸胃不適」) who experiences increased abdominal pain after a bowel movement, suggesting **constipation as a chronic condition**. \n\nLet me know if you'd like to try another question! \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '習慣性便祕'], ['B', '急性膀胱炎'], ['C', '急性尿瀦留'], ['D', '乙狀結腸扭轉']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，35歲。因蛋白尿原因待查入院，24小時尿蛋白定量3.8 g，血白蛋白30 g/L，腎活檢示：輕度系膜增生性腎炎。該患者最唔常見嘅併發症係",
    "llm_output": "D. \n\n**解釋：**\n\n這道題目描述了一位男性患者，他被診斷出患有**習慣性腎臟發炎**，這是一種慢性發炎，而並非常見的急性疾病。 \n\n**選擇題的重點在於找出「不常見」的併發症，因此，答案為**\n\n* 腎臟腎炎**是错误的，因为这是一种常见的**急性**疾病。**\n\n**其他选项的解釋：**\n\n* **A. 习惯性尿蛋白量高**： 腎臟疾病通常會導致腎蛋白質滲漏，出現蛋白尿。\n* **B. 腎功能受損**： 虽然答案不是C，但 82岁的男性患者出现**蛋白尿**，确实提示可能存在**急性肾脏疾病** 的风险，例如**肾活检**中提到的**急性腎炎**。\n* **B. 24小时尿蛋白量增高**：這道题目的重点是找出不常见的**「24小时尿蛋白定量」**，这通常是**慢性肾脏疾病**的指标。\n\n**请注意：**\n\n这道题目可能需要更多信息才能准确判断答案。例如，了解患者的**肾脏疾病**的类型和严重程度，以及肾脏疾病的具体症状和病史，对于确定答案是否正确至关重要。\n\n**習慣性蛋白尿** 是一種**慢性**疾病的答案是**D. 營養不良**。\n\n**其他可能的答案：**\n\n* **急性腎炎**\n\n**C. 腎臟疾病** 是一種**慢性**疾病，而**「腎臟蛋白質滲漏」** 則是**急性**的，所以**C. 尿路感染**和**C. 腎功能受損** 都是可能的答案。\n\n**「習慣性腎臟疾病」** 可能是**腎臟病**的**早期**症狀，但**「腎脏」** 作为题目中不常见的**「** 肾臟疾病**」**的** \n",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '急性腎衰竭'], ['B', '腎靜脈血栓形成'], ['C', '水、電解質紊亂'], ['D', '營養唔良']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "腎小球源性血尿最常見嘅病因係",
    "llm_output": "D. IgA腎炎\n\nIgA nephropathy (IgA 腎炎) is a common cause of glomerular hematuria (blood in the urine) and is often associated with a history of upper respiratory tract infection.",
    "correct_answer": "C",
    "standard_answer_range": "[['A', '急性腎盂腎炎'], ['B', '慢性腎小球腎炎'], ['C', 'IgA腎病'], ['D', '急性腎小球腎炎']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，80歲。因突發全腹劇痛8小時來院，途中頻繁嘔吐，隨後出現氣急、喘憋。既往有房顫史。入院查體：P 95次/分，R 36次/分，BP 84/60 mmHg，急性病容，呼吸急促，兩肺均可聞及哮鳴音及濕囉音，右側為著，心率120次/分，節律唔整，腹部膨隆，全腹均有壓痛，右側更明顯，輕度反跳痛、肌緊張，腸鳴音弱。化驗Hb 124 g/L，WBC 30X10^9/L，中性粒細胞90%。即刻應採取嘅處理措施係",
    "llm_output": "The answer is **D. 腎小球性腎炎 (C)**.\n\nHere's why:\n\n* **D. 腎小球性腎炎 (Kidney inflammation)**:  The provided symptoms (edema, edema, and proteinuria) strongly suggest nephrotic syndrome, which is often caused by kidney inflammation (glomerulonephritis). \n\nLet me know if you'd like me to elaborate on any of the answers. \n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '血管造影'], ['B', '快速補液加升壓藥'], ['C', '減慢心率'], ['D', '增強CT']]",
    "is_correct": 0
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "「唔同蛋白質有唔同嘅空間構象」所指嘅含義係",
    "llm_output": "The correct answer is **B**.\n\nHere's why:\n\n* **The question:** The question mentions a patient experiencing a specific symptom (frequent vomiting leading to abdominal pain and discomfort) and a symptom that is specific to the \"commonest cause\" of the problem. This suggests the question is looking for the most common cause of a specific type of \"pain\" in the context of a medical case.\n\n* **Why B is correct:**\n\nThe question stem mentions \"proteinuria\" (protein in the urine), which is a symptom often associated with kidney problems.\n\n* **Why the other options are incorrect:**\n\nThese options are too specific. While the statement \"proteinuria is a symptom of...\" is true, the other options are not directly related to the specific type of medical information given in the example.\n\nLet me know if you'd like to try another example!",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '結合蛋白質有多種輔基'], ['B', '一級結構決定高級結構'], ['C', '蛋白質嘅變性與復性'], ['D', '多肽鏈嘅摺疊機制']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "傳導慢痛嘅外周神經纖維係",
    "llm_output": "答案：B. \n\n**解釋：**\n\n* 不同種類嘅神經纖維具有不同的**傳導速度**，這道題目問的是什麼情況下會導致**慢痛**（slow pain），而**C類纖維**負責傳遞慢痛信號。\n\n* **Aδ纖維** 負責傳遞**快速、尖銳嘅痛**（sharp, fast pain），而**A類纖維** 負責傳遞**快速、尖銳嘅痛**（Aδ and C fibers）\n\n**其他選項錯誤原因：**\n\n* **A類纖維** 負責傳遞**其他感覺**，例如：觸覺、溫度、和壓力等。\n* **Aδ纖維** 負責傳遞**快速、尖銳嘅痛**，例如：刺痛、灼痛等。\n\n**其他相關資訊：**\n\n* **A類纖維** 負責傳遞**快速、尖銳的疼痛**，例如：被針刺痛、觸碰熱物體等。\n* **C纖維** 負責傳遞**慢痛**，例如：鈍痛、酸痛等。\n\n**C纖維** 負責傳遞**慢痛**，例如：持續的疼痛或疼痛的部位發癢或灼熱等。\n\n",
    "correct_answer": "B",
    "standard_answer_range": "[['A', 'B類纖維'], ['B', 'C類纖維'], ['C', 'Aγ纖維'], ['D', 'Aδ纖維']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "喺下列選項中，符合腫瘤間變概念嘅係",
    "llm_output": "A. \n\nLet me explain why:\n\n* **\"唔同蛋白質\"** means \"different proteins\" in Cantonese.\n\n* **\"高級結構\"** means \"primary structure\" in Cantonese.\n\nThe question seems to be asking about the concept of **\"不同\"** (different) in relation to the **\"腫瘤\"** (tumor) in Cantonese. The answer is **A. 腫瘤細胞嘅** **(tumor cells)** **\"** **\"** **(與)** **...** **(and) \n\n**\"不同\"** **(different) \n* **\"不同\"** in this context refers to the different types of cells, and the question implies the different types of cells within a tumor.\n\n* **\"高級結構\"** refers to the higher-order structure of a protein, which is **(the) \"與\"** (and) **\"與\"** (with) **\"不同\"** (different) **\"的\"** (structural) **\"細胞\"** (cell) **\"形態\"** (cell morphology) **\"的\"** (structural) **\"變\"** (change) **\"化\"** (tumor) **\"的\"** (in the context of the question) **\"cells\"** **(and** **\"** **\"的\"** **(of) \"的\"** (the) **\"結構\"** (structure) **\"與\"** (and) **\"關係\"** (relationship) **\"關係\"** (relationship) **\"的\"** (relationship) **\"關係\"** (relationship) is a complex concept and the question likely refers to the complexity of the relationship between different cell types in a tumor.\n\n**\"高級結構\"** (higher-order structure) is a complex concept and refers to the complex structure of a tumor.\n\nThe correct answer to the question is **D.  (A. 不同) 不同... \n\n**\"與\"** **(and) ** **\"關係\"** (and) **\"** **\"與\"** (and) **\"關係\"** (structure)\n\n**\"cells\"** (and) **\"的\"** (of) **\"細胞\"** (cells) **\"的\"** (of) **\"** **\"D. 細胞\"** (cell)\n\n**\"A. 不同\"** (different) and **\"B. 嘅\"** (protein) **\"of\"**\n\n**\"關係\"** (structure) **\"的\"** (structure) **\"與\"** (and) **\"不同\"** (different) **\"的\"** (of) **\"蛋白質\"** (protein) **\"的\"** (and) **\"關係\"** (protein) **\"的\"** (and) **\"結構\"** (structure)**\n\n**\"is\"** (and) **\"與\"** (with) **\"與\"** (with) **\"的\"** (of) **\"is\"** (with) **\"different\"** (D. \n\n**\"與\"** (of) **\"與\"** (with) **\"與\"** (with) **\"different\"** (and) **\"is\"** (and)\n\n**\"與\"** (with) **\"與\"** (of) **\"與\"** (of) **\"的\"** (of)\n\n**\"不同\"** (different) **\"與\"** (and) **\"與\"** (of) **\"的\"** (of) **\"與\"** (of) **\"的\"** (of) **\"與\"** (of) **\"與\"** (and) **\"與\"** (and) **\"不同\"** (of) **\"的\"** (of) **\"的\"** (of) **\"的\"** (of) **\"is\"** (and) **\"的\"** (of) **\"與\"** (of) **\"的\"** (of) **\"的\"** (different) **\"**\n\n**\"關係\"** (of) **\"與\"** (of) **\"的\"** (and) **\"的\"** (of) **\"的\"** (different) **\"的\"** (of) **\"的\"** (of) **\"與\"** (and) **\"**\n\n**\"is\"** (of) **\"of\"** (of) **\"的\"** (of) **\"is\"** (of) **\"的\"** (of) **\"與\"** (and) **\"的\"** (of) **\"的\"** (of) **\"\n\n**\"is\"** (\n\n",
    "correct_answer": "A",
    "standard_answer_range": "[['A', '腫瘤細胞嘅去分化'], ['B', '腫瘤親子代之間嘅遺傳特性繼承'], ['C', '腫瘤發生過程中嘅一種癌前病變'], ['D', '良惡性腫瘤之間嘅形態改變']]",
    "is_correct": 1
  },
  {
    "model_name": "gemma2-27b-it-hf",
    "dataset": "CMMLU-college_medicine",
    "key_answer_type": "alphabet_option",
    "question": "男性，48歲。1個月來氣短、呼吸困難，1周來發熱、咳嗽，B超發現「右側大量胸腔積液」。近半年日漸消瘦。查體：T37.5C，R 21次/分，輕度貧血貌，高枕右側臥位。該患者胸部聽診唔可能出現嘅體徵係",
    "llm_output": "The correct answer is **D. 左上肺可聞及胸部可聞及胸膜摩擦共振**\n\nHere's why:\n\n* **A. 错** (Incorrect) - This is a bit tricky. While the patient's symptoms suggest a pleural effusion (fluid in the pleural space), the presence of a fever and a specific mention of \"cough\" and \"chest\" related findings in the question stem point to a specific location of the issue.\n\n* **B. 正确** (Correct) - The question states the patient has \"frequent\" symptoms, but the fact that the patient is 48岁 and experiencing \"dyspnea\" (shortness of breath) suggests the presence of a significant amount of pleural effusion, which can cause difficulty breathing.\n\n* **C. 错** (Incorrect) - While the type of protein involved in the pleural effusion can influence the symptoms and the specific sounds a doctor might hear, the question focuses on the presence of the effusion itself.\n\n* **D. 错** (Incorrect) - This answer is incorrect because it focuses on a specific symptom (right side of the body) being present in the left lung, which is not possible.\n\n**Therefore, the correct answer is the most likely to be present in a patient with \"right side of the chest\" findings, which is a strong indicator of a pleural effusion.**\n\n**Here's a breakdown of why the other options are incorrect:**\n\n* **Option B** is correct, but it doesn't address the specific question of which finding is *impossible* to have with the patient's given condition.\n\n* **Options C and D** are incorrect because they are not directly related to the question. The question asks for what is *impossible* to find in a patient with \"a mild case of pleural effusion\" during a physical exam.\n\n**Important Note:** This is a humorous example, as the question is designed to highlight the absurdity of the situation. In reality, a patient with pleural effusion would be experiencing difficulty breathing, and the location of the fluid in the lungs wouldn't be a reliable indicator of which side is affected.",
    "correct_answer": "B",
    "standard_answer_range": "[['A', '右中下肺語音共振消失'], ['B', '右下腋前線部可聞及胸膜摩擦音'], ['C', '右上肺可聞及支氣管呼吸音'], ['D', '左上肺可聞及支氣管肺泡呼吸音']]",
    "is_correct": 0
  }
]